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Abstract 
Sarcophytonolides are cembranolide diterpenes isolated from the soft corals of genus 
Sarcophyton. Unified total synthesis of sarcophytonolides C, E, F, G, H, and J and 
isosarcophytonolide D was achieved. The synthetic routes feature NaHMDS- or 
SmI2-mediated fragment coupling, alkoxycarbonylallylation, macrolactonization, and 
transannular ring-closing metathesis. These total syntheses led to the absolute configurational 
confirmation of sarcophytonolide H, elucidation of sarcophytonolides C, E, F, and G, and 
revision of sarcophytonolide J and isosarcophytonolide D. We also evaluated the antifouling 
activity and toxicity of the synthetic sarcophytonolides H and J and their analogues as well as 
the cytotoxicity of the synthetic sarcophytonolides and the key synthetic intermediates. 
Introduction 
Corals are an important group of marine invertebrates and have proven to be a rich source of 
secondary metabolites with a diversity of the chemical structure and biological activity.1 
Among natural products isolated from soft corals, cembranolide diterpenes2 exhibit a variety 
of biological activities such as antibacterial,3 antifouling,4 antiviral,5 cytotoxic,6 ichthyotoxic,7 
and protein tyrosine phosphatase 1B inhibitory activities.8 In addition, it has been reported 
that cembranoid diterpens are implicated in defense of soft corals against predators and 
competition between soft corals and hard corals.1a,9 
Guo and co-workers have isolated sarcophytonolides, cembranolide diterpenes, from the soft 
corals of the genus Sarcophyton collected at Hainan Province in China since 2005.8,10 These 
natural products have a 14-membered carbon skeleton and butenolide unit as common 
structures as described in Figure 1. The gross structure of sarcophytonolide C (1) was 
determined by the 2D NMR analysis and comparison of its NMR data with those of 
brassicolide (5), of which the relative configuration was assigned by X-ray crystallographic 
analysis.6b,10a Although the relative stereochemistries at the C1 and C2 positions of 1 were 
elucidated by NOE observations between H-2 and H-15, the configuration at the C8 position, 
which is a chiral center remote from the C1 and C2 positions, could not be determined. The 
relative configurations at the C6 and C8 positions of sarcophytonolide E (2) were assigned by 
NOE correlations of H-6/H3-19 and analysis of coupling constants and splitting patterns of 
H2-5 in the model wherein a hydrogen bond between the hydroxy and the carbonyl groups is 
formed.10b The relative configurations of sarcophytonolides F (3) and G (4), which have the 
C7/C8 trisubstituted alkenes and the C6 stereoisomeric relationship, were revealed by NOE 
experiments and analysis of their coupling constants of H2-5.10b The relative stereochemistry 
of sarcophytonolide H (6) was clarified by the similarity of 1H and 13C NMR data between 6 
and 3 and NOE observations such as those of H-2/H-14 and H-2/H-15.10b The absolute 
configuration of 6 was determined by applying the modified Mosher method.11 The relative 
stereochemistry of sarcophytonolide D (7) possessing the α-oriented acetoxy group at the C14 
position was elucidated by NOE experiments.10a,12 The relative stereochemistries at the C1, 
C2, and C14 positions of sarcophytonolides I (8),10c J (9),10c and isosarcophytonolide D 
(10)10d were assigned by the analogy of their 1H and 13C NMR data to those of 
sarcophytonolide D (7), whereas the C8 stereochemistry of 9 has remained to be clarified as 
in the case of sarcophytonolide C (1). Among these sarcophytonolides, sarcophytonolides H 
(6) and J (9) display the antifouling activity against the cypris larvae of the barnacle Balanus 
(Amphibalanus) amphitrite with EC50 values of 5.9813 and 7.50 μg/mL,14 respectively. 
Interestingly, there is also a report wherein sarcophytonolide J (9) has no inhibitory activity 
against the larval settlement of the same barnacle.13 In 2013, as a preliminary communication, 
we reported the total synthesis of two possible diastereomers of sarcophytonolide C (1), 
which resulted in the absolute configurational determination of this natural product.15a,16 In 
2016, we also reported the total synthesis of sarcophytonolide H (6) and isosarcophytonolide 
D (10, proposed structure), which culminated in the absolute stereochemical confirmation of 6 
and revision of 10.15b In this full paper, we disclose the unified total synthesis of 
sarcophytonolides C, E, F, G, H, and J and isosarcophytonolide D by using NaHMDS- or 
SmI2-mediated fragment coupling, alkoxycarbonylallylation, macrolactonization, and 
transannular ring-closing metathesis (RCM) as key steps. These total syntheses culminated in 
the absolute stereochemical confirmation of sarcophytonolide H, determination of 
sarcophytonolides C, E, F, and G, and revision of sarcophytonolide J and isosarcophytonolide 
D. Furthermore, we report the cytotoxicity of the synthetic sarcophytonolides and the key 
synthetic intermediates, and the antifouling activity and toxicity of the synthetic 
sarcophytonolides H and J and their analogues. 
Figure 1. Structures of selected sarcophytonolides and brassicolide. 
Results and Discussion 
Retrosynthetic Analysis of 1a and 1b. Toward the absolute configurational determination 
of natural sarcophytonolide C (1), we decided to synthesize 1a and 1b (Scheme 1), which are 
two possible diastereomers of this natural product. In the retrosynthetic analysis, we designed 
hydroxycarboxylic acids 11a and 11b as the key synthetic intermediates to construct the 
cembranolide frameworks of 1a and its C8 epimer 1b by macrolactonization17 and subsequent 
transannular RCM18, respectively.19 We hypothesized that the macrolactonization precursors 
11a,b could possibly supplied by the connection of sulfone 12, allylic bromides 13a and 13b, 
and 2-alkoxycarbonyl allylic metal reagent 14. The chiral pool synthesis starting from (S)- 
and (R)-citronellols could provide the allylic bromides 13a,b, respectively. We envisioned that 
this retrosynthetic bond-disconnection could be also applied to the synthesis of C6 
hydroxylated and/or C14 acetoxylated sarcophytonolides. Moreover, the use of geraniol and 
nerol instead of citronellol as starting materials would potentially lead to the total synthesis of 
sarcophytonolides bearing the C7/C8 trisubstituted alkene moieties. 
Scheme 1. Retrosynthetic Analysis of 1a and 1b 
Total Synthesis of Two Possible Diastereomers 1a and 1b of Sarcophytonolide C (1). 
First, we investigated the enantioselective synthesis of sulfone 20 (Scheme 2). Monosilylation 
of cis-2-butene-1,4-diol with tert-butyldimethylsilyl chloride (TBSCl) followed by Sharpless 
asymmetric epoxidation20 with (+)-diethyl tartrate (DET) gave epoxy alcohol 15 in 86% yield. 
The enantiomeric ratio of 17:1 was assigned by the 1H NMR spectra of (S)- and 
(R)-α-methoxy-β-(trifluoromethyl)phenylacetyl (MTPA) esters prepared from 15. The 
epoxide 15 reacted with isopropenylmagnesium bromide in the presence of CuBr∙SMe221 to 
provide 1,3-diol 16, regioselectively.22 Hydrogenation of the alkene 16 with (Ph3P)3RhCl and 
subsequent selective thioetherification of diol 1723 with (PhS)2/n-Bu3P afforded sulfide 18. 
After the alcohol 18 was protected as the TBS ether, sulfide 19 was oxidized to furnish the 
sulfone 20.24 
Scheme 2. Synthesis of Sulfone 20 
Next, connection of the sulfone 20 and allylic bromides 21a and 21b, which were 
synthesized from (S)- and (R)-citronellols,25 was examined (Scheme 3). Thus, the anion 
derived from 20 with sodium hexamethyldisilazide (NaHMDS) was treated with the optically 
active 21a and 21b to produce the coupling products 22a and 22b in 88% and 91% yields, 
respectively. Reductive removal of the sulfonyl groups of 22a,b under Birch conditions,26 
wherein the pivaloyl (Piv) groups were partially removed,27 and protection of the resulting 
alcohols afforded the corresponding pivalates. The primary TBS ethers were selectively 
deprotected with camphorsulfonic acid (CSA) to give alcohols 23a and 23b. Oxidation of 
23a,b with 2,2,6,6-tetramethylpiperidinyloxyl (TEMPO)/PhI(OAc)228 and subsequent Wittig 
reaction yielded alkenes 24a and 24b. Reductive deprotection of the pivalates 24a,b was 
carried out with diisobutylaluminum hydride (DIBAL-H) to provide alcohols 25a and 25b. 
Scheme 3. Synthesis of Alcohols 25a and 25b 
We next tried to synthesize the macrolactonization precursors 30a and 30b as shown in 
Scheme 4. The alcohols 25a,b were oxidized with TEMPO/PhI(OAc)228 and the resulting 
aldehydes were treated with ethyl (2-bromomethyl)acrylate (26)/Zn dust in THF/aqueous 
NH4Cl29 to furnish the desired homoallylic alcohols 27a and 27b in 79% and 93% yields in 
two steps as 1:1 diastereomeric mixtures, respectively. After the resulting hydroxy groups of 
27a,b were protected as the methoxymethyl (MOM) ethers, the TBS moieties of 28a and 28b 
were removed with tetrabutylammounium fluoride (TBAF) to give alcohols 29a and 29b. 
Alkaline hydrolysis of the ethyl esters 29a,b with LiOH∙H2O afforded hydroxycarboxylic 
acids 30a and 30b. 
Scheme 4. Synthesis of Hydroxycarboxylic Acids 30a and 30b 
Scheme 5. Completion of the Total Synthesis of 1a and 1b 
With the macrolactonization precursors 30a and 30b in hand, we next investigated the 
construction of the cembranolide framework and completion of the total synthesis. Thus, the 
hydroxycarboxylic acids 30a,b were subjected to the Shiina macrolactonization conditions 
with 2-methyl-6-nitrobenzoic anhydride (MNBA)17,30 to give 15-membered macrolactones 
31a and 31b in 85% and 78% yields, respectively (Scheme 5). After the MOM ethers 31a,b 
were deprotected with BF3∙OEt2/Me2S,31 transannular RCM18 of 32a and 32b was conducted 
by using the second-generation Hoveyda–Grubbs catalyst (33)32 to produce butenolides 34a 
and 34b.33,34 In these reactions, the prolonged reaction time caused the formation of 
byproducts, therefore the starting materials 32a and 32b were recovered in 38% and 37% 
yields, respectively. Finally, TPAP (tetra-n-propylammonium perruthenate) oxidation35 of 
34a,b provided the target molecules 1a and 1b in 27% (43% based on recovered 32a) and 
30% (48% based on recovered 32b) in two steps, respectively.36 
Absolute Configuration of Sarcophytonolide C (1). Having succeeded in the total 
synthesis of 1a and 1b, we analyzed their 2D NMR spectra and assigned the signals in 
their 1H and 13C NMR spectra. Tables 1 and 2 depict the chemical shifts and their differences 
of natural sarcophytonolide C (1)10a and the synthetic products 1a and 1b in the 1H and 13C 
NMR spectra, respectively. The 1H and 13C NMR data of 1a were in excellent agreement with 
those of natural sarcophytonolide C (1), meanwhile the 1H and 13C NMR data of 1b were 
clearly different from those of natural product 1. It was found that there were critical 
differences of the chemical shifts between the natural product and the synthetic 1b at the C7, 
C8, and C9 positions in the 1H NMR data and at the C9, C10, and C11 positions in the 13C 
NMR data. The sign of specific rotation of the synthesized 1a, [α]D29 = +92.2 (c = 0.19, 
CHCl3), was same as that of the data reported for the natural product, [α]D20 = +31.0 (c = 0.20, 
CHCl3).10a,37 Therefore, the absolute configuration of sarcophytonolide C (1) isolated from 
nature was clarified to be 1S, 2S, and 8S as shown in 1a. 
Table 1. 1H NMR Chemical Shifts and Their Deviations of Natural Sarcophytonolide C 
(1) and the Synthetic Products 1a and 1ba 
position 1b 1a 1b Δ(δ1–δ1a) Δ(δ1–δ1b) 
1 1.46 1.47 1.51 –0.01 –0.05 
2 4.81 4.81 4.85 0.00 –0.04 
3 7.26 7.26 7.28 0.00 –0.02 
5 3.50 3.50 3.39 0.00 +0.11 
 3.16 3.16 3.20 0.00 –0.04 
7 2.37 2.37 2.56 0.00 –0.19 
 2.37 2.37 2.09 0.00 +0.28 
8 1.74 1.74 1.87 0.00 –0.13 
9 1.38 1.37 1.42 +0.01 –0.04 
 1.36 1.37 1.20 –0.01 +0.16 
10 2.12 2.11 2.05 +0.01 +0.07 
 1.95 1.94 2.05 +0.01 –0.10 
11 4.97 4.97 5.05 0.00 –0.08 
13 2.10 2.10 2.03 0.00 +0.07 
 1.93 1.94 2.03 –0.01 –0.10 
14 1.58 1.59 1.56 –0.01 +0.02 
 1.14 1.14 1.18 0.00 –0.04 
15 2.08 2.10 2.05 –0.02 +0.03 
16 0.99 1.00 1.03 –0.01 –0.04 
17 1.00 1.01 1.04 –0.01 –0.04 
19 0.93 0.93 0.92 0.00 +0.01 
20 1.60 1.61 1.59 –0.01 +0.01 
aNMR spectra of the natural product and the synthetic products were recorded at 400 MHz. 
Chemical shifts are reported in ppm with reference to the internal residual solvent (CDCl3, 
7.26 ppm). bData from reference 10a. 
Table 2. 13C NMR Chemical Shifts and Their Deviations of Natural Sarcophytonolide C 
(1) and the Synthetic Products 1a and 1ba 
position 1b 1a 1b Δ(δ1–δ1a) Δ(δ1–δ1b) 
1 45.8 45.9 45.8 –0.1 0.0 
2 83.7 83.6 83.3 +0.1 +0.4 
3 151.3 151.1 152.0 +0.2 –0.7 
4 127.4 127.4 128.2 0.0 –0.8 
5 40.3 40.3 39.9 0.0 +0.4 
6 205.9 205.7 205.8 +0.2 +0.1 
7 50.0 50.0 50.1 0.0 –0.1 
8 28.6 28.6 28.4 0.0 +0.2 
9 35.7 35.7 36.8 0.0 –1.1 
10 24.3 24.4 25.3 –0.1 –1.0 
11 127.1 127.0 128.2 +0.1 –1.1 
12 133.9 133.8 133.3 +0.1 +0.6 
13 38.7 38.8 38.2 –0.1 +0.5 
14 23.2 23.3 23.6 –0.1 –0.4 
15 29.5 29.6 29.4 –0.1 +0.1 
16 18.4 18.5 19.3 –0.1 –0.9 
17 19.9 20.0 19.8 –0.1 +0.1 
18 172.8 172.6 172.7 +0.2 +0.1 
19 20.7 20.7 19.9 0.0 +0.8 
20 16.1 16.1 16.0 0.0 +0.1 
aNMR spectra of the natural product and the synthetic products were recorded at 100 MHz. 
Chemical shifts are reported in ppm with reference to the internal residual solvent (CDCl3, 
77.0 ppm). bData from reference 10a. 
Calculations for 1a and 1b were carried out using density functional theory (DFT) 
calculations at the ωB97X-D/6-31G* level. Conformational analysis and geometry 
optimization of 1a and 1b were performed with the package SPARTAN’16 (Wavefunction 
Inc., Irvine, CA). As described in Figure 2, in the calculated most stable conformer of 1a, the 
C8 carbon is located more inside the macrocycle structure in comparison with the case of the 
most stable conformer of 1b, which seems to make the distances between C1/C2 and C8 in 1a 
shorter than those in 1b. This conformational difference of 1a and 1b may have resulted in the 
deviation in their NMR data in spite of the C8 stereocenter remote from the C1 and C2 
positions. 
Figure 2. Calculated lowest-energy conformers of 1a (above) and 1b (below). 
Total Synthesis of Sarcophytonolide E (2). Next, we examined the stereoselective 
synthesis of sarcophytonolide E (2) possessing the chiral alcohol moiety at the C6 position. 
First, we surveyed the reaction conditions in asymmetric alkoxycarbonylallylation of the 
aldehyde prepared from the alcohol 25a and it was proven that treatment of the aldehyde with 
chiral allylic boronate 3538 in toluene at room temperature provided the desired alcohol 36 in 
a 4.4:1 diastereomeric ratio (Scheme 6).22 Further transformation from 36 to sarcophytonolide 
E (2) was identical to that used for the total synthesis of 1a and 1b. Thus, MOM protection of 
the resulting hydroxy group of 36 and removal of the TBS moiety afforded alcohol 37. 
Alkaline hydrolysis of the ethyl ester 37 followed by Shiina macrolactonization17,30 yielded 
15-membered macrolactone 38. Deprotection of the MOM ether 38 with BF3∙OEt2/Me2S31 
and subsequent transannular RCM18 produced sarcophytonolide E (2).39 The 1H and 13C NMR 
data and the specific rotation of the synthesized 2 were in good accordance with those of the 
natural product,10b,40 which elucidated the absolute stereochemistry of natural 
sarcophytonolide E to be that described in 2. 
Scheme 6. Total Synthesis of Sarcophytonolide E (2) 
Total Synthesis of Sarcophytonolides F (3) and G (4). Having completed the total 
synthesis of 1a, 1b, and 2 bearing the chiral centers at the C8 positions, we next investigated 
the stereoselective synthesis of sarcophytonolides F (3) and G (4) with the C7/C8 
(E)-trisubstituted alkene portions. First, as shown in Scheme 7, the synthesis of allylic 
bromide 41, which is a coupling partner of the sulfone 20, was carried out. Protection of 
geraniol with PivCl gave pivalate 39. Treatment of 39 with SeO2/TBHP/salicylic acid41 
provided the mixture of allylic alcohol 40 and the corresponding α,β-unsaturated aldehyde. 
The mixture was treated with NaBH4 to afford the allylic alcohol 40 in 57% yield in two steps. 
The structure of 40 was confirmed by NOE observations of H2-1/H-3. The allylic alcohol 40 
was converted to the allylic bromide 41 with CBr4/PPh3. 
Scheme 7. Synthesis of Allylic Bromide 41 
We next tried the connection of the sulfone 20 and the allylic bromide 41, and 
transformation to sarcophytonolides F (3) and G (4). Thus, the sulfone 20 was coupled with 
the allylic bromide 41 in the presence of NaHMDS to afford the desired product 42 (Scheme 
8). After deprotection of the pivalate 42 with DIBAL-H, reductive desulfonylation was 
conducted under Birch conditions26 to give alcohol 43 in 79% yield in two steps.42 The 
alcohol 43 was converted to alkene 45 by the following sequence: 1) protection as the pivalate, 
2) selective removal of the primary TBS moiety, 3) TEMPO oxidation28 of alcohol 44, 4) 
Wittig methylenation, and 5) deprotection of the pivalate. The aldehyde, synthesized from the 
alcohol 45, was treated with the chiral allylic boronate 3538 to result in the diastereoselective 
formation of alcohol 46 in a 17:1 ratio.22 After protection of the alcohol 46 and subsequent 
desilylation, hydrolysis of 47 and Shiina lactonization17,30 were carried out to afford 
macrolactone 48. Transannular RCM18 of the tetraene 48 proceeded smoothly in the presence 
of the second-generation Hoveyda–Grubbs catalyst (33),32 wherein two trisubstituted alkene 
portions of 48 were inert to the reaction conditions, to produce the corresponding butenolide 
in 76% yield. Finally, the MOM protecting group was cleaved with trimethylsilyl iodide 
(TMSI)/HMDS43,44 to furnish sarcophytonolide F (3). We next tried to transform 
sarcophytonolide F (3) to sarcophytonolide G (4) by stereoinversion at the C6 position. 
Mitsunobu reaction45 of 3 with p-nitrobenzoic acid/diethyl azodicarboxylate (DEAD)/Ph3P46 
followed by alkaline hydrolysis with Na2CO3 in MeOH provided sarcophytonolides G (4) 
and F (3) in 31% and 13% yields in two steps, respectively. The formation of 3 was caused by 
the esterification with stereoretention in the first step.47 Changing reaction temperature and 
carboxylic acid in Mitsunobu reaction45 could not improve the chemical yield of 4. Therefore, 
we next examined the stereoselective reduction of the ketone. Treatment of the allylic alcohol 
3 with Dess–Martin periodinane48 gave α,β-unsaturated ketone 49. Corey–Bakshi–Shibata 
(CBS) reduction49 using (R)-Me-CBS/BH3∙SMe2 was applied to 49 to result in the formation 
of 4 and 3 in a 1:1 diastereomeric ratio. After investigation of the reaction conditions, 
fortunately, Luche reduction conditions50 in MeOH/CH2Cl2 was found to be effective and 
sarcophytonolide G (4) was produced in 72% yield as a sole product. Although the detailed 
conformational analysis of 49 was not conducted, the stereochemical outcome in this Luche 
reduction is understandable by the formation of chelation structure as described in Figure 3. 
In this structure, the proton of methanol could coordinate to two carbonyl oxygens at the C6 
and C18 positions and hydride could approach from the outside of the macrocyclic structure. 
Detailed comparison of the NMR data and specific rotations between the natural products10b 
and the synthetic products in 3 and 4 revealed the absolute configurations of natural 
sarcophytonolides F and G to be those shown in 3 and 4, respectively.40 
Scheme 8. Total Synthesis of Sarcophytonolides F (3) and G (4) 
Figure 3. Plausible rationale for the configurational outcome in Luche reduction of ketone 49. 
Total Synthesis of Sarcophytonolide H (6). We next focused on the total synthesis of 
sarcophytonolides possessing the acetoxy groups at their C14 positions. First, we tried to 
synthesize sarcophytonolide H (6). We initially envisioned that the oxygen-functional group at 
the C14 position could be introduced by oxidative desulfurization of the sulfone 42, which is 
the synthetic intermediate of the total synthesis of sarcophytonolides F (3) and G (4). Actually, 
deprotonation of 42 with n-BuLi or lithium diisopropylamide (LDA) and subsequent 
treatment with Davis oxaziridine (50)51 or bis(trimethylsilyl)peroxide52 did not produce the 
desired ketone 51 (Scheme 9). Therefore, we planned to introduce the C14 oxymethyne 
moiety by other fragment couplings. Our synthesis of the C14 stereoisomers 53a and 53b, 
wherein the SmI2-mediated reaction53 was used as the fragment coupling, is described in 
Scheme 10. Selective acetylation of the diol 16 followed by TBS protection of the resulting 
secondary alcohol gave the corresponding silyl ether. Reductive deprotection of the acetate 
with DIBAL-H afforded the alcohol, which was oxidized to aldehyde 52 with 
TEMPO/PhI(OAc)2.28 The aldehyde 52 was connected with the allylic bromide 41 by using 
SmI253,54 to furnish the desired α-adducts 53a and 53b in 53% and 40% yields, respectively. It 
is noteworthy that the coupling was successful by using 1.2 equiv of the allylic bromide 41 to 
the aldehyde 52 and the corresponding γ-allylated product was not formed at all.55 The 
observed NOEs of H-11/H2-13 of 53a and 53b confirmed the geometries at their C11/C12 
alkene portions, respectively. The stereochemistry at the C14 position of 53a was determined 
by the modified Mosher method.11,40 
Scheme 9. Unsuccessful Attempt for Oxidative Desulfurization of Sulfone 42 
Scheme 10. Synthesis of Alcohols 53a and 53b 
Scheme 11. Total Synthesis of Sarcophytonolide H (6) 
Further transformation toward the total synthesis of sarcophytonolide H (6) is depicted in 
Scheme 11. Thus, protection of the hydroxy group of 53a with MOMCl and subsequent 
selective removal of the primary TBS moiety gave the corresponding alcohol. Introduction of 
the terminal alkene portion followed by deprotection of the obtained pivalate 54 afforded 
alcohol 55. TEMPO oxidation28 of 55 and reaction of the aldehyde with the chiral boronate 
3538 provided the desired allylated product 56 in 88% yield in two steps in a diastereomeric 
ratio of 13:1. After the C6 hydroxy group of 56 was protected as the p-methoxybenzyl (PMB) 
ether, the TBS ether underwent deprotection and hydrolysis of the ester to yield 
hydroxycarboxylic acid 58. Shiina macrolactonization17,30 and subsequent transannular 
RCM18 were successfully performed to produce the corresponding butenolide. The obtained 
MOM ether was selectively deprotected with HCl in i-PrOH56 to provide alcohol 60. Finally, 
acetylation of the alcohol 60 and removal of the PMB moiety with 
2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) took place to furnish sarcophytonolide H 
(6). The synthetic sarcophytonolide H (6) was in full agreement with the natural product in 
the 1H and 13C NMR data and the specific rotation.10b,40 Therefore, the absolute configuration 
of natural sarcophytonolide H was confirmed as shown in 6. 
Total Synthesis and Structural Revision of Isosarcophytonolide D. We next investigated 
synthesis of the proposed structure 10 of isosarcophytonolide D with the 14R stereochemistry. 
Thus, as shown in Scheme 12, the alcohol 53b was converted to 10 in 15 steps by a synthetic 
route similar to that used toward the total synthesis of sarcophytonolide H (6).57 Having 
synthesized the proposed structure 10 of isosarcophytonolide D, we analyzed the 2D NMR 
data of the synthetic product 10. As a result, the significant differences in the 1H and 13C 
NMR data between natural isosarcophytonolide D10d and the synthesized 10 were observed.40 
The detailed comparison revealed that the chemical shift deviations were especially critical 
around the C14 position (Figure 4). We also considered that the stereochemistries at the C1 
and C2 positions of isosarcophytonolide D would be same as those of other sarcophytonolides. 
Therefore, we predicted the correct structure of isosarcophytonolide D isolated from nature to 
be that drawn in 68, which is the C14 stereoisomer of 10 (Scheme 13). The predicted structure 
68 was synthesized by oxidation of the synthetic sarcophytonolide H (6) with Dess–Martin 
periodinane.48 As anticipated, the 1H and 13C NMR data and the specific rotation of the 
synthetic 68 matched those of the natural product.10d,40 Therefore, the absolute configuration 
of natural isosarcophytonolide D was reassigned to be that shown in 68.58 
Scheme 12. Total Synthesis of the Proposed Structure 10 of Isosarcophytonolide D 
Figure 4. Deviations of the 13C NMR chemical shifts between natural isosarcophytonolide D 
and the synthetic product 10 (Δδ = δN – δ10 in ppm). N = natural product. The x and y axes 
represent the carbon number and Δδ, respectively. 
Scheme 13. Synthesis of the Predicted Structure 68 of Isosarcophytonolide D 
Structural Prediction, Total Synthesis, and Structural Determination of 
Sarcophytonolide J. As noted in Introduction, the relative configurations at the C1, C2, and 
C14 positions of natural sarcophytonolides I (8), J (9), and isosarcophytonolide D (10) were 
determined by the similarity of their NMR data to those of sarcophytonolide D (7). This way 
of structural assignment and the stereochemical revision at the C14 position of 
isosarcophytonolide D indicate that the C14 stereochemistries of sarcophytonolides D (7), I 
(8), and J (9), which were originally assigned as 14R, should be also reexamined. Therefore, 
we next decided to verify the stereostructure of sarcophytonolide J (9, Figure 5a), of which 
the C8 configuration was not identified. First, in order to predict the C14 stereochemistry of 
sarcophytonolide J, we compared the 1H and 13C NMR data of natural sarcophytonolide J10c 
with those of the synthetic products 68 (revised structure of isosarcophytonolide D) and 10 
(C14 epimer of 68).40 Deviations of the 13C NMR chemical shifts at the C1, C2, C13, and C14 
positions between natural sarcophytonolide J and the synthetic products 68 and 10 are 
graphically depicted in Figure 5b. From these comparisons, it was found that the chemical 
shift differences between natural sarcophytonolide J and 68 were smaller than those between 
natural sarcophytonolide J and 10. In addition, for the prediction of the C8 stereochemistry of 
sarcophytonolide J, the 1H and 13C NMR data between natural sarcophytonolide J10c and the 
synthetic products 1a (sarcophytonolide C) and 1b (C8 epimer of 1a) were compared.40 As a 
result, it was elucidated that the chemical shift characteristics at the C7 to C10 positions of 1a 
were more similar to those of 1b. Taken together, we could propose the predicted structure 69 
of sarcophytonolide J (Figure 6), which bears the 8S and 14S absolute configurations same as 
those of 1a and 68. 
Figure 5. (a) Structures of 9, 68, 10, 1a, and 1b. (b) Deviations of the 13C NMR chemical 
shifts between natural sarcophytonolide J and the synthetic products (Δδ = δN – δS in ppm). N 
= natural product. S = synthetic product. The x and y axes represent the carbon number and 
Δδ, respectively. 
Figure 6. Predicted structure 69 of sarcophytonolide J. 
Scheme 14. Total Synthesis of the Predicted Structure 69 of Sarcophytonolide J 
In order to confirm our stereostructural prediction of sarcophytonolide J as discussed above, 
we commenced the total synthesis of the predicted structure 69. Sequence of the 
transformation toward 69 was similar to that used toward the total synthesis of 
sarcophytonolide H (6). Thus, SmI2-mediated reaction of the aldehyde 52 and the allylic 
bromide 21a gave the desired product 70a and its C14 epimer 70b in 29% and 40% yields, 
respectively (Scheme 14). The absolute stereochemistry at the C14 position of 70a was 
verified by its derivatization and NOE experiments.40 Subsequently, the alcohol 70a was 
transformed to our predicted structure 69 of sarcophytonolide J in overall 16 steps. As 
expected, the synthetic 69 provided the 1H and 13C NMR data and the specific rotation which 
were identical to those reported for natural sarcophytonolide J.10c,40 These findings clearly 
revealed that our stereochemical prediction of sarcophytonolide J is correct and this natural 
product possesses the 8S and 14S absolute configurations as shown in 69. 
Cytotoxicity of the Synthetic Products. Having successfully completed the total synthesis 
and established the stereostructures of sarcophytonolides, we next turned our attention to 
assessment of the biological activity of the synthetic products. First, we evaluated the 
growth-inhibitory activity by using the MTT assay with HL60 human leukemia cells. The 
cells were treated in 96-well plates with various concentrations of the synthetic compounds 
for 72 h. As described in Table 3, interestingly, the synthetic sarcophytonolide C (1a) was 
inactive, whereas 8-epi-sarcophytonolide C (1b) inhibited the growth of the cells with an IC50 
value of 18.9 μM, which indicates that the activity is affected by the C8 stereochemistries. 
Compared to 1a, 1b was observed to be more soluble in water, which may also contribute to 
the growth-inhibitory activity. Sarcophytonolide E (2), which possesses the C6 alcohol moiety, 
exhibited the activity with an IC50 value of 33.0 μM. Sarcophytonolide F (3) bearing the 
C7/C8 trisubstituted alkene group showed the activity similar to that of 2 (IC50 = 35.9 μM). 
Introduction of the C14 acetoxy moiety was found to lower the inhibitory activity by 
comparing IC50 values of sarcophytonolides F (3, 35.9 μM) and H (6, 53.5 μM). Since 
8-epi-sarcophytonolide C (1b) was the most active among five sarcophytonolides, the key 
synthetic intermediates of 1b were next biologically evaluated. The cytotoxic activity of the 
butenolide construction precursor 32b (IC50 = 13.7 μM) was slightly improved in comparison 
with that of 1b. The macrolactonization precursor 30b and the alcohol 25b retained the 
activity, while their activities were decreased to IC50 values of 55.8 and 24.0 μM, 
respectively. 
Table 3. Growth-Inhibitory Activity against HL60 Human Leukemia Cellsa 
compound IC50 
1a >100 
1b 18.9 
2 33.0 
3 35.9 
6 53.5 
32b 13.7 
30b 55.8 
25b 24.0 
aIC50 values are given in μM 
Antifouling Activity and Toxicity of the Synthetic Products. Since sarcophytonolides H 
(6) and J (69) which were isolated from nature are reported to be antifouling active against the 
cypris larvae of barnacle Balanus (Amphibalanus) amphitrite,13,14 we next evaluated the 
antifouling activity59 and toxicity of the synthetic sarcophytonolides H (6) and J (69) and their 
analogues against the cypris larvae of the same barnacle. The larvae were treated in 24-well 
polystyrene plates with various concentrations of the synthetic compounds in the dark for 96 h 
and the results are summarized in Table 4. The synthetic sarcophytonolide H (6) displayed the 
antifouling activity with an EC50 value of 3.36 μg/mL, which was in good agreement with 
that of the natural product (5.98 μg/mL).13 Diol 7960 retained the antifoulant activity (EC50 = 
3.08 μg/mL), which indicates the acetyl group of 6 has little influence on this activity. The 
antifouling activity of the butenolide construction precursor 8060 was marginally increased in 
comparison with those of 6 and 79 (EC50 = 1.61 μg/mL). The hydroxycarboxylic acid 58 
turned out to be antifouling active (EC50 = 3.27 μg/mL), while the alkoxycarbonylallylation 
precursor 55 exhibited no antifouling activity. Furthermore, the toxicity was also evaluated 
and it was found that 58 was weak toxic (LC50 = 19.4 μg/mL) and other compounds 6, 79, 80, 
and 55 had no toxicity. In addition to the sarcophytonolide H series, we next evaluated the 
biological activity of the synthetic sarcophytonolide J (69) and its synthetic intermediates. The 
synthetic sarcophytonolide J (69), the triene 76, and the hydroxyester 74 were antifouling 
active with EC50 values of 0.95–2.36 μg/mL without regard to difference of the molecular 
framework. Interestingly, alcohol 81 also showed the antifoulant activity (EC50 = 1.74 μg/mL) 
in contrast to the allylic alcohol 55 in the sarcophytonolide H series. In the sarcophytonolide J 
series, only compound 69 displayed the weak toxicity with a LC50 value of 34.5 μg/mL and 
other compounds 76, 74, and 81 were non-toxic. These obtained results of the biological 
activity assessment shown in Table 4 denote that the triene 76, which exhibited the strongest 
antifouling activity and no toxicity, is a promising candidate for the creation of 
environmentally friendly antifouling agents. 
Table 4. Antifouling Activity (EC50) and Toxicity (LC50) of the Synthetic 
Sarcophytonolides H (6) and J (69) and Their Analoguesa 
compound EC50 LC50 
6 3.36 >50 
79 3.08 >50 
80 1.61 >50 
58 3.27 19.4 
55 >50 >50 
69 1.50 34.5 
76 0.95 >50 
74 2.36 >50 
81 1.74 >50 
aAgainst the cypris larvae of barnacle Balanus (Amphibalanus) amphitrite. EC50 and LC50 
values are given in μg/mL. 
Conclusion 
Unified total synthesis of sarcophytonolides, cembranolide diterpenes isolated from the soft 
corals of genus Sarcophyton, was accomplished. In their synthetic routes, NaHMDS-mediated 
reaction of allylic bromide/sulfone in methylene series at the C14 position and SmI2-mediated 
reaction of allylic bromide/aldehyde in acetoxymethyne series at the C14 position were 
utilized as the fragment couplings, respectively. In addition, the total synthesis features 
alkoxycarbonylallylation, macrolactonization, and transannular RCM. Because the chirality at 
the C8 position of sarcophytonolide C (1) was not determined, the C8 stereoisomers 1a and 
1b were stereoselectively synthesized, which elucidated the absolute configuration of natural 
1 to be that as drawn in 1a. Stereoselective total synthesis of sarcophytonolides E (2), F (3), G 
(4), and H (6) culminated in the absolute stereochemical determination of 2, 3, and 4 and 
confirmation of 6. Furthermore, total synthesis of the proposed structure 10 and the predicted 
structure 68 of isosarcophytonolide D revealed the correct structure of this natural product to 
be that in 68. This stereochemical revision at the C14 position of isosarcophytonolide D and 
the stereostructural elucidation of sarcophytonolide C led us to the stereochemical prediction 
of sarcophytonolide J. Total synthesis of the predicted structure 69 of this natural product 
verified the correct structure of natural sarcophytonolide J. After completing the total 
synthesis of sarcophytonolides, we assayed the cytotoxicity of selected synthetic products 
against HL60 cells and found that 1b, 2, 3, 6, 32b, 30b, and 25b showed the cytotoxicity, 
while 1a was inactive. Moreover, we conducted evaluation of the antifouling activity and 
toxicity of the synthetic sarcophytonolides H (6) and J (69) and their synthetic analogues 
against the cypris larvae of barnacle Balanus (Amphibalanus) amphitrite. The obtained 
findings suggest that 76, a synthetic intermediate of 69, is a good candidate for further 
developing environmentally benign antifouling compounds. Further synthetic study of other 
classes of cembranolide is currently underway. 
Experimental Section 
General Methods. Reagents were used as received from commercial suppliers unless 
otherwise indicated. All reactions were carried out under an atmosphere of argon. Reaction 
solvents were purchased as dehydrated solvents and stored with active molecular sieves 4Å 
under argon prior to use for reactions. All solvents for work-up procedure were used as 
received. Analytical thin-layer chromatography (TLC) was performed with aluminium TLC 
plates (Merck TLC silica gel 60F254). Column chromatography was performed with Fuji 
Silysia silica gel BW-300 or Kanto Chemical silica gel 60N. Optical rotations were recorded 
on a JASCO DIP-1000. IR spectra were recorded on a JASCO FT/IR-460 plus. 1H and 13C 
NMR spectra were recorded on JEOL JNM-AL400 or Varian 400-MR. Chemical shifts in the 
NMR spectra are reported in ppm with reference to the internal residual solvent (1H NMR, 
CDCl3 7.26 ppm, C6D6 7.15 ppm; 13C NMR, CDCl3 77.0 ppm, C6D6 128.0 ppm). The 
following abbreviations are used to designate the multiplicities: s = singlet, d = doublet, t = 
triplet, q = quartet, m = multiplet, br = broad. Coupling constants (J) are in hertz. High 
resolution mass spectra were recorded on a Micromass LCT (ESI–TOF–MS) spectrometer. 
TBS Ether S1. To a solution of cis-2-butene-1,4-diol (5.5 mL, 66.9 mmol) in DMF (67 mL) 
were added imidazole (4.55 g, 66.9 mmol) and TBSCl (10.1 g, 66.9 mmol) at –30 °C. The 
mixture was stirred at the same temperature for 2 h. The mixture was diluted with EtOAc, 
washed with H2O and brine, and then dried over Na2SO4. Concentration and column 
chromatography (hexane, hexane/EtOAc = 6:1) gave mono-TBS ether S1 (6.31 g, 47%): 
colorless oil; Rf = 0.36 (hexane/EtOAc = 4:1); IR (neat) 3367, 2953, 2929, 2858 cm–1; 1H 
NMR (400 MHz, CDCl3) δ 5.74–5.64 (m, 2 H), 4.26 (d, J = 5.1 Hz, 2 H), 4.20 (d, J = 5.9 Hz, 
2 H), 2.01 (brs, 1 H), 0.91 (s, 9 H), 0.09 (s, 6 H); 13C NMR (100 MHz, CDCl3) δ 131.3, 130.0, 
59.6, 58.9, 26.0, 18.4, –5.2; HRMS (ESI–TOF) calcd for C10H22O2SiNa [M + Na]+ 225.1287, 
found 225.1284. 
Epoxy Alcohol 15. To a suspension of powdered MS4Å (3.20 g) in CH2Cl2 (130 mL) were 
added (+)-DET (3.3 mL, 19.1 mmol), Ti(Oi-Pr)4 (5.7 mL, 19.1 mmol), and allylic alcohol S1 
(3.21 g, 15.9 mmol) in CH2Cl2 (17 mL + 6.0 mL) at –25 °C. After the resulting mixture was 
stirred at the same temperature for 20 min, TBHP (ca. 5.0 M solution in 
2,2,4-trimethylpentane, 6.4 mL, 32.0 mmol) was added to the mixture at the same temperature. 
After the resulting mixture was stirred at the same temperature for 63 h, the reaction was 
quenched with 3 M aqueous NaOH and the mixture was stirred at room temperature for 30 
min. The mixture was filtered through a Celite pad and washed with EtOAc. The mixture was 
washed with H2O and brine, and then dried over Na2SO4. Concentration and column 
chromatography (hexane/EtOAc = 4:1) gave epoxy alcohol 15 (2.98 g, 86%, enantiomeric 
ratio = 17:1): colorless oil; Rf = 0.34 (hexane/EtOAc = 2:1); [α]D25 –12.6 (c 1.00, CHCl3); IR 
(neat) 3399, 2953, 2930, 2858 cm–1; 1H NMR (400 MHz, CDCl3) δ 3.92 (dd, J = 11.7, 5.6 Hz, 
1 H), 3.79–3.71 (m, 3 H), 3.25–3.17 (m, 2 H), 2.24 (brs, 1 H), 0.90 (s, 9 H), 0.10 (s, 3 H), 
0.09 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 61.6, 60.9, 56.4, 56.0, 25.9, 18.3, –5.2, –5.3; 
HRMS (ESI–TOF) calcd for C10H22O3SiNa [M + Na]+ 241.1236, found 241.1231. 
Diol 16. To a suspension of CuBr·SMe2 (294 mg, 1.43 mmol) in Et2O (38 mL) was added 
isopropenylmagnesium bromide (0.5 M in THF, 31.4 mL, 15.7 mmol) at –50 °C. The mixture 
was gradually warmed up to –20 °C and stirred at the same temperature for 10 min. To the 
resulting mixture was added epoxy alcohol 15 (1.04 g, 4.76 mmol) in Et2O (5.2 mL + 2.0 mL) 
at –20 °C. The mixture was stirred at the same temperature for 21 h. The reaction was 
quenched with saturated aqueous NH4Cl. The mixture was diluted with Et2O, washed with 
saturated aqueous NH4Cl, H2O, and brine, and then dried over Na2SO4. Concentration and 
column chromatography (hexane/EtOAc = 3:1) gave diol 16 (1.09 g, 84%): colorless oil; Rf = 
0.43 (hexane/EtOAc = 2:1); [α]D25 –4.9 (c 1.00, CHCl3); IR (neat) 3399, 2929, 2857 cm–1; 1H 
NMR (400 MHz, CDCl3) δ 5.00 (t, J = 1.6 Hz, 1 H), 4.86 (s, 1 H), 3.81–3.60 (m, 5 H), 
2.46–2.37 (m, 3 H), 1.80 (s, 3 H), 0.91 (s, 9 H), 0.09 (s, 6 H); 13C NMR (100 MHz, CDCl3) δ 
143.4, 114.5, 71.3, 65.5, 62.2, 52.6, 25.9, 21.3, 18.3, –5.3, –5.3; HRMS (ESI–TOF) calcd for 
C13H28O3SiNa [M + Na]+ 283.1705, found 283.1711. 
Alkane 17. A mixture of alkene 16 (2.65 g, 10.2 mmol) and (Ph3P)3RhCl (236 mg, 0.255 
mmol) in benzene (48 mL) and EtOH (16 mL) was stirred for 5 h under H2 atmosphere at 
room temperature. Short column chromatography (hexane/EtOAc = 1:1), concentration, and 
column chromatography (hexane/EtOAc = 7:1) gave alkane 17 (2.48 g, 93%): colorless oil; Rf 
= 0.50 (hexane/EtOAc = 2:1); [α]D26 +9.9 (c 1.00, CHCl3); IR (neat) 3389, 2956, 2930, 2886, 
2855 cm–1; 1H NMR (400 MHz, CDCl3) δ 3.92–3.87 (m, 1 H), 3.80–3.63 (m, 4 H), 2.70 (brs, 
1 H), 1.86–1.78 (m, 1 H), 1.64–1.58 (m, 1 H), 0.99 (d, J = 6.8 Hz, 3 H), 0.94 (d, J = 6.8 Hz, 3 
H), 0.92 (s, 9 H), 0.11 (s, 6 H); 13C NMR (100 MHz, CDCl3) δ 72.8, 64.6, 60.9, 49.6, 26.2, 
25.9, 21.7, 20.0, 18.3, –5.2, –5.3; HRMS (ESI–TOF) calcd for C13H30O3SiNa [M + Na]+ 
285.1862, found 285.1862. 
Sulfide 18. To a solution of diol 17 (1.74 g, 6.63 mmol) and (PhS)2 (4.34 g, 19.9 mmol) in 
pyridine (33 mL) was added n-Bu3P (5.0 mL, 19.9 mmol) at room temperature. The mixture 
was stirred at the same temperature for 1 h. The mixture was diluted with Et2O, washed with 
H2O and brine, and then dried over Na2SO4. Concentration and column chromatography 
(hexane/EtOAc = 60:1) gave sulfide 18 (1.92 g, 82%): colorless oil; Rf = 0.51 (hexane/EtOAc 
= 7:1); [α]D27 –16.0 (c 1.00, CHCl3); IR (neat) 3490, 2955, 2928, 2855 cm–1; 1H NMR (400 
MHz, CDCl3) δ 7.36–7.33 (m, 2 H), 7.29–7.26 (m, 2 H), 7.17 (tt, J = 7.3, 1.5 Hz, 1 H), 
3.89–3.84 (m, 1 H), 3.75 (dd, J = 10.0, 3.4 Hz, 1 H), 3.60 (dd, J = 10.0, 8.3 Hz, 1 H), 2.99 (dd, 
J = 12.8, 4.5 Hz, 1 H), 2.90 (dd, J = 12.8, 7.6 Hz, 1 H), 2.56 (brd, J = 2.9 Hz, 1 H), 2.17–2.08 
(m, 1 H), 1.67–1.61 (m, 1 H), 0.98 (d, J = 6.8 Hz, 3 H), 0.95 (d, J = 6.8 Hz, 3 H), 0.91 (s, 9 H), 
0.08 (s, 6 H); 13C NMR (100 MHz, CDCl3) δ 137.2, 129.2, 128.8, 125.9, 72.5, 65.9, 45.9, 
31.7, 27.5, 26.0, 21.3, 18.7, 18.3, –5.2, –5.2; HRMS (ESI–TOF) calcd for C19H34O2SSiNa [M 
+ Na]+ 377.1946, found 377.1950. 
TBS Ether 19. To a solution of alcohol 18 (1.29 g, 3.64 mmol) in CH2Cl2 (36 mL) were 
added 2,6-lutidine (0.64 mL, 5.46 mmol) and TBSOTf (1.0 mL, 4.37 mmol) at 0 °C. The 
mixture was stirred at the same temperature for 30 min. The mixture was diluted with Et2O, 
washed with H2O and brine, and then dried over Na2SO4. Concentration and column 
chromatography (hexane/EtOAc = 1:0, 70:1) gave TBS ether 19 (1.68 g, 98%): colorless oil; 
Rf = 0.66 (hexane/EtOAc = 20:1); [α]D28 –34.8 (c 1.00, CHCl3); IR (neat) 2955, 2929, 2862 
cm–1; 1H NMR (400 MHz, CDCl3) δ 7.34–7.32 (m, 2 H), 7.27–7.24 (m, 2 H), 7.16–7.12 (m, 1 
H), 4.14 (td, J = 6.6, 2.9 Hz, 1 H), 3.58 (dd, J = 6.6, 2.7 Hz, 2 H), 3.05 (dd, J = 12.7, 3.9 Hz, 1 
H), 2.95 (dd, J = 12.7, 9.6 Hz, 1 H), 2.08–2.00 (m, 1 H), 1.75–1.70 (m, 1 H), 0.96 (d, J = 6.8 
Hz, 3 H), 0.93 (d, J = 6.8 Hz, 3 H), 0.88 (s, 9 H), 0.85 (s, 9 H), 0.09 (s, 3 H), 0.08 (s, 3 H), 
0.03 (s, 3 H), 0.02 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 137.2, 129.2, 128.6, 125.5, 73.3, 
65.0, 44.8, 31.0, 26.4, 26.0, 26.0, 22.6, 19.1, 18.3, 18.2, –4.1, –4.7, –5.2, –5.4; HRMS 
(ESI–TOF) calcd for C25H48O2SSi2Na [M + Na]+ 491.2811, found 491.2809. 
Sulfone 20. To a solution of sulfide 19 (1.68 g, 3.58 mmol) in EtOH (36 mL) were added 
30% aqueous H2O2 (3.6 mL, 35.8 mmol) and (NH4)6Mo7O24·4H2O (442 mg, 0.358 mmol) at 
0 °C. The mixture was stirred at the same temperature for 2 h and at room temperature for 4 h. 
The reaction was quenched with saturated aqueous Na2S2O3 at 0 °C. The mixture was diluted 
with Et2O, washed with H2O and brine, and then dried over Na2SO4. Concentration and 
column chromatography (hexane/EtOAc = 40:1) gave sulfone 20 (1.72 g, 96%): colorless oil; 
Rf = 0.34 (hexane/EtOAc = 10:1); [α]D29 –17.8 (c 1.00, CHCl3); IR (neat) 2955, 2929, 2855 
cm–1; 1H NMR (400 MHz, CDCl3) δ 7.92–7.90 (m, 2 H), 7.65–7.61 (m, 1 H), 7.56–7.52 (m, 2 
H), 4.16–4.12 (m, 1 H), 3.57 (dd, J = 10.0, 5.7 Hz, 1 H), 3.50 (dd, J = 10.0, 8.1 Hz, 1 H), 3.36 
(dd, J = 14.8, 8.6 Hz, 1 H), 2.97 (dd, J = 14.8, 2.3 Hz, 1 H), 2.17–2.14 (m, 1 H), 2.09–2.01 (m, 
1 H), 0.88 (s, 9 H), 0.87 (s, 9 H), 0.83 (d, J = 6.8 Hz, 3 H), 0.62 (d, J = 7.1 Hz, 3 H), 0.14 (s, 3 
H), 0.08 (s, 3 H), 0.07 (s, 3 H), 0.04 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 139.6, 133.3, 
129.0, 128.1, 73.4, 64.3, 52.5, 40.1, 25.9, 25.9, 25.6, 21.8, 18.4, 18.2, 18.1, –4.2, –4.7, –5.3, 
–5.5; HRMS (ESI–TOF) calcd for C25H48O4SSi2Na [M + Na]+ 523.2709, found 523.2709. 
Sulfone 22a. To a solution of sulfone 20 (1.83 g, 3.65 mmol) in THF (28 mL) was added 
NaHMDS (1.0 M in THF, 4.4 mL, 4.40 mmol) at –78 °C. The mixture was stirred at the same 
temperature for 30 min. To the mixture was added allylic bromide 21a (1.40 g, 4.38 mmol) in 
THF (4.0 mL + 2.0 mL + 2.0 mL) at –78 °C. The mixture was gradually warmed up to room 
temperature for 2 h. The reaction was quenched with saturated aqueous NH4Cl. The mixture 
was diluted with Et2O, washed with H2O and brine, and then dried over Na2SO4. 
Concentration and column chromatography (hexane/EtOAc = 20:1) gave sulfone 22a (2.38 g, 
88%): colorless oil; Rf = 0.14 (hexane/EtOAc = 20:1); [α]D26 +15.1 (c 1.00, CHCl3); IR (neat) 
2957, 2929, 2862, 1727 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.82–7.79 (m, 2 H), 7.58–7.54 
(m, 1 H), 7.49–7.45 (m, 2 H), 5.11 (t, J = 6.7 Hz, 1 H), 4.33–4.30 (m, 1 H), 4.10–4.06 (m, 2 
H), 3.73 (dd, J = 10.5, 4.4 Hz, 1 H), 3.67 (dd, J = 10.5, 6.8 Hz, 1 H), 3.48 (brd, J = 7.8 Hz, 1 
H), 2.70–2.58 (m, 2 H), 2.36 (brd, J = 7.8 Hz, 1 H), 2.17–2.09 (m, 1 H), 1.82–1.60 (m, 3 H), 
1.53–1.35 (m, 2 H), 1.33–1.06 (m, 2 H), 1.20 (s, 9 H), 1.20 (s, 3 H), 0.97–0.89 (m, 9 H), 0.94 
(s, 9 H), 0.87 (s, 9 H), 0.14 (s, 3 H), 0.13 (s, 9 H); 13C NMR (100 MHz, CDCl3) δ 178.5, 
140.9, 132.8, 130.3, 128.8, 128.5, 127.9, 73.8, 68.4, 62.9, 61.9, 44.3, 38.8, 36.6, 35.7, 35.6, 
35.5, 29.9, 27.3, 26.3, 26.2, 25.5, 23.2, 20.6, 19.6, 18.7, 18.5, 15.3, –3.2, –4.7, –5.1, –5.2; 
HRMS (ESI–TOF) calcd for C40H74O6SSi2Na [M + Na]+ 761.4642, found 761.4632. 
Sulfone 22b. To a solution of sulfone 20 (1.52 g, 3.03 mmol) in THF (24 mL) was added 
NaHMDS (1.0 M in THF, 3.6 mL, 3.60 mmol) at –78 °C. The mixture was stirred at the same 
temperature for 30 min. To the mixture was added allylic bromide 21b (1.22 g, 3.82 mmol) in 
THF (4.0 mL + 1.0 mL + 1.0 mL) at –78 °C. The mixture was gradually warmed up to room 
temperature for 2 h. The reaction was quenched with saturated aqueous NH4Cl. The mixture 
was diluted with Et2O, washed with H2O and brine, and then dried over Na2SO4. 
Concentration and column chromatography (hexane/EtOAc = 20:1) gave sulfone 22b (2.03 g, 
91%): colorless oil; Rf = 0.14 (hexane/EtOAc = 20:1); [α]D30 +17.7 (c 1.00, CHCl3); IR (neat) 
2956, 2929, 2858, 1728 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.82–7.79 (m, 2 H), 7.58–7.54 
(m, 1 H), 7.49–7.45 (m, 2 H), 5.10 (t, J = 6.7 Hz, 1 H), 4.31–4.30 (m, 1 H), 4.11–4.05 (m, 2 
H), 3.73 (dd, J = 10.5, 4.6 Hz, 1 H), 3.67 (dd, J = 10.5, 6.8 Hz, 1 H), 3.48 (brd, J = 8.3 Hz, 1 
H), 2.71–2.58 (m, 2 H), 2.36 (brd, J = 6.8 Hz, 1 H), 2.17–2.09 (m, 1 H), 1.78–1.60 (m, 3 H), 
1.53–1.38 (m, 2 H), 1.31–1.08 (m, 2 H), 1.20 (s, 9 H), 1.20 (s, 3 H), 0.96 (d, J = 6.6 Hz, 3 H), 
0.94 (s, 9 H), 0.90 (d, J = 6.6 Hz, 3 H), 0.89 (d, J = 6.6 Hz, 3 H), 0.87 (s, 9 H), 0.14 (s, 3 H), 
0.13 (s, 9 H); 13C NMR (100 MHz, CDCl3) δ 178.4, 141.0, 132.8, 130.3, 128.8, 128.5, 127.9, 
73.8, 68.4, 62.9, 61.9, 44.3, 38.7, 36.6, 35.7, 35.6, 29.9, 27.3, 26.3, 26.2, 26.2, 25.5, 23.2, 20.6, 
19.5, 18.7, 18.5, 15.3, –3.2, –4.7, –5.1, –5.2; HRMS (ESI–TOF) calcd for C40H74O6SSi2Na 
[M + Na]+ 761.4642, found 761.4641. 
Alcohol 23a. To a solution of lithium wire (2.23 g, 0.322 mol) in liquid NH3 (90 mL) was 
added sulfone 22a (2.38 g, 3.22 mmol) in THF/t-BuOH (44 mL/22 mL) and THF (6.0 mL for 
rinse) at –78 °C. The mixture was stirred at the same temperature for 5 min. The reaction was 
quenched with a 1:1 solution of saturated aqueous NH4Cl and MeOH. The mixture was 
diluted with EtOAc, warmed up to room temperature, and stirred at the same temperature. The 
mixture was washed with H2O and brine, and then dried over Na2SO4. Concentration gave 
the mixture of the corresponding pivalate and alcohol, which was used for the next step 
without further purification. 
To a solution of the mixture obtained above in CH2Cl2 (30 mL) were added pyridine (0.39 
mL, 4.83 mmol) and PivCl (0.47 mL, 3.86 mmol) at room temperature. The mixture was 
stirred at the same temperature for 11 h. The mixture was diluted with EtOAc, washed with 
H2O and brine, and then dried over Na2SO4. Concentration and short column 
chromatography (hexane/EtOAc = 100:1) gave the corresponding pivalate (1.23 g), which 
was used for the next step without further purification. 
To a solution of the bis-TBS ether obtained above (1.23 g) in MeOH (10 mL) and CH2Cl2 
(10 mL) was added CSA (142 mg, 0.615 mmol) at 0 °C. The mixture was stirred at the same 
temperature for 1 h. The reaction was quenched with Et3N. The mixture was diluted with 
Et2O, washed with H2O and brine, and then dried over Na2SO4. Concentration and column 
chromatography (hexane/EtOAc = 25:1) gave alcohol 23a (430 mg) and the bis-TBS ether 
(617 mg). 
To a solution of the bis-TBS ether recovered above (617 mg) in MeOH (5.0 mL) and 
CH2Cl2 (5.0 mL) was added CSA (71.8 mg, 0.309 mmol) at 0 °C. The mixture was stirred at 
the same temperature for 1 h. The reaction was quenched with Et3N. The mixture was diluted 
with Et2O, washed with H2O and brine, and then dried over Na2SO4. Concentration and 
column chromatography (hexane/EtOAc = 25:1) gave alcohol 23a (310 mg, totally 741 mg, 
47% in three steps): colorless oil; Rf = 0.29 (hexane/EtOAc = 10:1); [α]D25 +3.8 (c 1.00, 
CHCl3); IR (neat) 3520, 2956, 2930, 2862, 1731 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.09 (t, 
J = 6.6 Hz, 1 H), 4.14–4.04 (m, 2 H), 3.81–3.77 (m, 1 H), 3.61–3.53 (m, 2 H), 2.06–1.91 (m, 
4 H), 1.86–1.78 (m, 1 H), 1.71–1.53 (m, 3 H), 1.60 (s, 3 H), 1.48–1.15 (m, 6 H), 1.19 (s, 9 H), 
0.93–0.88 (m, 9 H), 0.91 (s, 9 H), 0.11 (s, 3 H), 0.09 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 
178.5, 135.4, 124.4, 74.6, 64.3, 62.9, 47.2, 39.7, 38.8, 37.1, 35.6, 29.7, 27.9, 27.3, 26.0, 25.4, 
24.7, 21.7, 19.5, 19.4, 18.2, 16.1, –4.2, –4.3; HRMS (ESI–TOF) calcd for C28H56O4SiNa [M 
+ Na]+ 507.3846, found 507.3836. 
Alcohol 23b. To a solution of lithium wire (1.91 g, 0.275 mol) in liquid NH3 (80 mL) was 
added sulfone 22b (2.03 g, 2.75 mmol) in THF/t-BuOH (39 mL/19 mL) and THF (4.0 mL for 
rinse) at –78 °C. The mixture was stirred at the same temperature for 10 min. The reaction 
was quenched with a 1:1 solution of saturated aqueous NH4Cl and MeOH. The mixture was 
diluted with EtOAc, warmed up to room temperature, and stirred at the same temperature. The 
mixture was washed with H2O and brine, and then dried over Na2SO4. Concentration gave 
the mixture of the corresponding pivalate and alcohol, which was used for the next step 
without further purification. 
To a solution of the mixture obtained above in CH2Cl2 (28 mL) were added pyridine (0.33 
mL, 4.13 mmol) and PivCl (0.40 mL, 3.30 mmol) at room temperature. The mixture was 
stirred at the same temperature for 11 h. The mixture was diluted with EtOAc, washed with 
H2O and brine, and then dried over Na2SO4. Concentration and short column 
chromatography (hexane/EtOAc = 100:1) gave the corresponding pivalate (1.37 g), which 
was used for the next step without further purification. 
To a solution of the bis-TBS ether obtained above (1.37 g) in MeOH (12 mL) and CH2Cl2 
(12 mL) was added CSA (160 mg, 0.687 mmol) at 0 °C. The mixture was stirred at the same 
temperature for 1 h. The reaction was quenched with Et3N. The mixture was diluted with 
Et2O, washed with H2O and brine, and then dried over Na2SO4. Concentration and column 
chromatography (hexane/EtOAc = 25:1) gave alcohol 23b (562 mg) and the bis-TBS ether 
(366 mg). 
To a solution of the bis-TBS ether recovered above (366 mg) in MeOH (3.0 mL) and 
CH2Cl2 (3.0 mL) was added CSA (42.6 mg, 0.183 mmol) at 0 °C. The mixture was stirred at 
the same temperature for 1 h. The reaction was quenched with Et3N. The mixture was diluted 
with Et2O, washed with H2O and brine, and then dried over Na2SO4. Concentration and 
column chromatography (hexane/EtOAc = 25:1) gave alcohol 23b (169 mg, totally 731 mg, 
55% in three steps): colorless oil; Rf = 0.29 (hexane/EtOAc = 10:1); [α]D29 +7.6 (c 1.20, 
CHCl3); IR (neat) 3475, 2956, 2929, 2858, 1731 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.09 (t, 
J = 7.1 Hz, 1 H), 4.14–4.04 (m, 2 H), 3.81–3.77 (m, 1 H), 3.61–3.53 (m, 2 H), 2.06–1.90 (m, 
4 H), 1.86–1.78 (m, 1 H), 1.71–1.51 (m, 2 H), 1.60 (s, 3 H), 1.48–1.26 (m, 6 H), 1.24–1.15 (m, 
1 H), 1.19 (s, 9 H), 0.93–0.88 (m, 9 H), 0.91 (s, 9 H), 0.11 (s, 3 H), 0.09 (s, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 178.5, 135.4, 124.3, 74.6, 64.4, 62.9, 47.2, 39.7, 38.7, 37.1, 35.6, 29.7, 
27.9, 27.3, 26.0, 25.4, 24.7, 21.7, 19.6, 19.4, 18.2, 16.1, –4.2, –4.3; HRMS (ESI–TOF) calcd 
for C28H56O4SiNa [M + Na]+ 507.3846, found 507.3843. 
Alkene 24a. To a solution of alcohol 23a (715 mg, 1.47 mmol) in CH2Cl2 (15 mL) were 
added PhI(OAc)2 (712 mg, 2.21 mmol) and TEMPO (45.9 mg, 0.294 mmol) at room 
temperature. The mixture was stirred at the same temperature for 3 h. The reaction was 
quenched with saturated aqueous Na2S2O3. The mixture was diluted with Et2O, washed with 
saturated aqueous NaHCO3, H2O, and brine, and then dried over Na2SO4. Concentration and 
short column chromatography (hexane/EtOAc = 70:1) gave the corresponding aldehyde (629 
mg), which was used for the next step without further purification. 
To a suspension of Ph3P+CH3Br− (1.31 g, 3.68 mmol) in THF (9.0 mL) was added NaHMDS 
(1.0 M in THF, 3.5 mL, 3.50 mmol) at 0 °C. The mixture was stirred at the same temperature 
for 20 min. To the mixture was added the aldehyde obtained above (629 mg) in THF (4.0 mL 
+ 1.0 mL + 1.0 mL) at 0 °C. The mixture was stirred at room temperature for 1 h. The reaction 
was quenched with saturated aqueous NH4Cl. The mixture was diluted with Et2O, washed 
with H2O and brine, and then dried over Na2SO4. Concentration and column chromatography 
(hexane/EtOAc = 70:1) gave alkene 24a (580 mg, 82% in two steps): colorless oil; Rf = 0.50 
(hexane/EtOAc = 20:1); [α]D26 +3.2 (c 1.00, CHCl3); IR (neat) 2957, 2930, 2855, 1731 
cm–1; 1H NMR (400 MHz, CDCl3) δ 5.81 (ddd, J = 16.6, 10.4, 5.9 Hz, 1 H), 5.15 (d, J = 16.6 
Hz, 1 H), 5.09–5.06 (m, 2 H), 4.14 (t, J = 5.9 Hz, 1 H), 4.11–4.07 (m, 2 H), 2.08–1.85 (m, 5 
H), 1.72–1.63 (m, 1 H), 1.58 (s, 3 H), 1.57–1.52 (m, 1 H), 1.48–1.26 (m, 6 H), 1.20 (s, 9 H), 
0.92 (d, J = 6.8 Hz, 3 H), 0.90 (d, J = 6.0 Hz, 3 H), 0.90 (s, 9 H), 0.88 (d, J = 6.4 Hz, 3 H), 
0.04 (s, 3 H), 0.02 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 178.5, 140.7, 135.6, 124.2, 114.5, 
75.5, 62.9, 50.0, 39.7, 38.8, 37.1, 35.6, 29.7, 27.7, 27.3, 26.0, 25.4, 24.5, 21.9, 19.5, 19.0, 18.3, 
16.0, –4.0, –4.8; HRMS (ESI–TOF) calcd for C29H56O3SiNa [M + Na]+ 503.3896, found 
503.3895. 
Alkene 24b. To a solution of alcohol 23b (700 mg, 1.44 mmol) in CH2Cl2 (15 mL) were 
added PhI(OAc)2 (696 mg, 2.16 mmol) and TEMPO (45.0 mg, 0.288 mmol) at room 
temperature. The mixture was stirred at the same temperature for 4 h. The reaction was 
quenched with saturated aqueous Na2S2O3. The mixture was diluted with Et2O, washed with 
saturated aqueous NaHCO3, H2O, and brine, and then dried over Na2SO4. Concentration and 
short column chromatography (hexane/EtOAc = 70:1) gave the corresponding aldehyde (626 
mg), which was used for the next step without further purification. 
To a suspension of Ph3P+CH3Br− (1.29 g, 3.60 mmol) in THF (9.0 mL) was added NaHMDS 
(1.0 M in THF, 3.5 mL, 3.50 mmol) at 0 °C. The mixture was stirred at the same temperature 
for 20 min. To the mixture was added the aldehyde obtained above (626 mg) in THF (4.0 mL 
+ 1.0 mL + 1.0 mL) at 0 °C. The mixture was stirred at room temperature for 1 h. The reaction 
was quenched with saturated aqueous NH4Cl. The mixture was diluted with Et2O, washed 
with H2O and brine, and then dried over Na2SO4. Concentration and column chromatography 
(hexane/EtOAc = 70:1) gave alkene 24b (605 mg, 87% in two steps): colorless oil; Rf = 0.50 
(hexane/EtOAc = 20:1); [α]D28 +6.1 (c 1.00, CHCl3); IR (neat) 2957, 2930, 2858, 1731 
cm–1; 1H NMR (400 MHz, CDCl3) δ 5.81 (ddd, J = 17.0, 10.4, 5.7 Hz, 1 H), 5.15 (dt, J = 17.0, 
1.5 Hz, 1 H), 5.09–5.06 (m, 2 H), 4.14 (t, J = 5.7 Hz, 1 H), 4.11–4.07 (m, 2 H), 2.07–1.85 (m, 
5 H), 1.72–1.63 (m, 1 H), 1.58 (s, 3 H), 1.57–1.52 (m, 1 H), 1.48–1.14 (m, 6 H), 1.20 (s, 9 H), 
0.92 (d, J = 6.4 Hz, 3 H), 0.90 (d, J = 6.4 Hz, 3 H), 0.90 (s, 9 H), 0.88 (d, J = 6.8 Hz, 3 H), 
0.04 (s, 3 H), 0.02 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 178.5, 140.7, 135.6, 124.2, 114.5, 
75.5, 62.9, 50.0, 39.7, 38.8, 37.1, 35.6, 29.7, 27.7, 27.3, 26.0, 25.4, 24.5, 21.9, 19.6, 19.0, 18.3, 
16.0, –4.0, –4.8; HRMS (ESI–TOF) calcd for C29H56O3SiNa [M + Na]+ 503.3896, found 
503.3903. 
Alcohol 25a. To a solution of pivalate 24a (554 mg, 1.15 mmol) in CH2Cl2 (12 mL) was 
added DIBAL-H (1.02 M in hexane, 3.4 mL, 3.45 mmol) at –78 °C. The mixture was stirred 
at the same temperature for 20 min. The reaction was quenched with MeOH. The mixture was 
filtered through a Celite pad and washed with EtOAc. Concentration and column 
chromatography (hexane/EtOAc = 10:1) gave alcohol 25a (443 mg, 97%): colorless oil; Rf = 
0.11 (hexane/EtOAc = 10:1); [α]D25 +3.0 (c 1.00, CHCl3); IR (neat) 3336, 2955, 2928, 2858 
cm–1; 1H NMR (400 MHz, CDCl3) δ 5.81 (ddd, J = 17.2, 10.4, 6.8 Hz, 1 H), 5.15 (dt, J = 17.2, 
1.6 Hz, 1 H), 5.10–5.06 (m, 2 H), 4.14 (t, J = 6.0 Hz, 1 H), 3.71–3.66 (m, 2 H), 2.08–1.85 (m, 
5 H), 1.66–1.54 (m, 2 H), 1.58 (s, 3 H), 1.45–1.15 (m, 7 H), 0.92–0.87 (m, 9 H), 0.90 (s, 9 H), 
0.05 (s, 3 H), 0.02 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 140.7, 135.5, 124.4, 114.5, 75.5, 
61.3, 49.9, 40.0, 39.7, 37.3, 29.3, 27.7, 26.0, 25.4, 24.4, 21.9, 19.6, 19.0, 18.3, 16.0, –4.0, 
–4.8; HRMS (ESI–TOF) calcd for C24H48O2SiNa [M + Na]+ 419.3321, found 419.3329. 
Alcohol 25b. To a solution of pivalate 24b (585 mg, 1.22 mmol) in CH2Cl2 (12 mL) was 
added DIBAL-H (1.02 M in hexane, 3.6 mL, 3.66 mmol) at –78 °C. The mixture was stirred 
at the same temperature for 15 min. The reaction was quenched with MeOH. The mixture was 
filtered through a Celite pad and washed with EtOAc. Concentration and column 
chromatography (hexane/EtOAc = 10:1) gave alcohol 25b (473 mg, 98%): colorless oil; Rf = 
0.11 (hexane/EtOAc = 10:1); [α]D30 +8.2 (c 1.00, CHCl3); IR (neat) 3347, 2955, 2929, 2858 
cm–1; 1H NMR (400 MHz, CDCl3) δ 5.81 (ddd, J = 17.2, 10.4, 6.3 Hz, 1 H), 5.15 (dt, J = 17.2, 
1.6 Hz, 1 H), 5.10–5.05 (m, 2 H), 4.14 (dd, J = 6.3, 5.1 Hz, 1 H), 3.73–3.63 (m, 2 H), 
2.08–1.85 (m, 5 H), 1.66–1.53 (m, 2 H), 1.58 (s, 3 H), 1.45–1.14 (m, 7 H), 0.92–0.87 (m, 9 H), 
0.90 (s, 9 H), 0.04 (s, 3 H), 0.02 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 140.7, 135.5, 124.4, 
114.5, 75.5, 61.3, 49.9, 40.0, 39.7, 37.3, 29.3, 27.7, 26.0, 25.4, 24.5, 21.9, 19.7, 19.0, 18.3, 
16.0, –4.0, –4.8; HRMS (ESI–TOF) calcd for C24H48O2SiNa [M + Na]+ 419.3321, found 
419.3318. 
Alcohol 27a. To a solution of alcohol 25a (420 mg, 1.05 mmol) in CH2Cl2 (10 mL) were 
added PhI(OAc)2 (509 mg, 1.58 mmol) and TEMPO (32.8 mg, 0.210 mmol) at room 
temperature. The mixture was stirred at the same temperature for 2 h. The reaction was 
quenched with saturated aqueous Na2S2O3. The mixture was diluted with Et2O, washed with 
saturated aqueous NaHCO3, H2O, and brine, and then dried over Na2SO4. Concentration and 
short column chromatography (hexane/EtOAc = 70:1) gave the corresponding aldehyde (386 
mg), which was used for the next step without further purification. 
To a solution of the aldehyde obtained above (386 mg) in THF (8.0 mL) and saturated 
aqueous NH4Cl (1.6 mL) were added ethyl (2-bromomethyl)acrylate (26) (0.20 mL, 1.47 
mmol) and zinc dust (192 mg, 2.93 mmol) at 0 °C. The mixture was stirred at the same 
temperature for 15 min. The mixture was filtered through a Celite pad and washed with 
EtOAc. The mixture was concentrated, washed with H2O and brine, and then dried over 
Na2SO4. Concentration and column chromatography (hexane/EtOAc = 10:1) gave alcohol 
27a (420 mg, 79% in two steps) as a 1:1 diastereomeric mixture: colorless oil; Rf = 0.20 
(hexane/EtOAc = 10:1); IR (neat) 3464, 2956, 2929, 2857, 1716, 1631 cm–1; 1H NMR (400 
MHz, CDCl3) δ 6.25 (t, J = 1.8 Hz, 1 H), 5.81 (ddd, J = 17.2, 10.5, 5.7 Hz, 1 H), 5.65 (s, 1 H), 
5.14 (d, J = 17.2 Hz, 1 H), 5.10–5.05 (m, 2 H), 4.26–4.18 (m, 2 H), 4.14 (t, J = 5.7 Hz, 1 H), 
3.85 (brs, 1 H), 2.61 (dd, J = 14.0, 3.2 Hz, 0.5 H), 2.56 (dd, J = 14.0, 3.6 Hz, 0.5 H), 2.34 (dd, 
J = 14.0, 8.4 Hz, 0.5 H), 2.26 (dd, J = 14.0, 8.4 Hz, 0.5 H), 2.07–1.85 (m, 6 H), 1.74–1.48 (m, 
2 H), 1.58 (s, 3 H), 1.44–1.35 (m, 3 H), 1.31 (t, J = 7.2 Hz, 3 H), 1.27–1.10 (m, 3 H), 
0.95–0.87 (m, 9 H), 0.89 (s, 9 H), 0.04 (s, 3 H), 0.01 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 
167.5, 140.7, 140.7, 137.8, 135.5, 135.4, 127.4, 127.3, 124.4, 124.4, 114.5, 75.5, 68.7, 68.4, 
61.0, 49.9, 44.8, 44.7, 41.2, 40.6, 39.7, 37.9, 36.9, 29.5, 29.2, 27.7, 26.0, 25.5, 25.4, 24.5, 21.9, 
20.2, 19.3, 19.0, 18.3, 16.0, 14.2, –4.0, –4.8; HRMS (ESI–TOF) calcd for C30H56O4SiNa [M 
+ Na]+ 531.3846, found 531.3845. 
Alcohol 27b. To a solution of alcohol 25b (453 mg, 1.14 mmol) in CH2Cl2 (11 mL) were 
added PhI(OAc)2 (550 mg, 1.71 mmol) and TEMPO (35.6 mg, 0.228 mmol) at room 
temperature. The mixture was stirred at the same temperature for 2 h. The reaction was 
quenched with saturated aqueous Na2S2O3. The mixture was diluted with Et2O, washed with 
saturated aqueous NaHCO3, H2O, and brine, and then dried over Na2SO4. Concentration and 
short column chromatography (hexane/EtOAc = 70:1) gave the corresponding aldehyde (429 
mg), which was used for the next step without further purification. 
To a solution of the aldehyde obtained above (429 mg) in THF (10 mL) and saturated 
aqueous NH4Cl (2.0 mL) were added ethyl (2-bromomethyl)acrylate (26) (0.23 mL, 1.71 
mmol) and zinc dust (224 mg, 3.42 mmol) at 0 °C. The mixture was stirred at the same 
temperature for 20 min. The mixture was filtered through a Celite pad and washed with 
EtOAc. The mixture was concentrated, washed with H2O and brine, and then dried over 
Na2SO4. Concentration and column chromatography (hexane/EtOAc = 10:1) gave alcohol 
27b (538 mg, 93% in two steps) as a 1:1 diastereomeric mixture: colorless oil; Rf = 0.20 
(hexane/EtOAc = 10:1); IR (neat) 3463, 2955, 2929, 2857, 1717, 1635 cm–1; 1H NMR (400 
MHz, CDCl3) δ 6.25 (t, J = 1.8 Hz, 1 H), 5.81 (ddd, J = 17.2, 10.4, 5.7 Hz, 1 H), 5.64 (s, 1 H), 
5.14 (dt, J = 17.2, 1.5 Hz, 1 H), 5.10–5.05 (m, 2 H), 4.26–4.18 (m, 2 H), 4.14 (t, J = 5.7 Hz, 1 
H), 3.88–3.82 (m, 1 H), 2.61 (dd, J = 14.0, 3.2 Hz, 0.5 H), 2.56 (dd, J = 14.0, 3.2 Hz, 0.5 H), 
2.34 (dd, J = 14.0, 8.4 Hz, 0.5 H), 2.26 (dd, J = 14.0, 8.4 Hz, 0.5 H), 2.07–1.85 (m, 6 H), 
1.73–1.61 (m, 2 H), 1.58 (s, 3 H), 1.54–1.35 (m, 3 H), 1.31 (t, J = 7.1 Hz, 3 H), 1.27–1.10 (m, 
3 H), 0.95–0.87 (m, 9 H), 0.89 (s, 9 H), 0.04 (s, 3 H), 0.02 (s, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 167.5, 140.7, 140.7, 137.8, 135.5, 135.4, 127.4, 127.3, 124.4, 124.4, 114.5, 75.5, 
68.8, 68.4, 61.0, 50.0, 50.0, 44.8, 44.7, 41.2, 40.7, 39.7, 37.9, 37.0, 29.5, 29.2, 27.7, 26.0, 25.5, 
25.4, 24.5, 24.5, 21.9, 20.2, 19.3, 19.0, 18.3, 16.0, 14.2, –4.0, –4.8; HRMS (ESI–TOF) calcd 
for C30H56O4SiNa [M + Na]+ 531.3846, found 531.3842. 
MOM Ether 28a. To a solution of alcohol 27a (395 mg, 0.777 mmol) in CH2Cl2 (8.0 mL) 
were added i-Pr2NEt (0.80 mL, 4.66 mmol), MOMCl (0.30 mL, 3.89 mmol), and TBAI (144 
mg, 0.389 mmol) at room temperature. The mixture was stirred at the same temperature for 6 
h. The reaction was quenched with saturated aqueous NH4Cl. The mixture was diluted with 
Et2O, washed with saturated aqueous NH4Cl, saturated aqueous NaHCO3, H2O, and brine, 
and then dried over Na2SO4. Concentration and column chromatography (hexane/EtOAc = 
40:1) gave MOM ether 28a (406 mg, 94%): colorless oil; Rf = 0.50 (hexane/EtOAc = 10:1); 
IR (neat) 2955, 2929, 2862, 1719, 1632 cm–1; 1H NMR (400 MHz, CDCl3) δ 6.21 (s, 1 H), 
5.81 (ddd, J = 17.3, 10.5, 5.7 Hz, 1 H), 5.61 (s, 0.5 H), 5.60 (s, 0.5 H), 5.14 (d, J = 17.3 Hz, 1 
H), 5.10–5.06 (m, 2 H), 4.68–4.57 (m, 2 H), 4.21 (q, J = 7.2 Hz, 2 H), 4.13 (t, J = 5.7 Hz, 1 H), 
3.88–3.80 (m, 1 H), 3.34 (s, 1.5 H), 3.33 (s, 1.5 H), 2.58–2.38 (m, 2 H), 2.07–1.84 (m, 5 H), 
1.66–1.51 (m, 2 H), 1.58 (s, 3 H), 1.42–1.35 (m, 3 H), 1.31 (t, J = 7.2 Hz, 3 H), 1.22–1.12 (m, 
3 H), 0.93–0.88 (m, 9 H), 0.89 (s, 9 H), 0.04 (s, 3 H), 0.01 (s, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 167.0, 166.9, 140.7, 137.7, 137.7, 135.5, 135.4, 127.1, 124.4, 124.3, 114.5, 95.6, 
95.5, 75.5, 74.4, 74.2, 60.7, 60.7, 55.7, 55.6, 50.0, 42.5, 39.7, 38.4, 38.0, 37.8, 37.1, 29.3, 29.0, 
27.7, 26.0, 25.5, 25.3, 24.5, 21.9, 20.0, 19.4, 19.0, 18.3, 16.0, 14.3, –4.0, –4.8; HRMS 
(ESI–TOF) calcd for C32H60O5SiNa [M + Na]+ 575.4108, found 575.4110. 
MOM Ether 28b. To a solution of alcohol 27b (518 mg, 1.02 mmol) in CH2Cl2 (10 mL) 
were added i-Pr2NEt (1.1 mL, 6.12 mmol), MOMCl (0.39 mL, 5.10 mmol), and TBAI (188 
mg, 0.510 mmol) at room temperature. The mixture was stirred at the same temperature for 11 
h. The reaction was quenched with saturated aqueous NH4Cl. The mixture was diluted with 
Et2O, washed with saturated aqueous NH4Cl, saturated aqueous NaHCO3, H2O, and brine, 
and then dried over Na2SO4. Concentration and column chromatography (hexane/EtOAc = 
40:1) gave MOM ether 28b (544 mg, 96%): colorless oil; Rf = 0.50 (hexane/EtOAc = 10:1); 
IR (neat) 2955, 2929, 2857, 1718, 1631 cm–1; 1H NMR (400 MHz, CDCl3) δ 6.21 (s, 1 H), 
5.81 (ddd, J = 17.1, 10.4, 5.6 Hz, 1 H), 5.61 (s, 0.5 H), 5.60 (s, 0.5 H), 5.14 (d, J = 17.1 Hz, 1 
H), 5.10–5.05 (m, 2 H), 4.67–4.57 (m, 2 H), 4.21 (q, J = 7.1 Hz, 2 H), 4.14 (t, J = 5.6 Hz, 1 H), 
3.88–3.80 (m, 1 H), 3.34 (s, 1.5 H), 3.33 (s, 1.5 H), 2.59–2.38 (m, 2 H), 2.07–1.84 (m, 5 H), 
1.65–1.51 (m, 2 H), 1.58 (s, 3 H), 1.44–1.34 (m, 3 H), 1.30 (t, J = 7.1 Hz, 3 H), 1.27–1.09 (m, 
3 H), 0.94–0.87 (m, 9 H), 0.90 (s, 9 H), 0.04 (s, 3 H), 0.02 (s, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 167.0, 166.9, 140.7, 137.7, 137.7, 135.5, 135.4, 127.1, 124.4, 124.3, 114.5, 95.6, 
95.5, 75.5, 74.4, 74.3, 60.7, 55.6, 55.6, 50.0, 42.5, 39.7, 38.4, 38.0, 37.8, 37.1, 29.3, 29.0, 27.7, 
26.0, 25.4, 25.3, 24.5, 21.9, 20.0, 19.4, 19.0, 18.3, 16.0, 14.3, –4.0, –4.8; HRMS (ESI–TOF) 
calcd for C32H60O5SiNa [M + Na]+ 575.4108, found 575.4108. 
Alcohol 29a. To a solution of TBS ether 28a (380 mg, 0.687 mmol) in THF (4.8 mL) was 
added TBAF (1.0 M in THF, 2.1 mL, 2.10 mmol) at room temperature. The mixture was 
stirred at 60 °C for 5 h. The mixture was diluted with EtOAc, washed with H2O and brine, 
and then dried over Na2SO4. Concentration and column chromatography (hexane/EtOAc = 
7:1) gave alcohol 29a (245 mg, 81%): colorless oil; Rf = 0.43 (hexane/EtOAc = 4:1); IR 
(neat) 3483, 2954, 2929, 1715, 1625 cm–1; 1H NMR (400 MHz, CDCl3) δ 6.21 (s, 1 H), 5.90 
(ddd, J = 17.3, 10.5, 6.1 Hz, 1 H), 5.61 (s, 0.5 H), 5.60 (s, 0.5 H), 5.24 (d, J = 17.3 Hz, 1 H), 
5.15 (d, J = 10.5 Hz, 1 H), 5.10 (t, J = 7.0 Hz, 1 H), 4.67–4.57 (m, 2 H), 4.21 (q, J = 7.1 Hz, 2 
H), 4.14–4.10 (m, 1 H), 3.87–3.79 (m, 1 H), 3.34 (s, 1.5 H), 3.33 (s, 1.5 H), 2.58–2.38 (m, 2 
H), 2.06–1.89 (m, 5 H), 1.67–1.50 (m, 2 H), 1.58 (s, 3 H), 1.45 (brs, 1 H), 1.42–1.24 (m, 5 H), 
1.30 (t, J = 7.1 Hz, 3 H), 1.22–1.13 (m, 1 H), 0.94–0.88 (m, 9 H); 13C NMR (100 MHz, 
CDCl3) δ 167.0, 166.9, 140.4, 137.7, 137.6, 135.1, 135.1, 127.1, 124.8, 124.7, 115.3, 95.6, 
95.5, 74.9, 74.4, 74.2, 60.7, 55.7, 55.6, 48.7, 42.4, 39.4, 38.4, 38.0, 37.7, 37.0, 29.2, 28.9, 27.8, 
25.4, 25.3, 24.6, 21.2, 20.0, 19.4, 18.9, 16.0, 14.3; HRMS (ESI–TOF) calcd for C26H46O5Na 
[M + Na]+ 461.3243, found 461.3236. 
Alcohol 29b. To a solution of TBS ether 28b (524 mg, 0.948 mmol) in THF (7.0 mL) was 
added TBAF (1.0 M in THF, 2.8 mL, 2.80 mmol) at room temperature. The mixture was 
stirred at 60 °C for 6 h. The mixture was diluted with EtOAc, washed with H2O and brine, 
and then dried over Na2SO4. Concentration and column chromatography (hexane/EtOAc = 
7:1) gave alcohol 29b (347 mg, 83%): colorless oil; Rf = 0.43 (hexane/EtOAc = 4:1); IR 
(neat) 3475, 2954, 2929, 1716, 1631 cm–1; 1H NMR (400 MHz, CDCl3) δ 6.21 (s, 1 H), 5.90 
(ddd, J = 17.1, 10.5, 6.1 Hz, 1 H), 5.61 (s, 0.5 H), 5.60 (s, 0.5 H), 5.24 (d, J = 17.1 Hz, 1 H), 
5.15 (d, J = 10.5 Hz, 1 H), 5.10 (t, J = 6.8 Hz, 1 H), 4.67–4.57 (m, 2 H), 4.21 (q, J = 7.1 Hz, 2 
H), 4.12 (t, J = 6.1 Hz, 1 H), 3.87–3.79 (m, 1 H), 3.34 (s, 1.5 H), 3.33 (s, 1.5 H), 2.58–2.38 (m, 
2 H), 2.06–1.89 (m, 5 H), 1.66–1.50 (m, 2 H), 1.58 (s, 3 H), 1.42–1.25 (m, 6 H), 1.30 (t, J = 
7.1 Hz, 3 H), 1.22–1.13 (m, 1 H), 0.94–0.88 (m, 9 H); 13C NMR (100 MHz, CDCl3) δ 167.0, 
167.0, 140.4, 137.7, 137.7, 135.1, 135.1, 127.1, 124.8, 124.7, 115.2, 95.6, 95.5, 74.9, 74.4, 
74.3, 60.7, 55.6, 55.6, 48.8, 42.5, 39.4, 38.4, 38.0, 37.7, 37.1, 29.2, 29.0, 27.8, 25.4, 25.3, 24.7, 
21.2, 20.0, 19.4, 18.9, 16.0, 14.3; HRMS (ESI–TOF) calcd for C26H46O5Na [M + Na]+ 
461.3243, found 461.3247. 
Carboxylic Acid 30a. To a solution of ester 29a (210 mg, 0.479 mmol) in THF (3.0 mL), 
MeOH (1.0 mL), and H2O (1.0 mL) was added LiOH·H2O (30.1 mg, 0.718 mmol) at room 
temperature. The mixture was stirred at the same temperature for 12 h. The mixture was 
neutralized with aqueous HCl at 0 °C. The mixture was diluted with EtOAc, washed with 
H2O and brine, and then dried over Na2SO4. Concentration and column chromatography 
(hexane/EtOAc = 6:1, 3:1) gave carboxylic acid 30a (174 mg, 88%): colorless oil; Rf = 0.17 
(hexane/EtOAc = 2:1); IR (neat) 3466, 2955, 2930, 1698, 1629 cm–1; 1H NMR (400 MHz, 
CDCl3) δ 6.34 (t, J = 2.1 Hz, 1 H), 5.90 (ddd, J = 17.3, 10.5, 5.8 Hz, 1 H), 5.74 (s, 0.5 H), 
5.72 (s, 0.5 H), 5.25 (d, J = 17.3 Hz, 1 H), 5.16 (dd, J = 10.5, 1.3 Hz, 1 H), 5.12–5.08 (m, 1 
H), 4.67–4.60 (m, 2 H), 4.15 (q, J = 5.8 Hz, 1 H), 3.89–3.82 (m, 1 H), 3.35 (s, 1.5 H), 3.34 (s, 
1.5 H), 2.58–2.40 (m, 2 H), 2.06–1.89 (m, 5 H), 1.67–1.53 (m, 2 H), 1.58 (s, 3 H), 1.43–1.12 
(m, 8 H), 0.93–0.90 (m, 9 H); 13C NMR (100 MHz, CDCl3) δ 170.9, 170.9, 140.2, 140.1, 
137.0, 136.9, 135.1, 135.0, 129.4, 124.9, 124.8, 115.4, 95.6, 95.5, 75.0, 74.6, 74.4, 55.7, 48.5, 
42.4, 42.3, 39.3, 39.3, 38.0, 37.6, 37.3, 37.0, 29.1, 28.8, 27.8, 27.8, 25.1, 24.5, 21.1, 20.0, 19.6, 
19.0, 18.9, 16.0; HRMS (ESI–TOF) calcd for C24H42O5Na [M + Na]+ 433.2930, found 
433.2934. 
Carboxylic Acid 30b. To a solution of ester 29b (326 mg, 0.743 mmol) in THF (4.5 mL), 
MeOH (1.5 mL), and H2O (1.5 mL) was added LiOH·H2O (46.6 mg, 1.11 mmol) at room 
temperature. The mixture was stirred at the same temperature for 10 h. The mixture was 
neutralized with aqueous HCl at 0 °C. The mixture was diluted with EtOAc, washed with 
H2O and brine, and then dried over Na2SO4. Concentration and column chromatography 
(hexane/EtOAc = 6:1, 3:1) gave carboxylic acid 30b (222 mg, 73%): colorless oil; Rf = 0.17 
(hexane/EtOAc = 2:1); IR (neat) 3433, 2955, 2930, 1697, 1631 cm–1; 1H NMR (400 MHz, 
CDCl3) δ 6.33 (d, J = 1.5 Hz, 1 H), 5.90 (ddd, J = 17.1, 10.5, 6.6 Hz, 1 H), 5.73 (s, 0.5 H), 
5.71 (s, 0.5 H), 5.25 (dt, J = 17.1, 1.4 Hz, 1 H), 5.16 (dd, J = 10.5, 1.4 Hz, 1 H), 5.14–5.10 (m, 
1 H), 4.66–4.60 (m, 2 H), 4.19–4.13 (m, 1 H), 3.88–3.82 (m, 1 H), 3.35 (s, 3 H), 2.57–2.42 (m, 
2 H), 2.06–1.89 (m, 5 H), 1.67–1.52 (m, 2 H), 1.58 (s, 3 H), 1.43–1.10 (m, 8 H), 0.93–0.90 (m, 
9 H); 13C NMR (100 MHz, CDCl3) δ 170.4, 140.1, 140.1, 136.9, 135.0, 134.9, 129.3, 129.2, 
125.0, 124.9, 115.5, 115.5, 95.6, 95.5, 75.1, 75.0, 74.7, 74.5, 55.7, 48.4, 48.4, 42.6, 42.4, 39.3, 
39.2, 38.0, 37.7, 37.3, 37.1, 29.2, 29.0, 27.8, 25.4, 25.3, 24.5, 24.4, 21.1, 20.0, 19.7, 19.1, 19.0, 
16.0; HRMS (ESI–TOF) calcd for C24H42O5Na [M + Na]+ 433.2930, found 433.2927. 
Lactone 31a. To a solution of MNBA (76.1 mg, 0.221 mmol) and DMAP (53.9 mg, 0.441 
mmol) in CH2Cl2 (64 mL) was slowly added hydroxycarboxylic acid 30a (60.4 mg, 0.147 
mmol) in CH2Cl2 (6.0 mL at 0.4 mL/h + 2.0 mL at 4.0 mL/h + 2.0 mL at 4.0 mL/h) at room 
temperature with a syringe pump for 16 h. The mixture was stirred at the same temperature 
for further 4 h. The reaction was quenched with saturated aqueous NH4Cl. The mixture was 
concentrated, washed with saturated aqueous NaHCO3, H2O, and brine, and then dried over 
Na2SO4. Concentration and column chromatography (hexane/EtOAc = 20:1) gave lactone 
31a (42.6 mg, 85%): colorless oil; Rf = 0.47 (hexane/EtOAc = 7:1); IR (neat) 2954, 2930, 
1714, 1631 cm–1; 1H NMR (400 MHz, CDCl3) δ 6.23 (s, 0.5 H), 6.21 (s, 0.5 H), 5.91–5.80 (m, 
1 H), 5.74 (s, 0.5 H), 5.66 (s, 0.5 H), 5.62–5.61 (m, 1 H), 5.26–5.18 (m, 2.5 H), 4.98 (t, J = 
6.8 Hz, 0.5 H), 4.73–4.52 (m, 2 H), 3.87–3.81 (m, 0.5 H), 3.53–3.47 (m, 0.5 H), 3.38 (s, 1.5 
H), 3.30 (s, 1.5 H), 2.89 (dd, J = 13.7, 4.8 Hz, 0.5 H), 2.77 (dd, J = 13.7, 3.7 Hz, 0.5 H), 
2.31–2.24 (m, 1 H), 2.11–1.91 (m, 4.5 H), 1.84–1.77 (m, 0.5 H), 1.58 (s, 1.5 H), 1.57 (s, 1.5 
H), 1.53–1.43 (m, 4.5 H), 1.37–1.21 (m, 3 H), 1.15–1.05 (m, 0.5 H), 0.97–0.86 (m, 9 H); 13C 
NMR (100 MHz, CDCl3) δ 166.0, 165.6, 138.0, 137.4, 135.8, 134.7, 134.1, 127.0, 125.9, 
125.7, 116.4, 115.9, 95.3, 94.8, 75.9, 75.3, 74.6, 55.6, 55.4, 45.9, 45.7, 43.4, 40.7, 38.3, 37.9, 
37.6, 37.1, 37.0, 35.5, 29.7, 28.3, 27.9, 27.1, 24.4, 23.7, 23.5, 23.3, 21.7, 21.0, 20.5, 20.0, 19.6, 
18.5, 16.2, 15.7; HRMS (ESI–TOF) calcd for C24H40O4Na [M + Na]+ 415.2824, found 
415.2818. 
Lactone 31b. To a solution of MNBA (54.3 mg, 0.158 mmol) and DMAP (38.6 mg, 0.316 
mmol) in CH2Cl2 (36 mL) was slowly added hydroxycarboxylic acid 30b (36.0 mg, 87.7 
μmol) in CH2Cl2 (4.0 mL at 0.4 mL/h + 2.0 mL at 4.0 mL/h + 2.0 mL at 4.0 mL/h) at 40 °C 
with a syringe pump for 11 h. The mixture was stirred at the same temperature for further 7 h. 
The reaction was quenched with saturated aqueous NH4Cl. The mixture was concentrated, 
washed with saturated aqueous NaHCO3, H2O, and brine, and then dried over Na2SO4. 
Concentration and column chromatography (hexane/EtOAc = 20:1) gave lactone 31b (26.7 
mg, 78%): colorless oil; Rf = 0.47 (hexane/EtOAc = 7:1); IR (neat) 2954, 2929, 1716, 1631 
cm–1; 1H NMR (400 MHz, CDCl3) δ 6.30 (s, 0.5 H), 6.25 (s, 0.5 H), 5.91–5.76 (m, 1 H), 
5.68–5.58 (m, 2 H), 5.26–5.16 (m, 2 H), 5.06 (t, J = 7.2 Hz, 1 H), 4.65–4.62 (m, 2 H), 
3.85–3.78 (m, 0.5 H), 3.72–3.66 (m, 0.5 H), 3.35 (s, 1.5 H), 3.34 (s, 1.5 H), 2.68–2.63 (m, 1 
H), 2.50–2.43 (m, 1 H), 2.13–1.86 (m, 4.5 H), 1.85–1.77 (m, 0.5 H), 1.60 (s, 1.5 H), 1.58 (s, 
1.5 H), 1.54–1.20 (m, 8 H), 0.97–0.92 (m, 6 H), 0.88 (d, J = 6.1 Hz, 3 H); 13C NMR (100 
MHz, CDCl3) δ 166.1, 166.0, 137.8, 137.1, 135.5, 135.4, 134.6, 127.7, 127.6, 126.0, 125.5, 
116.9, 115.7, 95.1, 94.9, 76.3, 76.2, 75.3, 73.7, 55.5, 55.5, 47.1, 45.9, 42.9, 38.5, 38.4, 37.4, 
37.3, 36.6, 36.5, 28.8, 28.5, 28.2, 28.0, 25.3, 24.6, 24.1, 23.8, 21.3, 21.1, 20.1, 20.0, 19.9, 18.8, 
16.3, 15.9; HRMS (ESI–TOF) calcd for C24H40O4Na [M + Na]+ 415.2824, found 415.2825. 
Alcohol 32a. To a solution of MOM ether 31a (29.5 mg, 75.1 μmol) in Me2S (1.5 mL) was 
added BF3·OEt2 (46 μL, 0.376 mmol) at 0 °C. The mixture was stirred at the same 
temperature for 10 min. The mixture was quenched with saturated aqueous NaHCO3. The 
mixture was diluted with EtOAc, washed with H2O and brine, and then dried over Na2SO4. 
Concentration and column chromatography (hexane/EtOAc = 8:1) gave alcohol 32a (24.8 mg, 
95%): colorless oil; Rf = 0.29 (hexane/EtOAc = 4:1); IR (neat) 3417, 2955, 2928, 2873, 1714, 
1625 cm–1; 1H NMR (400 MHz, CDCl3) δ 6.28 (brs, 0.5 H), 6.20 (brs, 0.5 H), 5.91–5.80 (m, 1 
H), 5.67 (s, 0.5 H), 5.65 (s, 0.5 H), 5.62–5.59 (m, 1 H), 5.26–5.18 (m, 2.5 H), 5.02 (t, J = 6.3 
Hz, 0.5 H), 3.92–3.86 (m, 0.5 H), 3.68–3.62 (m, 0.5 H), 2.87 (ddd, J = 13.8, 3.4, 1.1 Hz, 0.5 
H), 2.69 (ddd, J = 13.4, 5.9, 1.0 Hz, 0.5 H), 2.36 (ddd, J = 13.4, 6.6, 0.7 Hz, 0.5 H), 2.26 (dd, 
J = 13.8, 7.1 Hz, 0.5 H), 2.12–1.95 (m, 4 H), 1.86–1.78 (m, 1 H), 1.61–1.37 (m, 8 H), 1.59 (s, 
1.5 H), 1.58 (s, 1.5 H), 1.25–1.10 (m, 1 H), 0.98–0.90 (m, 9 H); 13C NMR (100 MHz, CDCl3) 
δ 166.6, 165.8, 137.8, 137.7, 135.5, 134.6, 134.4, 134.0, 127.7, 127.0, 125.8, 125.7, 116.4, 
115.9, 76.0, 75.8, 69.5, 69.0, 46.3, 45.9, 45.3, 42.6, 41.7, 40.7, 37.5, 37.2, 37.1, 35.0, 29.3, 
28.8, 28.3, 28.1, 25.4, 23.8, 23.4, 23.1, 21.8, 20.8, 20.7, 20.3, 20.0, 18.5, 16.1, 15.9; HRMS 
(ESI–TOF) calcd for C22H36O3Na [M + Na]+ 371.2562, found 371.2559. 
Alcohol 32b. To a solution of MOM ether 31b (42.7 mg, 0.109 mmol) in Me2S (2.2 mL) 
was added BF3·OEt2 (67 μL, 0.545 mmol) at 0 °C. The mixture was stirred at the same 
temperature for 10 min. The mixture was quenched with saturated aqueous NaHCO3. The 
mixture was diluted with EtOAc, washed with H2O and brine, and then dried over Na2SO4. 
Concentration and column chromatography (hexane/EtOAc = 8:1) gave alcohol 32b (34.6 mg, 
91%): colorless oil; Rf = 0.29 (hexane/EtOAc = 4:1); IR (neat) 3417, 2955, 2927, 2868, 1714, 
1627 cm–1; 1H NMR (400 MHz, CDCl3) δ 6.29 (t, J = 1.3 Hz, 1 H), 5.91–5.78 (m, 1 H), 
5.69–5.62 (m, 2 H), 5.26–5.18 (m, 2 H), 5.14–5.06 (m, 1 H), 3.90–3.83 (m, 0.5 H), 3.81–3.75 
(m, 0.5 H), 2.74 (dd, J = 14.3, 3.8 Hz, 0.5 H), 2.55 (d, J = 5.6 Hz, 1 H), 2.30 (dd, J = 14.3, 7.7 
Hz, 0.5 H), 2.11–1.95 (m, 4 H), 1.89–1.76 (m, 1 H), 1.65–1.29 (m, 8 H), 1.60 (s, 1.5 H), 1.58 
(s, 1.5 H), 1.18–1.07 (m, 1 H), 0.96–0.91 (m, 9 H); 13C NMR (100 MHz, CDCl3) δ 166.3, 
165.9, 138.1, 137.2, 135.5, 135.0, 134.4, 134.4, 127.9, 127.6, 126.2, 125.6, 117.0, 116.2, 76.3, 
75.6, 69.9, 68.2, 47.6, 46.0, 44.6, 44.6, 40.7, 40.6, 38.6, 37.4, 36.7, 36.2, 29.1, 28.9, 28.4, 25.4, 
25.0, 24.4, 24.2, 21.3, 21.0, 21.0, 20.6, 20.0, 19.4, 16.3, 16.1; HRMS (ESI–TOF) calcd for 
C22H36O3Na [M + Na]+ 371.2562, found 371.2567. 
Butenolide 1a. To a solution of triene 32a (10.3 mg, 29.6 μmol) in toluene (6.0 mL) was 
added the second-generation Hoveyda–Grubbs catalyst (33) (1.9 mg, 2.96 μmol) at room 
temperature. The mixture was stirred at 100 °C for 30 h. The mixture was filtered through 
short column chromatography (hexane/EtOAc = 1:1). Concentration and column 
chromatography (hexane/EtOAc = 3:1) gave butenolide 34a (3.3 mg) and triene 32a (3.9 mg, 
38% recovery). Butenolide 34a was used for the next step without further purification. 
To a solution of alcohol 34a obtained above (3.3 mg) in CH2Cl2 (1.0 mL) were added MS4Å 
(3.0 mg), NMO (6.0 mg, 51.5 μmol), and a catalytic amount of TPAP at room temperature. 
The mixture was stirred at the same temperature for 10 min. The mixture was filtered through 
short column chromatography (hexane/EtOAc = 3:1). Concentration and column 
chromatography (hexane/EtOAc = 8:1) gave butenolide 1a (2.5 mg, 27% in two steps, 43% 
based on recovered 32a in two steps): colorless amorphous solid; Rf = 0.46 (hexane/EtOAc = 
2:1); [α]D29 +92.2 (c 0.19, CHCl3); IR (neat) 2955, 2914, 2886, 1746, 1710 cm–1; 1H and 13C 
NMR Table S1; HRMS (ESI–TOF) calcd for C20H30O3Na [M + Na]+ 341.2093, found 
341.2092. 
Butenolide 1b. To a solution of triene 32b (13.0 mg, 37.3 μmol) in toluene (7.5 mL) was 
added the second-generation Hoveyda–Grubbs catalyst (33) (1.2 mg, 1.87 μmol) at room 
temperature. The mixture was stirred at 100 °C for 30 h. The mixture was filtered through 
short column chromatography (hexane/EtOAc = 1:1). Concentration and column 
chromatography (hexane/EtOAc = 3:1) gave butenolide 34b (4.2 mg) and triene 32b (4.8 mg, 
37% recovery). Butenolide 34b was used for the next step without further purification. 
To a solution of alcohol 34b obtained above (4.2 mg) in CH2Cl2 (1.0 mL) were added 
MS4Å (5.0 mg), NMO (7.7 mg, 65.5 μmol), and a catalytic amount of TPAP at room 
temperature. The mixture was stirred at the same temperature for 10 min. The mixture was 
filtered through short column chromatography (hexane/EtOAc = 3:1). Concentration and 
column chromatography (hexane/EtOAc = 8:1) gave butenolide 1b (3.6 mg, 30% in two steps, 
48% based on recovered 32b in two steps): colorless amorphous solid; Rf = 0.46 
(hexane/EtOAc = 2:1); [α]D29 +97.4 (c 0.21, CHCl3); IR (neat) 2956, 2925, 2876, 1751, 1710 
cm–1; 1H and 13C NMR Table S2; HRMS (ESI–TOF) calcd for C20H30O3Na [M + Na]+ 
341.2093, found 341.2098. 
Alcohol 37. To a solution of alcohol 25a (77.3 mg, 0.195 mmol) in CH2Cl2 (2.0 mL) were 
added PhI(OAc)2 (94.2 mg, 0.293 mmol) and TEMPO (6.01 mg, 39.0 μmol) at room 
temperature. The mixture was stirred at the same temperature for 2 h. The reaction was 
quenched with saturated aqueous Na2S2O3. The mixture was diluted with Et2O, washed with 
saturated aqueous NaHCO3, H2O, and brine, and then dried over Na2SO4. Concentration and 
short column chromatography (hexane/EtOAc = 80:1) gave the corresponding aldehyde (62.5 
mg), which was used for the next step without further purification. 
A mixture of the aldehyde obtained above (62.5 mg) and chiral allylic boronate 35 (68.7 mg, 
0.187 mmol) in toluene (0.1 mL) was stirred at room temperature for 38 h. After the reaction 
was quenched with H2O, the mixture was diluted with EtOAc and dried over Na2SO4. 
Concentration and short column chromatography (hexane/EtOAc = 10:1) gave a 
diastereomeric mixture of alcohol 36 and its C6 stereoisomer (100 mg, dr = 4.4:1), which was 
used for the next step without further purification. 
To a solution of a diastereomeric mixture of alcohol 36 and its C6 stereoisomer (100 mg, dr 
= 4.4:1) in CH2Cl2 (1.5 mL) were added i-Pr2NEt (0.48 mL, 2.78 mmol), MOMCl (0.18 mL, 
2.34 mmol), and TBAI (28.8 mg, 78.0 μmol) at room temperature. The mixture was stirred at 
the same temperature for 1 h. The reaction was quenched with saturated aqueous NH4Cl. The 
mixture was diluted with EtOAc, washed with saturated aqueous NH4Cl, saturated aqueous 
NaHCO3, H2O, and brine, and then dried over Na2SO4. Concentration and short column 
chromatography (hexane/EtOAc = 30:1) gave a diastereomeric mixture of the corresponding 
MOM ethers (96.7 mg, dr = 4.4:1), which was used for the next step without further 
purification. 
To a solution of a diastereomeric mixture of the TBS ethers obtained above (96.7 mg, dr = 
4.4:1) in THF (1.6 mL) was added TBAF (1.0 M in THF, 0.8 mL, 0.800 mmol) at room 
temperature. The mixture was stirred at 60 °C for 5 h. The mixture was diluted with EtOAc, 
washed with H2O and brine, and then dried over Na2SO4. Concentration and column 
chromatography (hexane/EtOAc = 7:1) gave a diastereomeric mixture of alcohol 37 and its 
C6 stereoisomer (52.2 mg, 61% in four steps, dr = 4.4:1): colorless oil; Rf = 0.42 
(hexane/EtOAc = 4:1); [α]D26 +7.8 (c 0.98, CHCl3); IR (neat) 3476, 2955, 2927, 1715 
cm–1; 1H NMR (400 MHz, CDCl3) δ 6.21 (brs, 1 H), 5.90 (ddd, J = 17.2, 10.4, 6.4 Hz, 1 H), 
5.62–5.59 (m, 1 H), 5.25 (d, J = 17.2 Hz, 1 H), 5.15 (d, J = 10.4 Hz, 1 H), 5.10 (t, J = 7.2 Hz, 
1 H), 4.68–4.57 (m, 2 H), 4.21 (q, J = 7.2 Hz, 2 H), 4.14–4.11 (m, 1 H), 3.86–3.80 (m, 1 H), 
3.34–3.33 (m, 3 H), 2.58–2.38 (m, 2 H), 2.06–1.91 (m, 5 H), 1.59 (s, 3 H), 1.44–1.26 (m, 7 H), 
1.30 (t, J = 7.2 Hz, 3 H), 1.22–1.09 (m, 1 H), 0.94–0.90 (m, 9 H); 13C NMR (100 MHz, 
CDCl3) δ 167.0, 140.3, 137.7, 135.1, 127.1, 124.8, 124.7, 115.3, 95.6, 95.5, 74.9, 74.4, 60.7, 
55.6, 48.8, 42.5, 39.4, 38.4, 38.0, 37.7, 37.0, 29.2, 28.9, 27.8, 25.4, 25.3, 24.6, 21.2, 20.0, 19.4, 
18.9, 16.0, 14.2; HRMS (ESI–TOF) calcd for C26H46O5Na [M + Na]+ 461.3243, found 
461.3241. 
Lactone 38. To a solution of a diastereomeric mixture of ester 37 and its C6 stereoisomer 
(148 mg, 0.339 mmol, dr = 4.4:1) in THF (4.1 mL), MeOH (1.4 mL), and H2O (1.4 mL) was 
added LiOH·H2O (42.6 mg, 1.01 mmol) at room temperature. The mixture was stirred at the 
same temperature for 17 h. The mixture was neutralized with aqueous HCl at 0 °C. The 
mixture was diluted with EtOAc and washed with H2O and brine. The aqueous phase was 
extracted with EtOAc three times and the combined organic phase was dried over Na2SO4. 
Concentration and short column chromatography (hexane/EtOAc = 3:1) gave a diastereomeric 
mixture of the corresponding carboxylic acids (130 mg, dr = 4.4:1), which was used for the 
next step without further purification. 
To a solution of MNBA (158 mg, 0.458 mmol) and DMAP (112 mg, 0.918 mmol) in CH2Cl2 
(138 mL) was slowly added a diastereomeric mixture of the hydroxycarboxylic acids obtained 
above (130 mg, dr = 4.4:1) in CH2Cl2 (9.0 mL at 0.4 mL/h + 3.0 mL at 6.0 mL/h + 3.0 mL at 
6.0 mL/h) at room temperature with a syringe pump for 24 h. The mixture was stirred at the 
same temperature for further 11 h. The reaction was quenched with saturated aqueous NH4Cl. 
The mixture was concentrated, washed with saturated aqueous NaHCO3, H2O, and brine, and 
then dried over Na2SO4. Concentration and column chromatography (hexane/EtOAc = 30:1) 
gave a diastereomeric mixture of lactone 38 and its C6 stereoisomer (102 mg, 77% in two 
steps, dr = 4.4:1): colorless oil; Rf = 0.58 (hexane/EtOAc = 7:1); [α]D27 –2.8 (c 0.99, CHCl3); 
IR (neat) 2954, 2927, 1714 cm–1; 1H NMR (400 MHz, CDCl3) δ 6.25–6.20 (m, 1 H), 
5.92–5.80 (m, 1 H), 5.74 (s, 1 H), 5.69–5.62 (m, 1 H), 5.27–5.18 (m, 2 H), 4.98 (t, J = 6.8 Hz, 
1 H), 4.73–4.52 (m, 2 H), 3.87–3.81 (m, 1 H), 3.39–3.29 (m, 3 H), 2.91–2.74 (m, 1 H), 
2.31–2.24 (m, 1 H), 2.11–1.93 (m, 5 H), 1.85–1.77 (m, 1 H), 1.59–1.21 (m, 10 H), 0.98–0.86 
(m, 9 H); 13C NMR (100 MHz, CDCl3) δ 165.6, 137.4, 135.8, 134.7, 134.1, 127.0, 125.7, 
116.4, 115.9, 95.3, 94.8, 75.9, 75.3, 74.6, 55.5, 55.4, 45.9, 45.7, 43.4, 40.8, 38.4, 37.9, 37.6, 
37.1, 37.0, 35.5, 29.7, 28.3, 27.9, 27.1, 24.4, 23.7, 23.5, 23.3, 21.7, 21.0, 20.5, 20.0, 19.6, 18.5, 
16.2, 15.7; HRMS (ESI–TOF) calcd for C24H40O4Na [M + Na]+ 415.2824, found 415.2825. 
Alcohol S8. To a solution of a diastereomeric mixture of MOM ether 38 and its C6 
stereoisomer (6.9 mg, 17.6 μmol, dr = 4.4:1) in Me2S (0.4 mL) was added BF3·OEt2 (11 μL, 
88.0 μmol) at 0 °C. The mixture was stirred at the same temperature for 30 min. The mixture 
was quenched with saturated aqueous NaHCO3. The mixture was diluted with EtOAc, 
washed with H2O and brine, and then dried over Na2SO4. Concentration and column 
chromatography (hexane/EtOAc = 7:1) gave a diastereomeric mixture of alcohol S8 and its 
C6 stereoisomer (5.3 mg, 86%, dr = 4.4:1): colorless oil; Rf = 0.38 (hexane/EtOAc = 4:1); 
[α]D26 –1.5 (c 1.02, CHCl3); IR (neat) 3415, 2955, 2927, 2870, 1713 cm–1; 1H NMR (400 
MHz, CDCl3) δ 6.28 (s, 0.19 H), 6.20 (s, 0.81 H), 6.28–6.20 (m, 1 H), 5.86 (ddd, J = 16.8, 
10.8, 5.6 Hz, 1 H), 5.67–5.60 (m, 2 H), 5.23 (d, J = 16.8 Hz, 1 H), 5.20 (d, J = 10.8 Hz, 1 H), 
5.03–5.00 (m, 1 H), 3.92–3.86 (m, 1 H), 2.87 (dd, J = 13.6, 3.6 Hz, 0.19 H), 2.69 (dd, J = 13.6, 
6.0 Hz, 0.81 H), 2.38–2.23 (m, 1 H), 2.05–1.96 (m, 4 H), 1.86–1.78 (m, 1 H), 1.68–1.36 (m, 7 
H), 1.57 (s, 3 H), 1.17–1.10 (m, 1 H), 0.99–0.89 (m, 9 H); 13C NMR (100 MHz, CDCl3) δ 
166.6, 165.8, 137.8, 137.7, 135.5, 135.0, 134.6, 134.4, 134.0, 127.6, 127.0, 125.8, 116.4, 
116.0, 76.0, 75.8, 69.5, 69.0, 46.3, 45.9, 45.3, 42.6, 41.7, 40.7, 37.4, 37.2, 37.1, 35.0, 29.3, 
28.8, 28.3, 28.1, 25.4, 23.8, 23.4, 23.1, 21.8, 20.8, 20.7, 20.3, 20.0, 18.5, 16.1, 16.0; HRMS 
(ESI–TOF) calcd for C22H36O3Na [M + Na]+ 371.2562, found 371.2562. 
Sarcophytonolide E (2). To a solution of a diastereomeric mixture of triene S8 and its C6 
stereoisomer (4.0 mg, 11.5 μmol, dr = 4.4:1) in toluene (2.3 mL) was added the 
second-generation Hoveyda–Grubbs catalyst (33) (0.7 mg, 1.15 μmol) at room temperature. 
The mixture was stirred at 100 °C for 32 h. The mixture was filtered through short column 
chromatography (hexane/EtOAc = 1:1). Concentration and column chromatography 
(hexane/EtOAc = 7:1, 2:1) gave sarcophytonolide E (2) (1.3 mg, 35%, 51% based on 
recovered S8) and triene S8 (1.2 mg, 30% recovery): colorless oil; Rf = 0.39 (hexane/EtOAc = 
1:1); [α]D27 +48.7 (c 0.17, CHCl3); literature10b [α]D20 +30 (c 0.29, CHCl3); IR (neat) 3424, 
2950, 2925, 2870, 2852, 1754 cm–1; 1H and 13C NMR Table S3; HRMS (ESI–TOF) calcd for 
C20H32O3Na [M + Na]+ 343.2249, found 343.2250. 
Pivalate 39. To a solution of geraniol (1.0 mL, 5.71 mmol) in CH2Cl2 (19 mL) were added 
pyridine (0.69 mL, 8.57 mmol) and PivCl (0.83 mL, 6.85 mmol) at room temperature. After 
the mixture was stirred at the same temperature for 2 h, the reaction was quenched with 
saturated aqueous NH4Cl. The mixture was diluted with EtOAc, washed with H2O and brine, 
and then dried over Na2SO4. Concentration and column chromatography (hexane/EtOAc = 
30:1) gave pivalate 39 (1.31 g, 96%): colorless oil; Rf = 0.50 (hexane/EtOAc = 10:1); IR 
(neat) 2970, 2924, 2870, 1730 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.32 (td, J = 6.8, 1.2 Hz, 
1 H), 5.10–5.06 (m, 1 H), 4.57 (d, J = 6.8 Hz, 2 H), 2.13–2.02 (m, 4 H), 1.70 (s, 3 H), 1.68 (s, 
3 H), 1.61 (s, 3 H), 1.20 (s, 9 H); 13C NMR (100 MHz, CDCl3) δ 178.4, 141.5, 131.6, 123.7, 
118.7, 61.3, 39.5, 38.8, 27.3, 26.4, 25.7, 17.7, 16.5; HRMS (ESI–TOF) calcd for C15H26O2Na 
[M + Na]+ 261.1830, found 261.1832. 
Allylic Alcohol 40. To a mixture of SeO2 (8.2 mg, 73.5 μmol) and salicylic acid (20.3 mg, 
0.147 mmol) in CH2Cl2 (2.0 mL) was added TBHP (ca. 5.0 M solution in 
2,2,4-trimethylpentane, 0.59 mL, 2.94 mmol) at room temperature. After the mixture was 
stirred at the same temperature for 10 min, to the mixture was added alkene 39 (351 mg, 1.47 
mmol) in CH2Cl2 (0.5 mL + 0.3 mL + 0.2 mL) at room temperature. After the mixture was 
stirred at the same temperature for 7 h, the reaction was quenched with saturated aqueous 
Na2S2O3 at 0 °C. The mixture was diluted with EtOAc, washed with H2O and brine, and then 
dried over Na2SO4. Concentration gave the mixture of allylic alcohol 40 and the 
corresponding α,β-unsaturated aldehyde (414 mg), which was used for the next step without 
further purification. 
To a solution of the mixture obtained above (414 mg) in EtOH (7.4 mL) was added NaBH4 
(27.8 mg, 0.735 mmol) at 0 °C. After the mixture was stirred at the same temperature for 1 h, 
the reaction was quenched with saturated aqueous NH4Cl. The mixture was diluted with 
EtOAc, washed with H2O and brine, and then dried over Na2SO4. Concentration and column 
chromatography (hexane/EtOAc = 5:1) gave allylic alcohol 40 (214 mg, 57% in two steps): 
colorless oil; Rf = 0.22 (hexane/EtOAc = 4:1); IR (neat) 3437, 2973, 2927, 2868, 1727 
cm–1; 1H NMR (400 MHz, CDCl3) δ 5.36 (td, J = 6.8, 1.3 Hz, 1 H), 5.31 (td, J = 6.8, 1.2 Hz, 
1 H), 4.56 (d, J = 6.8 Hz, 2 H), 3.99 (s, 2 H), 2.20–2.14 (m, 2 H), 2.10–2.07 (m, 2 H), 1.70 (s, 
3 H), 1.67 (s, 3 H), 1.19 (s, 9 H); 13C NMR (100 MHz, CDCl3) δ 178.5, 140.9, 135.1, 125.3, 
119.1, 68.9, 61.4, 39.1, 38.8, 27.3, 25.8, 16.5, 13.8; HRMS (ESI–TOF) calcd for C15H26O3Na 
[M + Na]+ 277.1780, found 277.1783. 
Allylic Bromide 41. To a solution of allylic alcohol 40 (524 mg, 2.06 mmol) in CH3CN (10 
mL) were added PPh3 (808 mg, 3.08 mmol) and CBr4 (1.01 g, 3.05 mmol) at 0 °C. After the 
mixture was stirred at the same temperature for 20 min, the mixture was filtered through short 
column chromatography (hexane/EtOAc = 10:1). Concentration and column chromatography 
(hexane/EtOAc = 50:1) gave allylic bromide 41 (615 mg, 94%): colorless oil; Rf = 0.36 
(hexane/EtOAc = 20:1); IR (neat) 2972, 2932, 2870, 1726 cm–1; 1H NMR (400 MHz, CDCl3) 
δ 5.57 (t, J = 6.8 Hz, 1 H), 5.34–5.30 (m, 1 H), 4.57 (d, J = 6.8 Hz, 2 H), 3.96 (s, 2 H), 
2.19–2.07 (m, 4 H), 1.76 (s, 3 H), 1.70 (s, 3 H), 1.20 (s, 9 H); 13C NMR (100 MHz, CDCl3) δ 
178.4, 140.6, 132.3, 130.4, 119.3, 61.2, 41.5, 38.8, 38.6, 27.3, 26.5, 16.5, 14.7; HRMS 
(ESI–TOF) calcd for C15H25BrO2Na [M + Na]+ 339.0936, found 339.0946. 
Sulfone 42. To a solution of sulfone 20 (142 mg, 0.284 mmol) in THF (2.0 mL) was added 
NaHMDS (1.0 M in THF, 0.34 mL, 0.340 mmol) at –78 °C. The mixture was stirred at the 
same temperature for 30 min. To the mixture was added allylic bromide 41 (117 mg, 0.369 
mmol) in THF (0.5 mL + 0.3 mL + 0.2 mL) at –78 °C. The mixture was gradually warmed up 
to room temperature for 3 h. The reaction was quenched with saturated aqueous NH4Cl. The 
mixture was diluted with EtOAc, washed with H2O and brine, and then dried over Na2SO4. 
Concentration and column chromatography (hexane/EtOAc = 20:1) gave sulfone 42 (186 mg, 
89%): colorless oil; Rf = 0.36 (hexane/EtOAc = 10:1); [α]D25 +18.0 (c 1.05, CHCl3); IR (neat) 
2956, 2924, 2852, 1728 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.82–7.80 (m, 2 H), 7.58–7.55 
(m, 1 H), 7.49–7.45 (m, 2 H), 5.29 (t, J = 6.8 Hz, 1 H), 5.11 (t, J = 6.3 Hz, 1 H), 4.55 (d, J = 
6.8 Hz, 2 H), 4.33–4.30 (m, 1 H), 3.74–3.64 (m, 2 H), 3.47 (d, J = 8.5 Hz, 1 H), 2.72–2.58 (m, 
2 H), 2.36 (d, J = 6.7 Hz, 1 H), 2.17–2.09 (m, 1 H), 1.98–1.96 (m, 2 H), 1.91–1.84 (m, 2 H), 
1.67 (s, 3 H), 1.22 (s, 3 H), 1.20 (s, 9 H), 0.95 (d, J = 8.4 Hz, 3 H), 0.94 (s, 9 H), 0.90 (d, J = 
6.8 Hz, 3 H), 0.87 (s, 9 H), 0.14 (s, 3 H), 0.13 (s, 3 H), 0.13 (s, 3 H), 0.13 (s, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 178.4, 141.3, 140.9, 132.9, 130.8, 128.8, 128.5, 127.0, 118.8, 73.8, 68.3, 
61.8, 61.3, 44.2, 39.0, 38.8, 35.6, 27.3, 26.4, 26.3, 26.2, 23.2, 20.6, 18.7, 18.4, 16.5, 15.4, –3.2, 
–4.7, –5.1, –5.2; HRMS (ESI–TOF) calcd for C40H72O6SSi2Na [M + Na]+ 759.4486, found 
759.4490. 
Alcohol 43. To a solution of pivalate 42 (1.14 g, 1.55 mmol) in CH2Cl2 (16 mL) was added 
DIBAL-H (1.02 M in hexane, 4.6 mL, 4.69 mmol) at –78 °C. The mixture was stirred at the 
same temperature for 20 min. The reaction was quenched with MeOH. The mixture was 
filtered through a Celite pad and washed with EtOAc. Concentration and short column 
chromatography (hexane/EtOAc = 3:1) gave the corresponding alcohol (949 mg), which was 
used for the next step without further purification. 
To a solution of lithium wire (1.01 g, 145 mmol) in liquid NH3 (60 mL) was added sulfone 
42 (949 mg, 1.45 mmol) in THF/t-BuOH (20 mL/10 mL) and THF (3.0 mL + 2.0 mL for 
rinse) at –78 °C. The mixture was stirred at the same temperature for 20 min. The reaction 
was quenched with a 1:1 solution of saturated aqueous NH4Cl and MeOH. The mixture was 
diluted with EtOAc, warmed up to room temperature, and stirred at the same temperature. The 
mixture was washed with H2O and brine, and then dried over Na2SO4. Concentration and 
column chromatography (hexane/EtOAc = 7:1, 3:1) gave alcohol 43 (508 mg) and sulfone 42 
(201 mg). 
To a solution of lithium wire (214 mg, 30.8 mmol) in liquid NH3 (30 mL) was added sulfone 
42 recovered above (201 mg) in THF/t-BuOH (4.2 mL/2.1 mL) and THF (1.0 mL + 1.0 mL 
for rinse) at –78 °C. The mixture was stirred at the same temperature for 20 min. The reaction 
was quenched with a 1:1 solution of saturated aqueous NH4Cl and MeOH. The mixture was 
diluted with EtOAc, warmed up to room temperature, and stirred at the same temperature. The 
mixture was washed with H2O and brine, and then dried over Na2SO4. Concentration and 
column chromatography (hexane/EtOAc = 7:1) gave alcohol 43 (117 mg, totally 625 mg, 79% 
in two steps): colorless oil; Rf = 0.41 (hexane/EtOAc = 4:1); [α]D24 –3.9 (c 1.07, CHCl3); IR 
(neat) 3324, 2955, 2727, 2856 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.42 (td, J = 6.8, 1.2 Hz, 
1 H), 5.11 (t, J = 6.2 Hz, 1 H), 4.16 (d, J = 6.8 Hz, 2 H), 3.79–3.76 (m, 1 H), 3.60–3.50 (m, 2 
H), 2.14–2.02 (m, 5 H), 1.92–1.85 (m, 2 H), 1.69 (s, 3 H), 1.61 (s, 3 H), 1.48–1.29 (m, 4 H), 
0.90–0.88 (m, 6 H), 0.89 (s, 9 H), 0.88 (s, 9 H), 0.07 (s, 3 H), 0.06 (s, 3 H), 0.05 (s, 3 H), 0.05 
(s, 3 H); 13C NMR (100 MHz, CDCl3) δ 139.8, 135.9, 123.6, 123.3, 74.8, 65.8, 59.4, 46.1, 
39.7, 39.1, 27.1, 26.4, 26.1, 26.1, 24.3, 22.6, 19.4, 18.4, 18.3, 16.4, 16.1, –3.9, –4.7, –5.2, 
–5.3; HRMS (ESI–TOF) calcd for C29H60O3Si2Na [M + Na]+ 535.3979, found 535.3976. 
Alcohol 44. To a solution of alcohol 43 (701 mg, 1.37 mmol) in CH2Cl2 (14 mL) were 
added pyridine (0.17 mL, 2.06 mmol) and PivCl (0.20 mL, 1.64 mmol) at room temperature. 
The mixture was stirred at the same temperature for 5 h. The reaction was quenched with 
saturated aqueous NH4Cl. The mixture was diluted with EtOAc, washed with H2O, and brine, 
and then dried over Na2SO4. Concentration and short column chromatography 
(hexane/EtOAc = 60:1) gave the corresponding pivalate (770 mg), which was used for the 
next step without further purification. 
To a solution of the bis-TBS ether obtained above (770 mg) in MeOH (6.5 mL) and CH2Cl2 
(6.5 mL) was added CSA (89.9 mg, 0.387 mmol) at 0 °C. The mixture was stirred at the same 
temperature for 1 h. The reaction was quenched with Et3N. The mixture was diluted with 
EtOAc, washed with H2O and brine, and then dried over Na2SO4. Concentration and column 
chromatography (hexane/EtOAc = 15:1) gave alcohol 44 (317 mg) and the bis-TBS ether 
(309 mg). 
To a solution of the bis-TBS ether recovered above (309 mg) in MeOH (2.6 mL) and 
CH2Cl2 (2.6 mL) was added CSA (36.0 mg, 0.155 mmol) at 0 °C. The mixture was stirred at 
the same temperature for 1 h. The reaction was quenched with Et3N. The mixture was diluted 
with EtOAc, washed with H2O and brine, and then dried over Na2SO4. Concentration and 
column chromatography (hexane/EtOAc = 15:1) gave alcohol 44 (135 mg) and the bis-TBS 
ether (112 mg). 
To a solution of the bis-TBS ether recovered above (112 mg) in MeOH (1.0 mL) and 
CH2Cl2 (1.0 mL) was added CSA (13.1 mg, 56.4 μmol) at 0 °C. The mixture was stirred at 
the same temperature for 1 h. The reaction was quenched with Et3N. The mixture was diluted 
with EtOAc, washed with H2O and brine, and then dried over Na2SO4. Concentration and 
column chromatography (hexane/EtOAc = 15:1) gave alcohol 44 (50.8 mg, totally 503 mg, 
76% in two steps): colorless oil; Rf = 0.39 (hexane/EtOAc = 7:1); [α]D24 +5.9 (c 1.05, 
CHCl3); IR (neat) 3501, 2956, 2927, 2852, 1730 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.32 (td, 
J = 6.8, 1.2 Hz, 1 H), 5.11–5.08 (m, 1 H), 4.57 (d, J = 6.8 Hz, 2 H), 3.81–3.77 (m, 1 H), 
3.58–3.56 (m, 2 H), 2.11–1.94 (m, 6 H), 1.86–1.78 (m, 1 H), 1.70 (s, 3 H), 1.63 (brs, 1 H), 
1.60 (s, 3 H), 1.43–1.25 (m, 3 H), 1.20 (s, 9 H), 0.92 (s, 9 H), 0.91 (d, J = 6.0 Hz, 3 H), 0.89 
(d, J = 6.8 Hz, 3 H), 0.11 (s, 3 H), 0.10 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 178.4, 141.6, 
135.8, 123.6, 118.7, 74.6, 64.3, 61.4, 47.2, 39.7, 39.6, 38.8, 27.9, 27.3, 26.4, 26.0, 24.7, 21.7, 
19.4, 18.2, 16.6, 16.1, –4.2, –4.3; HRMS (ESI–TOF) calcd for C28H54O4SiNa [M + Na]+ 
505.3689, found 505.3694. 
Alcohol 45. To a solution of alcohol 44 (250 mg, 0.518 mmol) in CH2Cl2 (5.2 mL) were 
added PhI(OAc)2 (250 mg, 0.777 mmol) and TEMPO (16.3 mg, 0.104 mmol) at room 
temperature. The mixture was stirred at the same temperature for 22 h. The reaction was 
quenched with saturated aqueous Na2S2O3. The mixture was diluted with EtOAc, washed 
with saturated aqueous NaHCO3, H2O, and brine, and then dried over Na2SO4. Concentration 
and short column chromatography (hexane/EtOAc = 30:1) gave the corresponding aldehyde 
(212 mg), which was used for the next step without further purification. 
To a suspension of Ph3P+CH3Br− (393 mg, 1.10 mmol) in THF (3.0 mL) was added 
NaHMDS (1.0 M in THF, 1.06 mL, 1.06 mmol) at 0 °C. The mixture was stirred at the same 
temperature for 20 min. To the mixture was added the aldehyde obtained above (212 mg) in 
THF (1.0 mL + 0.2 mL + 0.2 mL) at 0 °C. The mixture was stirred at room temperature for 1 
h. The reaction was quenched with saturated aqueous NH4Cl. The mixture was diluted with 
EtOAc, washed with H2O and brine, and then dried over Na2SO4. Concentration and short 
column chromatography (hexane/EtOAc = 60:1) gave the corresponding alkene (199 mg), 
which was used for the next step without further purification. 
To a solution of the pivalate obtained above (199 mg) in CH2Cl2 (4.1 mL) was added 
DIBAL-H (1.02 M in hexane, 1.2 mL, 1.24 mmol) at –78 °C. The mixture was stirred at the 
same temperature for 20 min. The reaction was quenched with MeOH. The mixture was 
filtered through a Celite pad and washed with EtOAc. Concentration and column 
chromatography (hexane/EtOAc = 7:1) gave alcohol 45 (152 mg, 74% in three steps): 
colorless oil; Rf = 0.36 (hexane/EtOAc = 4:1); [α]D24 +7.0 (c 1.08, CHCl3); IR (neat) 3324, 
2955, 2927, 2856 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.81 (ddd, J = 17.2, 10.4, 6.4 Hz, 1 H), 
5.42 (td, J = 6.9, 1.1 Hz, 1 H), 5.15 (dt, J = 17.2, 1.4 Hz, 1 H), 5.09–5.06 (m, 2 H), 4.16–4.12 
(m, 3 H), 2.14–2.01 (m, 5 H), 1.95–1.85 (m, 2 H), 1.69 (s, 3 H), 1.59 (s, 3 H), 1.43–1.35 (m, 2 
H), 1.30–1.17 (m, 2 H), 0.90 (d, J = 6.0 Hz, 3 H), 0.90 (s, 9 H), 0.88 (d, J = 6.8 Hz, 3 H), 0.05 
(s, 3 H), 0.02 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 140.7, 139.8, 136.0, 123.6, 123.3, 
114.5, 75.5, 59.4, 49.9, 39.6, 27.7, 26.4, 26.0, 24.5, 21.9, 19.0, 18.3, 16.4, 16.0, –4.0, –4.8; 
HRMS (ESI–TOF) calcd for C24H46O2SiNa [M + Na]+ 417.3165, found 417.3166. 
Alcohol 47. To a solution of alcohol 45 (127 mg, 0.322 mmol) in CH2Cl2 (3.2 mL) were 
added PhI(OAc)2 (156 mg, 0.483 mmol) and TEMPO (10.1 mg, 64.4 μmol) at room 
temperature. The mixture was stirred at the same temperature for 5 h. The reaction was 
quenched with saturated aqueous Na2S2O3. The mixture was diluted with EtOAc, washed 
with saturated aqueous NaHCO3, H2O, and brine, and then dried over Na2SO4. Concentration 
and short column chromatography (hexane/EtOAc = 20:1) gave the corresponding aldehyde 
(121 mg), which was used for the next step without further purification. 
A mixture of the aldehyde obtained above (121 mg) and chiral allylic boronate 35 (136 mg, 
0.370 mmol) in toluene (0.2 mL) was stirred at room temperature for 2 days. After the 
reaction was quenched with H2O, the mixture was diluted with EtOAc and dried over 
Na2SO4. Concentration and short column chromatography (hexane/EtOAc = 8:1) gave 
alcohol 46 (231 mg, dr = 17:1), which was used for the next step without further purification. 
To a solution of alcohol 46 obtained above (231 mg) in CH2Cl2 (3.1 mL) were added 
i-Pr2NEt (0.95 mL, 5.54 mmol), MOMCl (0.35 mL, 4.62 mmol), and TBAI (56.9 mg, 0.154 
mmol) at room temperature. The mixture was stirred at the same temperature for 2 h. The 
reaction was quenched with saturated aqueous NH4Cl. The mixture was diluted with EtOAc, 
washed with saturated aqueous NH4Cl, saturated aqueous NaHCO3, H2O, and brine, and then 
dried over Na2SO4. Concentration and short column chromatography (hexane/EtOAc = 15:1) 
gave the corresponding MOM ether (210 mg), which was used for the next step without 
further purification. 
To a solution of the TBS ether obtained above (210 mg) in THF (3.1 mL) was added TBAF 
(1.0 M in THF, 1.5 mL, 1.50 mmol) at room temperature. The mixture was stirred at 60 °C for 
5 h. The mixture was diluted with EtOAc, washed with H2O and brine, and then dried over 
Na2SO4. Concentration and column chromatography (hexane/EtOAc = 5:1) gave alcohol 47 
(107 mg, 76% in four steps): colorless oil; Rf = 0.31 (hexane/EtOAc = 4:1); [α]D21 +53.2 (c 
1.06, CHCl3); IR (neat) 3481, 2954, 2932, 1716 cm–1; 1H NMR (400 MHz, CDCl3) δ 6.20 (d, 
J = 1.6 Hz, 1 H), 5.90 (ddd, J = 17.1, 10.5, 6.4 Hz, 1 H), 5.60 (s, 1 H), 5.25 (d, J = 17.1 Hz, 1 
H), 5.16 (d, J = 10.5 Hz, 1 H), 5.07 (t, J = 6.5 Hz, 1 H), 5.01 (d, J = 9.0 Hz, 1 H), 4.64 (d, J = 
6.4 Hz, 1 H), 4.58–4.53 (m, 1 H), 4.45 (d, J = 6.4 Hz, 1 H), 4.22 (q, J = 7.1 Hz, 2 H), 4.12 (t, 
J = 6.4 Hz, 1 H), 3.31 (s, 3 H), 2.60 (dd, J = 13.8, 7.9 Hz, 1 H), 2.47 (dd, J = 13.8, 5.7 Hz, 1 
H), 2.10–1.91 (m, 7 H), 1.66 (d, J = 1.0 Hz, 3 H), 1.59 (s, 3 H), 1.54 (brs, 1 H), 1.37–1.26 (m, 
3 H), 1.31 (t, J = 7.1 Hz, 3 H), 0.92 (d, J = 6.8 Hz, 3 H), 0.91 (d, J = 6.8 Hz, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 167.0, 140.4, 137.2, 135.6, 127.1, 124.5, 123.9, 115.3, 93.2, 74.9, 70.4, 
60.6, 55.2, 48.8, 39.6, 39.4, 38.6, 27.8, 26.4, 24.6, 21.2, 18.9, 16.7, 16.1, 14.3; HRMS 
(ESI–TOF) calcd for C26H44O5Na [M + Na]+ 459.3087, found 459.3083. 
Lactone 48. To a solution of ester 47 (38.8 mg, 88.9 μmol) in THF (0.6 mL), MeOH (0.2 
mL), and H2O (0.2 mL) was added LiOH·H2O (7.5 mg, 0.178 mmol) at room temperature. 
The mixture was stirred at the same temperature for 41 h. The mixture was neutralized with 
aqueous HCl at 0 °C. The mixture was diluted with EtOAc and washed with H2O and brine. 
The aqueous phase was extracted with EtOAc three times and the combined organic phase 
was dried over Na2SO4. Concentration and short column chromatography (CH2Cl2/MeOH = 
20:1) gave the corresponding carboxylic acid (39.9 mg), which was used for the next step 
without further purification. 
To a solution of MNBA (73.3 mg, 0.213 mmol) and DMAP (52.2 mg, 0.427 mmol) in 
CH2Cl2 (34 mL) was slowly added the hydroxycarboxylic acid obtained above (39.9 mg) in 
CH2Cl2 (6.4 mL at 0.4 mL/h + 2.0 mL at 2.0 mL/h + 2.0 mL at 2.0 mL/h) at 40 °C with a 
syringe pump for 18 h. The mixture was stirred at the same temperature for further 33 h. The 
reaction was quenched with saturated aqueous NH4Cl. The mixture was concentrated, washed 
with saturated aqueous NaHCO3, H2O, and brine, and then dried over Na2SO4. Concentration 
and column chromatography (hexane/EtOAc = 30:1) gave lactone 48 (22.8 mg, 66% in two 
steps): colorless oil; Rf = 0.44 (hexane/EtOAc = 7:1); [α]D21 +134 (c 1.03, CHCl3); IR (neat) 
2954, 2929, 1714 cm–1; 1H NMR (400 MHz, CDCl3) δ 6.22 (d, J = 1.2 Hz, 1 H), 5.93–5.85 
(m, 1 H), 5.73 (s, 1 H), 5.71–5.69 (m, 1 H), 5.27–5.18 (m, 2 H), 4.96–4.91 (m, 2 H), 
4.87–4.81 (m, 1 H), 4.68 (d, J = 6.4 Hz, 1 H), 4.54 (d, J = 6.4 Hz, 1 H), 3.39 (s, 3 H), 3.04 (dd, 
J = 13.2, 5.2 Hz, 1 H), 2.35 (dd, J = 13.2, 8.9 Hz, 1 H), 2.19–1.99 (m, 6 H), 1.76–1.68 (m, 1 
H), 1.58 (s, 3 H), 1.54 (s, 3 H), 1.51–1.38 (m, 3 H), 0.94 (d, J = 7.1 Hz, 3 H), 0.92 (d, J = 7.1 
Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 165.2, 140.7, 137.4, 134.6, 127.3, 125.1, 124.2, 
116.3, 93.3, 76.0, 69.3, 55.3, 45.1, 38.5, 38.4, 36.9, 29.9, 24.3, 23.8, 21.6, 20.0, 15.9, 15.8; 
HRMS (ESI–TOF) calcd for C24H38O4Na [M + Na]+ 413.2668, found 413.2673. 
Butenolide S11. To a solution of tetraene 48 (4.0 mg, 10.2 μmol) in toluene (2.0 mL) was 
added the second-generation Hoveyda–Grubbs catalyst (33) (0.6 mg, 1.02 μmol) at room 
temperature. The mixture was stirred at 100 °C for 2 days. The mixture was filtered through 
short column chromatography (EtOAc). Concentration and column chromatography 
(hexane/EtOAc = 6:1) gave butenolide S11 (2.8 mg, 76%): colorless solid; Rf = 0.22 
(hexane/EtOAc = 4:1); [α]D22 +212 (c 0.49, CHCl3); IR (neat) 2959, 2928, 2845, 1747 
cm–1; 1H NMR (400 MHz, CDCl3) δ 7.21 (s, 1 H), 4.98–4.91 (m, 2 H), 4.69 (d, J = 6.4 Hz, 1 
H), 4.69–4.64 (m, 2 H), 4.56 (d, J = 6.4 Hz, 1 H), 3.40 (s, 3 H), 2.83 (d, J = 12.8 Hz, 1 H), 
2.40 (dd, J = 12.8, 11.1 Hz, 1 H), 2.18–2.10 (m, 6 H), 1.71–1.50 (m, 2 H), 1.54 (s, 3 H), 1.50 
(s, 3 H), 1.31–1.21 (m, 2 H), 0.94 (d, J = 5.9 Hz, 3 H), 0.92 (d, J = 6.3 Hz, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 173.0, 151.6, 141.1, 133.0, 129.0, 125.6, 124.9, 93.4, 83.6, 69.4, 55.4, 
44.9, 38.7, 37.0, 32.5, 28.8, 23.8, 22.8, 20.1, 17.7, 16.1, 16.0; HRMS (ESI–TOF) calcd for 
C22H34O4Na [M + Na]+ 385.2355, found 385.2353. 
Sarcophytonolide F (3). To a solution of MOM ether S11 (5.0 mg, 13.8 μmol) in CH2Cl2 
(1.0 mL) were added HMDS (58 μL, 0.276 mmol) and TMSI (20 μL, 0.138 mmol) at 0 °C. 
The mixture was stirred at the same temperature for 20 min. The reaction was quenched with 
saturated aqueous NaHCO3. The mixture was diluted with EtOAc, washed with H2O and 
brine, and then dried over Na2SO4. Concentration and column chromatography 
(hexane/EtOAc = 2:1) gave sarcophytonolide F (3) (3.3 mg, 75%): colorless solid; Rf = 0.28 
(hexane/EtOAc = 1:1); [α]D23 +145 (c 0.54, CHCl3); literature10b [α]D20 +115 (c 0.54, 
CHCl3); IR (neat) 3438, 2936, 2883, 1727 cm–1; 1H and 13C NMR Table S4; HRMS 
(ESI–TOF) calcd for C20H30O3Na [M + Na]+ 341.2093, found 341.2092. 
Synthesis of Sarcophytonolide G (4) by Mitsunobu Reaction. To a mixture of 
sarcophytonolide F (3) (1.6 mg, 5.02 μmol), Ph3P (5.2 mg, 20.1 μmol), and p-nitrobenzoic 
acid (3.4 mg, 20.1 μmol) in THF (1.0 mL) was added DEAD (40% solution in toluene, 9.1 μL, 
20.1 μmol) at 0 °C. After the mixture was stirred at the same temperature for 20 min, the 
reaction was quenched with saturated aqueous NH4Cl. The mixture was diluted with EtOAc, 
washed with H2O and brine, and then dried over Na2SO4. Concentration and column 
chromatography (hexane/EtOAc = 6:1, 2:1) gave the diastereomeric mixture of the 
corresponding benzoates (2.0 mg), which was used for the next step without further 
purification. 
To a solution of the mixture of benzoates obtained above (2.0 mg) in MeOH (0.5 mL) was 
added Na2CO3 (0.6 mg, 6.02 μmol) at 0 °C. The mixture was stirred at the same temperature 
for 20 min. To the mixture was added Na2CO3 (0.6 mg, 6.02 μmol) at 0 °C. The mixture was 
stirred at the same temperature for 10 min. After the mixture was stirred at room temperature 
for 1 h, the mixture was filtered through short column chromatography (EtOAc). 
Concentration and column chromatography (hexane/EtOAc = 3:2) gave sarcophytonolide G 
(4) (0.5 mg, 31% in two steps) and sarcophytonolide F (3) (0.2 mg, 13% in two steps). 
Sarcophytonolide G (4): colorless solid; Rf = 0.41 (hexane/EtOAc = 1:1); [α]D21 +18.1 (c 0.12, 
CHCl3); literature10b,61 [α]D20 –1.6 (c 0.17, CHCl3); IR (neat) 3420, 2958, 2923, 2851, 1736 
cm–1; 1H and 13C NMR Table S5; HRMS (ESI–TOF) calcd for C20H30O3Na [M + Na]+ 
341.2093, found 341.2096. 
Ketone 49. To a solution sarcophytonolide F (3) (4.3 mg, 13.5 μmol) in CH2Cl2 (1.0 mL) 
was added Dess–Martin periodinane (17.2 mg, 40.5 μmol) at room temperature. After the 
mixture was stirred at 40 °C for 10 h, to the mixture were added CH2Cl2 (0.5 mL) and 
Dess–Martin periodinane (5.7 mg, 13.5 μmol) at the same temperature. After the mixture was 
stirred at the same temperature for 13 h, the mixture was filtered through short column 
chromatography (hexane/EtOAc = 1:1). Concentration and column chromatography 
(hexane/EtOAc = 7:2) gave ketone 49 (4.1 mg, 96%): colorless oil; Rf = 0.49 (hexane/EtOAc 
= 2:1); [α]D23 –8.1 (c 0.21, CHCl3); IR (neat) 2958, 2922, 1758, 1686, 1617 cm–1; 1H NMR 
(400 MHz, CDCl3) δ 7.17 (s, 1 H), 6.05 (s, 1 H), 5.04 (dd, J = 6.1, 1.2 Hz, 1 H), 4.91–4.88 (m, 
1 H), 3.58 (d, J = 14.1 Hz, 1 H), 3.13 (d, J = 14.1 Hz, 1 H), 2.33–2.26 (m, 2 H), 2.19–2.12 (m, 
2 H), 2.09 (s, 3 H), 2.03–1.96 (m, 2 H), 1.84–1.76 (m, 1 H), 1.66–1.61 (m, 2 H), 1.54 (s, 3 H), 
1.44–1.35 (m, 1 H), 1.02 (d, J = 6.8 Hz, 3 H), 1.01 (d, J = 6.8 Hz, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 194.8, 160.8, 150.3, 135.9, 129.3, 124.9, 123.9, 123.2, 83.8, 47.0, 41.7, 41.1, 39.3, 
30.0, 26.9, 24.3, 20.4, 20.2, 18.7, 16.2; HRMS (ESI–TOF) calcd for C20H28O3Na [M + Na]+ 
339.1936, found 339.1935. 
Synthesis of Sarcophytonolide G (4) by Stereoselective Reduction. To a solution of 
ketone 49 (2.9 mg, 9.16 μmol) in MeOH (0.6 mL) and CH2Cl2 (0.4 mL) were added CeCl3 
(6.8 mg, 27.5 μmol) and NaBH4 (0.5 mg, 13.7 μmol) at –78 °C. After the mixture was stirred 
at the same temperature for 2 h, the mixture was diluted with Et2O. The reaction was 
quenched with 1 M aqueous NaHSO4. The mixture was warmed up to room temperature, and 
stirred at the same temperature for 20 min. The mixture was washed with H2O and brine, and 
then dried over Na2SO4. Concentration and column chromatography (hexane/EtOAc = 3:2) 
gave sarcophytonolide G (4) (2.1 mg, 72%). 
Alcohol S12. To a solution of diol 16 (3.95 g, 15.0 mmol) in CH2Cl2 (150 mL) were added 
pyridine (2.4 mL, 29.3 mmol) and AcCl (1.8 mL, 24.8 mmol) at –20 °C. After the mixture 
was stirred at the same temperature for 1 h, the reaction was quenched with saturated aqueous 
NH4Cl. The mixture was diluted with EtOAc, washed with H2O and brine, and then dried 
over Na2SO4. Concentration gave the corresponding acetate (4.61 g), which was used for the 
next step without further purification. 
To a solution of the alcohol obtained above (4.61 g) in CH2Cl2 (150 mL) were added 
2,6-lutidine (2.7 mL, 22.8 mmol) and TBSOTf (4.2 mL, 18.2 mmol) at 0 °C. After the mixture 
was stirred at the same temperature for 30 min, the mixture was diluted with EtOAc, washed 
with H2O and brine, and then dried over Na2SO4. Concentration and short column 
chromatography (hexane, hexane/EtOAc = 50:1) gave the corresponding TBS ether (5.44 g), 
which was used for the next step without further purification. 
To a solution of the acetate obtained above (5.44 g) in CH2Cl2 (130 mL) was added 
DIBAL-H (1.02 M in hexane, 31.0 mL, 31.6 mmol) at –78 °C. After the mixture was stirred at 
the same temperature for 20 min, the reaction was quenched with MeOH. The mixture was 
filtered through a Celite pad and washed with EtOAc. Concentration and column 
chromatography (hexane/EtOAc = 20:1) gave alcohol S12 (4.79 g, 85% in three steps): 
colorless oil; Rf = 0.33 (hexane/EtOAc = 10:1); [α]D25 +2.0 (c 0.96, CHCl3); IR (neat) 3436, 
2955, 2858 cm–1; 1H NMR (400 MHz, CDCl3) δ 3.99–3.95 (m, 1 H), 3.83 (brd, J = 2.3 Hz, 1 
H), 3.73–3.71 (m, 2 H), 3.64–3.59 (m, 2 H), 1.79–1.70 (m, 1 H), 1.52–1.48 (m, 1 H), 0.97 (d, 
J = 6.8 Hz, 3 H), 0.92 (d, J = 5.9 Hz, 3 H), 0.91 (s, 9 H), 0.90 (s, 9 H), 0.10 (s, 3 H), 0.09 (s, 3 
H), 0.09 (s, 3 H), 0.09 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 74.0, 64.9, 60.4, 51.6, 26.1, 
26.0, 25.9, 21.8, 20.6, 18.4, 18.1, –4.2, –4.9, –5.3; HRMS (ESI–TOF) calcd for 
C19H44O3Si2Na [M + Na]+ 399.2727, found 399.2728. 
Aldehyde 52. To a solution of alcohol S12 (643 mg, 1.71 mmol) in CH2Cl2 (17 mL) were 
added PhI(OAc)2 (1.05 g, 3.26 mmol) and TEMPO (79.7 mg, 0.510 mmol) at room 
temperature. After the mixture was stirred at the same temperature for 10 h, the reaction was 
quenched with saturated aqueous Na2S2O3. The mixture was diluted with EtOAc, washed 
with saturated aqueous NaHCO3, H2O, and brine, and then dried over Na2SO4. Concentration 
and column chromatography (hexane/EtOAc = 50:1) gave aldehyde 52 (620 mg, 97%): 
colorless oil; Rf = 0.48 (hexane/EtOAc = 20:1); [α]D26 +0.4 (c 1.34, CHCl3); IR (neat) 2956, 
2927, 2856, 1723 cm–1; 1H NMR (400 MHz, CDCl3) δ 9.77 (d, J = 3.4 Hz, 1 H), 4.17–4.10 
(m, 1 H), 3.65 (dd, J = 10.2, 4.9 Hz, 1 H), 3.56 (dd, J = 10.2, 5.6 Hz, 1 H), 2.30–2.17 (m, 2 H), 
1.03 (d, J = 6.6 Hz, 3 H), 0.99 (d, J = 6.8 Hz, 3 H), 0.89 (s, 9 H), 0.88 (s, 9 H), 0.09 (s, 3 H), 
0.09 (s, 3 H), 0.04 (s, 3 H), 0.04 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 204.3, 71.9, 65.9, 
62.2, 26.0, 25.9, 25.7, 21.6, 19.7, 18.4, 18.1, –4.1, –4.9, –5.4; HRMS (ESI–TOF) calcd for 
C19H42O3Si2Na [M + Na]+ 397.2570, found 397.2574. 
Alcohols 53a and 53b. To a solution of aldehyde 52 (176 mg, 0.468 mmol) and allylic 
bromide 41 (178 mg, 0.562 mmol) in THF (4.7 mL) was slowly added SmI2 (0.1 M in THF, 
14.1 mL, 1.41 mmol) at 0 °C for 10 min. After the mixture was stirred at the same 
temperature for 1 h, to the mixture was added SmI2 (0.1 M in THF, 7.0 mL, 0.700 mmol) at 
0 °C for 5 min. After the mixture was stirred at the same temperature for 20 min, the reaction 
was quenched with saturated aqueous NH4Cl. The mixture was diluted with EtOAc, washed 
with saturated aqueous Na2S2O3, H2O, and brine, and then dried over Na2SO4. Concentration 
and column chromatography (hexane/EtOAc = 30:1) gave alcohols 53a (154 mg, 53%) and 
53b (115 mg, 40%). Alcohol 53a: colorless oil; Rf = 0.43 (hexane/EtOAc = 10:1); [α]D21 +1.5 
(c 1.27, CHCl3); IR (neat) 3547, 2956, 2930, 2857, 1731 cm–1; 1H NMR (400 MHz, CDCl3) δ 
5.35–5.23 (m, 1 H), 5.22–5.16 (m, 1 H), 4.57 (d, J = 6.8 Hz, 2 H), 4.10–4.03 (m, 1 H), 
3.98–3.92 (m, 1 H), 3.68–3.62 (m, 2 H), 2.48 (brs, 1 H), 2.27–2.03 (m, 6 H), 2.03–1.93 (m, 1 
H), 1.70 (s, 3 H), 1.65 (s, 3 H), 1.47–1.41 (m, 1 H), 1.20 (s, 9 H), 1.05 (d, J = 6.8 Hz, 3 H), 
1.01 (d, J = 6.8 Hz, 3 H), 0.90 (s, 9 H), 0.89 (s, 9 H), 0.08 (s, 3 H), 0.08 (s, 3 H), 0.07 (s, 3 H), 
0.07 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 178.4, 141.4, 133.4, 126.9, 118.8, 73.5, 67.3, 
66.3, 61.3, 53.2, 46.6, 39.5, 38.8, 27.3, 26.4, 26.1, 26.0, 25.9, 22.7, 22.5, 18.5, 18.2, 16.5, 16.1, 
–3.9, –4.7, –5.3; HRMS (ESI–TOF) calcd for C34H68O5Si2Na [M + Na]+ 635.4503, found 
635.4504. Alcohol 53b: colorless oil; Rf = 0.44 (hexane/EtOAc = 10:1); [α]D24 +1.3 (c 0.75, 
CHCl3); IR (neat) 3448, 2954, 2929, 2856, 1730 cm–1; 1H NMR (400 MHz, CDCl3) δ 
5.36–5.29 (m, 1 H), 5.21–5.14 (m, 1 H), 4.57 (d, J = 7.1 Hz, 2 H), 4.16–4.10 (m, 1 H), 
3.95–3.88 (m, 1 H), 3.74–3.65 (m, 2 H), 3.07 (d, J = 4.6 Hz, 1 H), 2.36–1.94 (m, 7 H), 1.70 (s, 
3 H), 1.67 (s, 3 H), 1.49–1.44 (m, 1 H), 1.20 (s, 9 H), 1.05 (d, J = 6.8 Hz, 3 H), 0.94 (d, J = 
7.1 Hz, 3 H), 0.90 (s, 9 H), 0.89 (s, 9 H), 0.11 (s, 3 H), 0.11 (s, 3 H), 0.07 (s, 3 H), 0.06 (s, 3 
H); 13C NMR (100 MHz, CDCl3) δ 178.4, 141.5, 133.2, 126.6, 118.8, 74.3, 68.7, 66.1, 61.3, 
51.2, 47.5, 39.5, 38.8, 27.3, 26.5, 26.1, 26.0, 22.1, 20.8, 18.4, 18.1, 16.5, 16.4, –4.0, –4.7, –5.2, 
–5.3; HRMS (ESI–TOF) calcd for C34H68O5Si2Na [M + Na]+ 635.4503, found 635.4501. 
MOM Ether S15. To a mixture of alcohol 53a (104 mg, 0.167 mmol) and TBAI (19.9 mg, 
53.9 μmol) in CH2Cl2 (0.5 mL) were added i-Pr2NEt (0.17 mL, 1.00 mmol) and MOMCl (60 
μL, 0.835 mmol) at room temperature. After the mixture was stirred at reflux for 24 h, to the 
mixture were added i-Pr2NEt (0.17 mL, 1.00 mmol) and MOMCl (60 μL, 0.835 mmol) at 
room temperature. After the mixture was stirred at reflux for 4 h, the reaction was quenched 
with saturated aqueous NH4Cl. The mixture was diluted with EtOAc, washed with saturated 
aqueous NH4Cl, saturated aqueous NaHCO3, H2O, and brine, and then dried over Na2SO4. 
Concentration and column chromatography (hexane/EtOAc = 30:1) gave MOM ether S15 
(107 mg, 97%): colorless oil; Rf = 0.46 (hexane/EtOAc = 10:1); [α]D22 –19.0 (c 1.44, CHCl3); 
IR (neat) 2955, 2929, 2857, 1731 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.35–5.29 (m, 1 H), 
5.22–5.15 (m, 1 H), 4.62 (d, J = 6.8 Hz, 1 H), 4.57 (d, J = 7.1 Hz, 2 H), 4.46 (d, J = 6.8 Hz, 1 
H), 4.07–4.01 (m, 1 H), 3.96–3.89 (m, 1 H), 3.63 (dd, J = 10.0, 5.0 Hz, 1 H), 3.55 (dd, J = 
10.0, 6.8 Hz, 1 H), 3.31 (s, 3 H), 2.27–2.01 (m, 6 H), 1.99–1.94 (m, 1 H), 1.70 (s, 3 H), 1.66 
(s, 3 H), 1.68–1.51 (m, 1 H), 1.20 (s, 9 H), 1.02 (d, J = 6.8 Hz, 3 H), 0.96 (d, J = 6.8 Hz, 3 H), 
0.90 (s, 9 H), 0.88 (s, 9 H), 0.10 (s, 3 H), 0.09 (s, 3 H), 0.05 (s, 3H), 0.04 (s, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 178.4, 141.5, 133.1, 126.1, 118.7, 95.1, 74.9, 72.5, 68.0, 61.3, 55.5, 49.3, 
42.7, 39.4, 38.8, 27.3, 26.6, 26.2, 26.1, 25.6, 22.9, 22.0, 18.6, 18.3, 16.6, 16.2, –3.4, –4.6, –5.2, 
–5.2; HRMS (ESI–TOF) calcd for C36H72O6Si2Na [M + Na]+ 679.4765, found 679.4769. 
Alcohol S16. To a solution of bis-TBS ether S15 (326 mg, 0.500 mmol) in MeOH (2.5 mL) 
and CH2Cl2 (2.5 mL) was added CSA (34.0 mg, 0.146 mmol) at 0 °C. After the mixture was 
stirred at the same temperature for 1 h, the reaction was quenched with Et3N. The mixture 
was diluted with EtOAc, washed with H2O and brine, and then dried over Na2SO4. 
Concentration and column chromatography (hexane/EtOAc = 30:1, 7:1) gave alcohol S16 
(113 mg) and bis-TBS ether S15 (176 mg). 
To a solution of bis-TBS ether S15 recovered above (176 mg) in MeOH (1.4 mL) and 
CH2Cl2 (1.4 mL) was added CSA (18.4 mg, 80.7 μmol) at 0 °C. After the mixture was stirred 
at the same temperature for 1 h, the reaction was quenched with Et3N. The mixture was 
diluted with EtOAc, washed with H2O and brine, and then dried over Na2SO4. Concentration 
and column chromatography (hexane/EtOAc = 30:1, 7:1) gave alcohol S16 (63.3 mg) and 
bis-TBS ether S15 (90.1 mg). 
To a solution of bis-TBS ether S15 recovered above (90.1 mg) in MeOH (0.7 mL) and 
CH2Cl2 (0.7 mL) was added CSA (9.2 mg, 39.6 μmol) at 0 °C. After the mixture was stirred 
at the same temperature for 1 h, the reaction was quenched with Et3N. The mixture was 
diluted with EtOAc, washed with H2O and brine, and then dried over Na2SO4. Concentration 
and column chromatography (hexane/EtOAc = 30:1, 7:1) gave alcohol S16 (31.7 mg, totally 
208 mg, 77%) and bis-TBS ether S15 (46.5 mg). Alcohol S16: colorless oil; Rf = 0.33 
(hexane/EtOAc = 4:1); [α]D22 –14.1 (c 0.53, CHCl3); IR (neat) 3501, 2956, 2930, 2857, 1729 
cm–1; 1H NMR (400 MHz, CDCl3) δ 5.35–5.28 (m, 1 H), 5.21–5.14 (m, 1 H), 4.62 (d, J = 6.8 
Hz, 1 H), 4.57 (d, J = 7.1 Hz, 2 H), 4.54 (d, J = 6.8 Hz, 1 H), 4.00–3.91 (m, 2 H), 3.69 (dd, J 
= 11.5, 5.4 Hz, 1 H), 3.61 (dd, J = 11.5, 4.6 Hz, 1 H), 3.33 (s, 3 H), 2.32–2.17 (m, 2 H), 
2.17–2.00 (m, 5 H), 1.70 (s, 3 H), 1.66 (s, 3 H), 1.67–1.61 (m, 1 H), 1.20 (s, 9 H), 1.04 (d, J = 
6.8 Hz, 3 H), 0.96 (d, J = 6.8 Hz, 3 H), 0.90 (s, 9 H), 0.12 (s, 3 H), 0.08 (s, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 178.4, 141.4, 132.7, 126.6, 118.8, 95.9, 75.1, 71.9, 66.4, 61.3, 55.7, 50.4, 
43.3, 39.3, 38.8, 27.3, 26.5, 26.0, 25.6, 22.4, 21.6, 18.3, 16.5, 16.2, –3.9, –4.3; HRMS 
(ESI–TOF) calcd for C30H58O6SiNa [M + Na]+ 565.3900, found 565.3901. 
Alkene 54. To a solution of alcohol S16 (97.5 mg, 0.180 mmol) in CH2Cl2 (1.8 mL) were 
added PhI(OAc)2 (86.6 mg, 0.269 mmol) and TEMPO (5.6 mg, 35.8 μmol) at room 
temperature. After the mixture was stirred at the same temperature for 1 h, the reaction was 
quenched with saturated aqueous Na2S2O3. The mixture was diluted with EtOAc, washed 
with saturated aqueous NaHCO3, H2O, and brine, and then dried over Na2SO4. Concentration 
and short column chromatography (hexane/EtOAc = 30:1) gave the corresponding aldehyde 
(91.0 mg), which was used for the next step without further purification. 
To a suspension of Ph3P+CH3Br− (147 mg, 0.412 mmol) in THF (1.1 mL) was added 
NaHMDS (1.0 M in THF, 0.40 mL, 0.400 mmol) at 0 °C. After the mixture was stirred at the 
same temperature for 20 min, to the mixture was added the aldehyde obtained above (91.0 
mg) in THF (0.2 mL + 0.2 mL + 0.2 mL) at 0 °C. After the mixture was stirred at room 
temperature for 1 h, the reaction was quenched with saturated aqueous NH4Cl. The mixture 
was diluted with EtOAc, washed with H2O and brine, and then dried over Na2SO4. 
Concentration and column chromatography (hexane/EtOAc = 30:1) gave alkene 54 (83.1 mg, 
86% in two steps): colorless oil; Rf = 0.31 (hexane/EtOAc = 30:1); [α]D22 –8.0 (c 0.87, 
CHCl3); IR (neat) 2956, 2930, 2857, 1730 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.93 (ddd, J = 
17.2, 10.4, 6.8 Hz, 1 H), 5.36–5.29 (m, 1 H), 5.20–5.11 (m, 2 H), 5.04 (d, J = 10.4 Hz, 1 H), 
4.58–4.56 (m, 3 H), 4.49 (d, J = 6.6 Hz, 1 H), 4.45–4.42 (m, 1 H), 3.87 (td, J = 6.8, 3.0 Hz, 1 
H), 3.32 (s, 3 H), 2.26 (d, J = 6.8 Hz, 2 H), 2.15–1.95 (m, 5 H), 1.70 (s, 3 H), 1.63 (s, 3 H), 
1.48–1.43 (m, 1 H), 1.20 (s, 9 H), 1.04 (d, J = 6.7 Hz, 3 H), 1.03 (d, J = 6.7 Hz, 3 H), 0.89 (s, 
9 H), 0.06 (s, 3 H), 0.03 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 178.4, 141.9, 141.5, 133.0, 
126.3, 118.7, 114.1, 96.1, 75.6, 73.0, 61.3, 55.6, 53.7, 44.1, 39.4, 38.8, 27.3, 26.5, 26.1, 25.8, 
22.9, 21.8, 18.3, 16.6, 16.2, –3.6, –4.6; HRMS (ESI–TOF) calcd for C31H58O5SiNa [M + 
Na]+ 561.3951, found 561.3951. 
Alcohol 55. To a solution of pivalate 54 (145 mg, 0.268 mmol) in CH2Cl2 (2.7 mL) was 
added DIBAL-H (1.02 M in hexane, 0.79 mL, 0.806 mmol) at –78 °C. After the mixture was 
stirred at the same temperature for 20 min, the reaction was quenched with MeOH. The 
mixture was filtered through a Celite pad and washed with EtOAc. Concentration and column 
chromatography (hexane/EtOAc = 4:1) gave alcohol 55 (120 mg, 98%): colorless oil; Rf = 
0.27 (hexane/EtOAc = 4:1); [α]D21 –8.4 (c 0.97, CHCl3); IR (neat) 3349, 2955, 2929, 2857 
cm–1; 1H NMR (400 MHz, CDCl3) δ 5.93 (ddd, J = 17.2, 10.4, 6.8 Hz, 1 H), 5.45–5.38 (m, 1 
H), 5.20–5.10 (m, 2 H), 5.04 (d, J = 10.4 Hz, 1 H), 4.57 (d, J = 6.8 Hz, 1 H), 4.50 (d, J = 6.8 
Hz, 1 H), 4.46–4.41 (m, 1 H), 4.15 (d, J = 6.8 Hz, 2 H), 3.90–3.83 (m, 1 H), 3.32 (s, 3 H), 
2.26 (d, J = 6.8 Hz, 2 H), 2.17–1.95 (m, 5 H), 1.68 (s, 3 H), 1.63 (s, 3 H), 1.48–1.43 (m, 1 H), 
1.04 (d, J = 6.8 Hz, 3 H), 1.03 (d, J = 6.8 Hz, 3 H), 0.89 (s, 9 H), 0.07 (s, 3 H), 0.04 (s, 3 
H); 13C NMR (100 MHz, CDCl3) δ 141.9, 139.4, 133.0, 126.4, 123.5, 114.2, 96.0, 75.7, 73.0, 
59.4, 55.6, 53.8, 44.0, 39.4, 26.4, 26.1, 25.8, 22.8, 21.8, 18.3, 16.3, –3.6, –4.6; HRMS 
(ESI–TOF) calcd for C26H50O4SiNa [M + Na]+ 477.3376, found 477.3373. 
Alcohol 56. To a solution of alcohol 55 (114 mg, 0.252 mmol) in CH2Cl2 (2.5 mL) were 
added PhI(OAc)2 (121 mg, 0.377 mmol) and TEMPO (11.4 mg, 73.0 μmol) at room 
temperature. After the mixture was stirred at the same temperature for 4 h, the reaction was 
quenched with saturated aqueous Na2S2O3. The mixture was diluted with EtOAc, washed 
with saturated aqueous NaHCO3, H2O, and brine, and then dried over Na2SO4. Concentration 
and short column chromatography (hexane/EtOAc = 10:1) gave the corresponding aldehyde 
(106 mg), which was used for the next step without further purification. 
A mixture of the aldehyde obtained above (106 mg) and chiral allylic boronate 35 (104 mg, 
0.281 mmol) in toluene (0.2 mL) was stirred at room temperature for 2 days. After the 
reaction was quenched with H2O, the mixture was diluted with EtOAc and dried over 
Na2SO4. Concentration and column chromatography (hexane/EtOAc = 7:1) gave alcohol 56 
(127 mg, 88% in two steps, dr = 13:1): colorless oil; Rf = 0.29 (hexane/EtOAc = 4:1); [α]D21 
–10.5 (c 1.01, CHCl3); IR (neat) 3460, 2955, 2929, 2857, 1716 cm–1; 1H NMR (400 MHz, 
CDCl3) δ 6.24 (d, J = 1.4 Hz, 1 H), 5.94 (ddd, J = 17.2, 10.4, 6.8 Hz, 1 H), 5.64 (brs, 1 H), 
5.22–5.10 (m, 3 H), 5.04 (d, J = 10.4 Hz, 1 H), 4.60–4.53 (m, 2 H), 4.50 (d, J = 6.6 Hz, 1 H), 
4.46–4.41 (m, 1 H), 4.23 (q, J = 7.1 Hz, 2 H), 3.90–3.83 (m, 1 H), 3.32 (s, 3 H), 2.57–2.44 (m, 
2 H), 2.26 (d, J = 5.8 Hz, 2 H), 2.15–1.95 (m, 5 H), 1.68 (d, J = 1.2 Hz, 3 H), 1.63 (s, 3 H), 
1.48–1.42 (m, 1 H), 1.31 (t, J = 7.1 Hz, 3 H), 1.04 (d, J = 6.6 Hz, 3 H), 1.03 (d, J = 6.6 Hz, 3 
H), 0.89 (s, 9 H), 0.07 (s, 3 H), 0.03 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 167.3, 142.0, 
138.4, 137.2, 133.0, 127.5, 127.0, 126.4, 114.1, 96.0, 75.7, 72.9, 67.5, 60.9, 55.6, 53.9, 43.9, 
40.7, 39.4, 26.5, 26.1, 25.8, 22.8, 21.8, 18.3, 16.7, 16.3, 14.3, –3.6, –4.5; HRMS (ESI–TOF) 
calcd for C32H58O6SiNa [M + Na]+ 589.3900, found 589.3897. 
Alcohol S19. To a solution of alcohol 56 (120 mg, 0.211 mmol) in CH2Cl2 (2.1 mL) were 
added p-methoxybenzyl 2,2,2-trichloroacetimidate (97 μL, 0.528 mmol) and PPTS (26.4 mg, 
0.106 mmol) at room temperature. After the mixture was stirred at reflux for 9 h, the reaction 
was quenched with saturated aqueous NaHCO3. The mixture was diluted with EtOAc, 
washed with H2O and brine, and then dried over Na2SO4. Concentration and short column 
chromatography (hexane/EtOAc = 10:1, 5:1) gave the corresponding PMB ether (79.9 mg) 
and alcohol 56 (97.4 mg including impurity). 
To a solution of alcohol 56 recovered above (97.4 mg including impurity) in CH2Cl2 (1.7 
mL) were added p-methoxybenzyl 2,2,2-trichloroacetimidate (70 μL, 0.379 mmol) and PPTS 
(20.8 mg, 82.4 μmol) at room temperature. After the mixture was stirred at reflux for 13 h, the 
reaction was quenched with saturated aqueous NaHCO3. The mixture was diluted with EtOAc, 
washed with H2O and brine, and then dried over Na2SO4. Concentration and short column 
chromatography (hexane/EtOAc = 10:1, 5:1) gave the corresponding PMB ether (42.2 mg) 
and alcohol 56 (82.7 mg including impurity). 
To a solution of alcohol 56 recovered above (82.7 mg including impurity) in CH2Cl2 (1.4 
mL) were added p-methoxybenzyl 2,2,2-trichloroacetimidate (63 μL, 0.365 mmol) and PPTS 
(18.0 mg, 71.3 μmol) at room temperature. After the mixture was stirred at reflux for 16 h, the 
reaction was quenched with saturated aqueous NaHCO3. The mixture was diluted with EtOAc, 
washed with H2O and brine, and then dried over Na2SO4. Concentration and short column 
chromatography (hexane/EtOAc = 10:1, 5:1) gave the corresponding PMB ether (27.6 mg) 
and alcohol 56 (80.2 mg including impurity). The combined PMB ether (150 mg) was used 
for the next step without further purification. 
To a solution of the TBS ether obtained above (150 mg) in THF (1.5 mL) was added TBAF 
(1.0 M in THF, 0.45 mL, 0.450 mmol) at room temperature. After the mixture was stirred at 
reflux for 10 h, the mixture was diluted with EtOAc, washed with H2O and brine, and then 
dried over Na2SO4. Concentration and column chromatography (hexane/EtOAc = 10:1, 5:1) 
gave alcohol S19 (73.7 mg, 61% in two steps): colorless oil; Rf = 0.22 (hexane/EtOAc = 4:1); 
[α]D21 +24.7 (c 0.87, CHCl3); IR (neat) 3478, 2932, 1714 cm–1; 1H NMR (400 MHz, CDCl3) 
δ 7.20 (d, J = 8.6 Hz, 2 H), 6.84 (d, J = 8.6 Hz, 2 H), 6.18 (d, J = 1.7 Hz, 1 H), 6.01 (ddd, J = 
17.2, 10.4, 6.8 Hz, 1 H), 5.57 (brs, 1 H), 5.29 (d, J = 17.2 Hz, 1 H), 5.24–5.18 (m, 1 H), 
5.15–5.07 (m, 2 H), 4.61 (d, J = 6.8 Hz, 1 H), 4.53 (d, J = 6.8 Hz, 1 H), 4.51–4.43 (m, 2 H), 
4.31–4.21 (m, 2 H), 4.15 (q, J = 7.1 Hz, 2 H), 3.98–3.92 (m, 1 H), 3.79 (s, 3 H), 3.35 (s, 3 H), 
2.63 (dd, J = 13.9, 7.6 Hz, 1 H), 2.48–2.31 (m, 3 H), 2.25–2.00 (m, 5 H), 1.96–1.86 (m, 1 H), 
1.68–1.60 (m, 1 H), 1.64 (s, 3 H), 1.59 (s, 3 H), 1.25 (t, J = 7.1 Hz, 3 H), 1.06 (d, J = 6.8 Hz, 
3 H), 1.03 (d, J = 6.8 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 167.1, 158.9, 141.4, 139.5, 
137.2, 132.4, 131.0, 129.1, 127.0, 125.6, 114.5, 113.6, 96.0, 77.4, 73.3, 72.9, 69.4, 60.5, 55.7, 
55.3, 51.7, 42.8, 39.5, 38.6, 26.6, 26.0, 22.8, 21.6, 16.8, 16.1, 14.3; HRMS (ESI–TOF) calcd 
for C34H52O7Na [M + Na]+ 595.3611, found 595.3608. 
Carboxylic Acid 58. To a solution of ester S19 (68.2 mg, 0.119 mmol) in THF (0.7 mL), 
MeOH (0.2 mL), and H2O (0.2 mL) was added LiOH·H2O (7.5 mg, 0.179 mmol) at room 
temperature. After the mixture was stirred at 40 °C for 5 h, to the mixture was added 
LiOH·H2O (7.5 mg, 0.179 mmol) at room temperature. After the mixture was stirred at 40 °C 
for 5 h, the mixture was neutralized with aqueous HCl at 0 °C. The mixture was diluted with 
EtOAc and washed with H2O and brine. The aqueous phase was extracted with EtOAc three 
times and the combined organic phase was dried over Na2SO4. Concentration and column 
chromatography (CH2Cl2/MeOH = 30:1) gave carboxylic acid 58 (62.0 mg, 96%): colorless 
oil; Rf = 0.41 (hexane/EtOAc = 1:1); [α]D25 +18.1 (c 0.27, CHCl3); IR (neat) 3459, 2925, 
1697 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.21 (d, J = 8.6 Hz, 2 H), 6.85 (d, J = 8.6 Hz, 2 H), 
6.28 (d, J = 1.5 Hz, 1 H), 6.01 (ddd, J = 17.2, 10.4, 6.8 Hz, 1 H), 5.64 (brs, 1 H), 5.28 (dt, J = 
17.2, 1.5 Hz, 1 H), 5.24–5.19 (m, 1 H), 5.14–5.11 (m, 2 H), 4.62 (d, J = 7.2 Hz, 1 H), 
4.54–4.50 (m, 3 H), 4.30–4.26 (m, 2 H), 3.99–3.95 (m, 1 H), 3.79 (s, 3 H), 3.34 (s, 3 H), 2.63 
(dd, J = 13.9, 7.3 Hz, 1 H), 2.51 (dd, J = 13.9, 5.8 Hz, 1 H), 2.41 (dd, J = 13.9, 9.0 Hz, 1 H), 
2.25–2.04 (m, 5 H), 1.98–1.87 (m, 1 H), 1.68–1.63 (m, 1 H), 1.64 (s, 3 H), 1.61 (s, 3 H), 1.06 
(d, J = 6.8 Hz, 3 H), 1.03 (d, J = 6.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 169.8, 159.1, 
141.6, 140.0, 136.9, 132.4, 130.3, 129.3, 128.9, 126.9, 125.1, 114.4, 113.7, 95.8, 77.2, 74.4, 
72.6, 69.5, 55.7, 55.3, 51.9, 42.5, 39.4, 38.0, 26.2, 25.9, 22.7, 21.8, 16.8, 16.1; HRMS 
(ESI–TOF) calcd for C32H48O7Na [M + Na]+ 567.3298, found 567.3311. 
Lactone 59. To a solution of MNBA (33.3 mg, 96.7 μmol) and DMAP (23.7 mg, 0.194 
mmol) in CH2Cl2 (16 mL) was slowly added hydroxycarboxylic acid 58 (22.2 mg, 40.8 
μmol) in CH2Cl2 (3.2 mL at 0.2 mL/h + 1.0 mL at 1.0 mL/h + 1.0 mL at 1.0 mL/h) at 40 °C 
with a syringe pump for 18 h. After the mixture was stirred at the same temperature for further 
2 h, the reaction was quenched with saturated aqueous NH4Cl. The mixture was diluted with 
EtOAc, washed with saturated aqueous NaHCO3, H2O, and brine, and then dried over 
Na2SO4. Concentration and column chromatography (hexane/EtOAc = 10:1) gave lactone 59 
(14.7 mg, 68%): colorless oil; Rf = 0.30 (hexane/EtOAc = 7:1); [α]D23 +49.5 (c 1.00, CHCl3); 
IR (neat) 2928, 1714, 1613 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.25 (d, J = 8.3 Hz, 2 H), 
6.86 (d, J = 8.3 Hz, 2 H), 6.09 (s, 1 H), 6.00 (ddd, J = 17.2, 10.4, 6.8 Hz, 1 H), 5.79–5.71 (m, 
1 H), 5.58 (s, 1 H), 5.22 (d, J = 17.2 Hz, 1 H), 5.13 (d, J = 10.4 Hz, 1 H), 5.06–4.92 (m, 2 H), 
4.65 (s, 2 H), 4.65–4.58 (m, 1 H), 4.46 (d, J = 11.2 Hz, 1 H), 4.31 (d, J = 11.2 Hz, 1 H), 
3.90–3.83 (m, 1 H), 3.80 (s, 3 H), 3.38 (s, 3 H), 3.05 (dd, J = 13.1, 5.1 Hz, 1 H), 2.44–1.98 (m, 
8 H), 1.96–1.86 (m, 1 H), 1.62 (s, 3 H), 1.62 (s, 3 H), 1.11 (d, J = 6.8 Hz, 3 H), 1.06 (d, J = 
6.8 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 165.1, 158.9, 141.3, 137.6, 134.8, 131.8, 131.2, 
129.1, 127.0, 126.5, 125.7, 115.5, 113.7, 96.6, 75.2, 73.4, 72.7, 69.5, 55.9, 55.3, 51.1, 44.9, 
38.9, 37.7, 26.2, 23.8, 21.9, 19.4, 17.0; HRMS (ESI–TOF) calcd for C32H46O6Na [M + Na]+ 
549.3192, found 549.3190. 
Alcohol 60. To a solution of tetraene 59 (34.2 mg, 64.9 μmol) in toluene (13 mL) was added 
the second-generation Hoveyda–Grubbs catalyst (33) (10.0 mg, 16.2 μmol) at room 
temperature. After the mixture was stirred at 100 °C for 2 days, the mixture was filtered 
through short column chromatography (hexane/EtOAc = 2:1). Concentration and column 
chromatography (hexane/EtOAc = 10:1, 7:1, 4:1) gave the corresponding butenolide (25.8 
mg) and tetraene 59 (3.8 mg, 11% recovery). The butenolide (25.8 mg) was used for the next 
step without further purification. 
To a solution of the MOM ether obtained above (25.8 mg) in i-PrOH (5.2 mL) was added 
concentrated aqueous HCl (0.1 mL) at room temperature. After the mixture was stirred at 
50 °C for 10 h, the reaction was quenched with saturated aqueous NaHCO3. The mixture was 
diluted with EtOAc, washed with H2O and brine, and then dried over Na2SO4. Concentration 
and column chromatography (hexane/EtOAc = 2:1) gave alcohol 60 (15.3 mg, 52% in two 
steps): colorless solid; Rf = 0.35 (hexane/EtOAc = 1:1); [α]D23 +88.2 (c 0.58, CHCl3); IR 
(neat) 3547, 2922, 2842, 1742, 1613 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.29 (s, 1 H), 7.26 
(d, J = 8.8 Hz, 2 H), 6.87 (d, J = 8.8 Hz, 2 H), 5.17 (d, J = 8.5 Hz, 1 H), 5.04 (d, J = 8.6 Hz, 1 
H), 4.89–4.81 (m, 1 H), 4.50–4.38 (m, 3 H), 3.80 (s, 3 H), 3.81–3.77 (m, 1 H), 2.86 (d, J = 
13.2 Hz, 1 H), 2.46 (dd, J = 12.9, 9.8 Hz, 1 H), 2.31–1.98 (m, 7 H), 1.62 (s, 3 H), 1.46 (s, 3 H), 
1.46–1.41 (m, 1 H), 1.16 (d, J = 6.8 Hz, 3 H), 1.06 (d, J = 6.8 Hz, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 173.3, 159.1, 152.0, 141.5, 132.9, 130.4, 129.7, 129.4, 125.3, 124.9, 113.8, 81.5, 
72.8, 72.3, 69.9, 55.3, 51.4, 43.7, 39.1, 31.1, 25.3, 24.7, 24.1, 19.7, 19.2, 15.8; HRMS 
(ESI–TOF) calcd for C28H38O5Na [M + Na]+ 477.2617, found 477.2616. 
Sarcophytonolide H (6). To a solution of alcohol 60 (11.5 mg, 25.3 μmol) in CH2Cl2 (0.5 
mL) were added pyridine (10 μL, 0.131 mmol) and AcCl (7.9 μL, 0.111 mmol) at 0 °C. After 
the mixture was stirred at the same temperature for 30 min, the reaction was quenched with 
saturated aqueous NH4Cl. The mixture was diluted with EtOAc, washed with H2O and brine, 
and then dried over Na2SO4. Concentration and short column chromatography 
(hexane/EtOAc = 4:1) gave the corresponding acetate (11.0 mg), which was used for the next 
step without further purification. 
To a solution of the PMB ether obtained above (11.0 mg) in CH2Cl2 (0.5 mL) and phosphate 
pH standard solution (0.1 mL) was added DDQ (10.8 mg, 44.4 μmol) at 0 °C. After the 
mixture was stirred at the same temperature for 1 h, the reaction was quenched with saturated 
aqueous NaHCO3. The mixture was diluted with EtOAc, washed with saturated aqueous 
NaHCO3, H2O, and brine, and then dried over Na2SO4. Concentration and column 
chromatography (hexane/EtOAc = 2:1) gave sarcophytonolide H (6) (7.3 mg, 77% in two 
steps): colorless solid; Rf = 0.27 (hexane/EtOAc = 1:1); [α]D23 +115 (c 0.10, CHCl3); 
literature10b [α]D20 +74.7 (c 0.20, CHCl3); IR (neat) 3275, 2968, 2948, 2924, 1759, 1732 
cm–1; 1H and 13C NMR Table S6; HRMS (ESI–TOF) calcd for C22H32O5Na [M + Na]+ 
399.2148, found 399.2153. 
Acetate S22. To a solution of alcohol 53b (415 mg, 0.677 mmol) in toluene (6.8 mL) were 
added pyridine (0.32 mL, 4.06 mmol), Ac2O (0.32 mL, 3.39 mmol), and DMAP (8.6 mg, 70.4 
μmol) at room temperature. After the mixture was stirred at 100 °C for 10 h, the reaction was 
quenched with saturated aqueous NH4Cl. The mixture was diluted with EtOAc, washed with 
H2O and brine, and then dried over Na2SO4. Concentration and column chromatography 
(hexane/EtOAc = 30:1) gave acetate S22 (444 mg, quant): colorless oil; Rf = 0.45 
(hexane/EtOAc = 10:1); [α]D25 +5.4 (c 0.48, CHCl3); IR (neat) 2954, 2929, 2856, 1737 
cm–1; 1H NMR (400 MHz, CDCl3) δ 5.36–5.27 (m, 2 H), 5.14–5.06 (m, 1 H), 4.57 (d, J = 7.1 
Hz, 2 H), 4.03–3.97 (m, 1 H), 3.67–3.55 (m, 2 H), 2.33 (dd, J = 13.7, 9.5 Hz, 1 H), 2.17–1.97 
(m, 5 H), 1.97–1.87 (m, 1 H), 1.96 (s, 3 H), 1.69 (s, 3 H), 1.65 (s, 3 H), 1.53–1.46 (m, 1 H), 
1.19 (s, 9 H), 0.97 (d, J = 5.6 Hz, 3 H), 0.96 (d, J = 5.6 Hz, 3 H), 0.91 (s, 9 H), 0.89 (s, 9 H), 
0.09 (s, 3 H), 0.08 (s, 3 H), 0.07 (s, 3 H), 0.06 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 178.4, 
169.8, 141.5, 132.3, 126.7, 118.7, 73.4, 71.1, 66.8, 61.3, 50.4, 45.1, 39.3, 38.8, 27.3, 26.6, 
26.3, 26.1, 26.1, 22.7, 21.4, 20.7, 18.5, 18.3, 16.6, 16.1, –3.9, –4.6, –5.1, –5.2; HRMS 
(ESI–TOF) calcd for C36H70O6Si2Na [M + Na]+ 677.4609, found 677.4609. 
Alcohol 61. To a solution of bis-TBS ether S22 (444 mg, 0.677 mmol) in MeOH (3.4 mL) 
and CH2Cl2 (3.4 mL) was added CSA (47.5 mg, 0.204 mmol) at 0 °C. After the mixture was 
stirred at the same temperature for 1 h, the reaction was quenched with Et3N. The mixture 
was diluted with EtOAc, washed with H2O and brine, and then dried over Na2SO4. 
Concentration and column chromatography (hexane/EtOAc = 30:1, 8:1) gave alcohol 61 (200 
mg) and bis-TBS ether S22 (179 mg). 
To a solution of bis-TBS ether S22 recovered above (179 mg) in MeOH (1.4 mL) and 
CH2Cl2 (1.4 mL) was added CSA (18.8 mg, 80.9 μmol) at 0 °C. After the mixture was stirred 
at the same temperature for 1 h, the reaction was quenched with Et3N. The mixture was 
diluted with EtOAc, washed with H2O and brine, and then dried over Na2SO4. Concentration 
and column chromatography (hexane/EtOAc = 30:1, 8:1) gave alcohol 61 (72.5 mg) and 
bis-TBS ether S22 (82.2 mg). 
To a solution of bis-TBS ether S22 recovered above (82.2 mg) in MeOH (0.6 mL) and 
CH2Cl2 (0.6 mL) was added CSA (8.7 mg, 37.5 μmol) at 0 °C. After the mixture was stirred 
at the same temperature for 1 h, the reaction was quenched with Et3N. The mixture was 
diluted with EtOAc, washed with H2O and brine, and then dried over Na2SO4. Concentration 
and column chromatography (hexane/EtOAc = 30:1, 8:1) gave alcohol 61 (21.8 mg, totally 
294 mg, 80%) and bis-TBS ether S22 (51.2 mg). Alcohol 61: colorless oil; Rf = 0.39 
(hexane/EtOAc = 4:1); [α]D24 +6.5 (c 0.77, CHCl3); IR (neat) 3437, 2958, 2929, 2856, 1732 
cm–1; 1H NMR (400 MHz, CDCl3) δ 5.32 (t, J = 6.8 Hz, 1 H), 5.26–5.20 (m, 1 H), 5.17 (t, J = 
6.5 Hz, 1 H), 4.57 (d, J = 6.6 Hz, 2 H), 3.99–3.92 (m, 1 H), 3.76 (dd, J = 11.5, 4.9 Hz, 1 H), 
3.67 (dd, J = 11.5, 3.4 Hz, 1 H), 2.34 (dd, J = 13.2, 8.2 Hz, 1 H), 2.22 (dd, J = 13.2, 5.6 Hz, 1 
H), 2.13–1.99 (m, 4 H), 1.97 (s, 3 H), 1.94–1.86 (m, 1 H), 1.69 (s, 3 H), 1.66 (s, 3 H), 1.61 (td, 
J = 5.7, 2.0 Hz, 1 H), 1.20 (s, 9 H), 0.94 (d, J = 7.1 Hz, 3 H), 0.92 (s, 9 H), 0.87 (d, J = 6.8 Hz, 
3 H), 0.13 (s, 3 H), 0.11 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 178.4, 169.7, 141.4, 131.7, 
127.4, 118.7, 72.7, 70.2, 65.3, 61.3, 49.2, 45.0, 39.3, 38.8, 27.3, 26.5, 26.4, 26.0, 22.1, 21.4, 
19.2, 18.2, 16.5, 16.1, –4.2, –4.4; HRMS (ESI–TOF) calcd for C30H56O6SiNa [M + Na]+ 
563.3744, found 563.3738. 
Alkene 62. To a solution of alcohol 61 (294 mg, 0.544 mmol) in CH2Cl2 (5.4 mL) were 
added PhI(OAc)2 (264 mg, 0.819 mmol) and TEMPO (25.4 mg, 0.163 mmol) at room 
temperature. After the mixture was stirred at the same temperature for 10 h, the reaction was 
quenched with saturated aqueous Na2S2O3. The mixture was diluted with EtOAc, washed 
with saturated aqueous NaHCO3, H2O, and brine, and then dried over Na2SO4. Concentration 
and short column chromatography (hexane/EtOAc = 20:1) gave the corresponding aldehyde 
(288 mg), which was used for the next step without further purification. 
To a suspension of Ph3P+CH3Br− (478 mg, 1.34 mmol) in THF (3.4 mL) was added 
NaHMDS (1.0 M in THF, 1.3 mL, 1.30 mmol) at 0 °C. After the mixture was stirred at the 
same temperature for 20 min, to the mixture was added the aldehyde obtained above (288 mg) 
in THF (1.0 mL + 0.5 mL + 0.5 mL) at 0 °C. After the mixture was stirred at room 
temperature for 1 h, the reaction was quenched with saturated aqueous NH4Cl. The mixture 
was diluted with EtOAc, washed with H2O and brine, and then dried over Na2SO4. 
Concentration and column chromatography (hexane/EtOAc = 30:1) gave alkene 62 (259 mg, 
89% in two steps): colorless oil; Rf = 0.53 (hexane/EtOAc = 7:1); [α]D24 +9.2 (c 0.47, 
CHCl3); IR (neat) 2958, 2927, 2856, 1737 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.94 (ddd, J = 
17.2, 10.4, 6.4 Hz, 1 H), 5.35–5.25 (m, 2 H), 5.22 (d, J = 17.2 Hz, 1 H), 5.14–5.04 (m, 2 H), 
4.57 (d, J = 7.1 Hz, 2 H), 4.34 (t, J = 6.4 Hz, 1 H), 2.30–2.17 (m, 2 H), 2.11–1.98 (m, 5 H), 
1.96 (s, 3 H), 1.69 (s, 3 H), 1.61 (s, 3 H), 1.53 (td, J = 5.9, 2.4 Hz, 1 H), 1.20 (s, 9 H), 0.96 (d, 
J = 7.1 Hz, 3 H), 0.94 (d, J = 7.1 Hz, 3 H), 0.91 (s, 9 H), 0.06 (s, 3 H), 0.03 (s, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 178.4, 169.7, 141.5, 141.0, 132.2, 126.9, 118.7, 114.7, 73.0, 70.6, 61.3, 
53.1, 43.7, 39.3, 38.8, 27.3, 26.4, 26.0, 21.8, 21.4, 20.3, 18.3, 16.5, 16.0, –3.8, –4.7; HRMS 
(ESI–TOF) calcd for C31H56O5SiNa [M + Na]+ 559.3795, found 559.3796. 
Aldehyde 63. To a solution of pivalate 62 (259 mg, 0.482 mmol) in CH2Cl2 (4.8 mL) was 
added DIBAL-H (1.02 M in hexane, 1.1 mL, 1.12 mmol) at –78 °C. After the mixture was 
stirred at the same temperature for 30 min, to the mixture was added DIBAL-H (1.02 M in 
hexane, 0.55 mL, 0.561 mmol) at –78 °C. After the mixture was stirred at the same 
temperature for 20 min, the reaction was quenched with MeOH. The mixture was filtered 
through a Celite pad and washed with EtOAc. Concentration and short column 
chromatography (hexane/EtOAc = 6:1) gave the corresponding alcohol (185 mg), which was 
used for the next step without further purification. 
To a solution of the alcohol obtained above (185 mg) in CH2Cl2 (4.5 mL) were added 
PhI(OAc)2 (215 mg, 0.667 mmol) and TEMPO (21.1 mg, 0.135 mmol) at room temperature. 
After the mixture was stirred at the same temperature for 3 h, the reaction was quenched with 
saturated aqueous Na2S2O3. The mixture was diluted with EtOAc, washed with saturated 
aqueous NaHCO3, H2O, and brine, and then dried over Na2SO4. Concentration and column 
chromatography (hexane/EtOAc = 7:1) gave aldehyde 63 (167 mg, 85% in two steps): 
colorless oil; Rf = 0.37 (hexane/EtOAc = 4:1); [α]D24 +19.2 (c 0.30, CHCl3); IR (neat) 3462, 
2954, 2928, 2856, 1676 cm–1; 1H NMR (400 MHz, CDCl3) δ 9.99 (d, J = 8.0 Hz, 1 H), 6.05 
(ddd, J = 17.2, 10.8, 6.8 Hz, 1 H), 5.88 (d, J = 8.0 Hz, 1 H), 5.26–5.12 (m, 3 H), 4.62–4.54 (m, 
1 H), 4.03–3.93 (m, 1 H), 3.39–3.28 (m, 1 H), 2.30–2.21 (m, 5 H), 2.17 (s, 3 H), 2.17–2.10 (m, 
1 H), 2.05–1.95 (m, 1 H), 1.67 (s, 3 H), 1.49–1.43 (m, 1 H), 1.07 (d, J = 6.8 Hz, 3 H), 0.91 (d, 
J = 8.8 Hz, 3 H), 0.90 (s, 9 H), 0.10 (s, 3 H), 0.06 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 
191.0, 163.4, 140.0, 134.4, 127.4, 125.2, 115.4, 74.7, 69.1, 54.1, 46.7, 40.6, 26.6, 25.9, 25.8, 
21.2, 21.0, 18.1, 17.7, 16.3, –4.0, –4.8; HRMS (ESI–TOF) calcd for C24H44O3SiNa [M + 
Na]+ 431.2957, found 431.2961. 
Diol 64. To a solution of aldehyde 63 (160 mg, 0.392 mmol) in THF (3.2 mL) and saturated 
aqueous NH4Cl (0.6 mL) were added ethyl (2-bromomethyl)acrylate (26) (0.14 mL, 1.18 
mmol) and zinc dust (154 mg, 2.35 mmol) at 0 °C. After the mixture was stirred at the same 
temperature for 10 min, the mixture was filtered through a Celite pad and washed with EtOAc. 
The mixture was washed with H2O and brine and dried over Na2SO4. Concentration and 
column chromatography (hexane/EtOAc = 5:1) gave diol 64 (205 mg, quant) as a 1:1 
diastereomeric mixture: colorless oil; Rf = 0.56 (hexane/EtOAc = 2:1); IR (neat) 3428, 2956, 
2927, 2856, 1716 cm–1; 1H NMR (400 MHz, CDCl3) δ 6.23 (d, J = 1.6 Hz, 0.5 H), 6.22 (d, J 
= 1.6 Hz, 0.5 H), 6.08–5.96 (m, 1 H), 5.65–5.59 (m, 1 H), 5.23–5.11 (m, 4 H), 4.61–4.48 (m, 
2 H), 4.26–4.16 (m, 2 H), 4.00–3.88 (m, 1 H), 2.53–2.44 (m, 2 H), 2.29–1.95 (m, 7 H), 
1.69–1.59 (m, 6 H), 1.47–1.39 (m, 1 H), 1.31 (t, J = 7.2 Hz, 1.5 H), 1.31 (t, J = 7.2 Hz, 1.5 H), 
1.06 (d, J = 7.1 Hz, 1.5 H), 1.06 (d, J = 7.1 Hz, 1.5 H), 0.93 (d, J = 7.1 Hz, 3 H), 0.91 (s, 9 H), 
0.10 (s, 1.5 H), 0.09 (s, 1.5 H), 0.05 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 167.3, 140.4, 
138.2, 137.8, 137.3, 133.1, 128.2, 127.4, 127.3, 127.3, 127.1, 126.7, 115.2, 115.0, 74.5, 74.4, 
68.9, 68.2, 67.5, 67.3, 60.8, 60.8, 54.2, 54.1, 46.8, 46.7, 40.6, 40.5, 39.3, 39.3, 26.5, 26.4, 26.3, 
26.1, 26.0, 21.5, 21.3, 21.1, 21.0, 18.2, 18.1, 16.7, 16.4, 16.3, 16.0, 14.3, –4.0, –4.1, –4.8, 
–4.8; HRMS (ESI–TOF) calcd for C30H54O5SiNa [M + Na]+ 545.3638, found 545.3641. 
Diol S23. To a solution of diol 64 (199 mg, 0.381 mmol) in CH2Cl2 (3.8 mL) were added 
p-methoxybenzyl 2,2,2-trichloroacetimidate (0.17 mL, 0.964 mmol) and PPTS (44.0 mg, 
0.174 mmol) at room temperature. After the mixture was stirred at reflux for 12 h, the reaction 
was quenched with saturated aqueous NaHCO3. The mixture was diluted with EtOAc, 
washed with H2O and brine, and then dried over Na2SO4. Concentration and short column 
chromatography (hexane/EtOAc = 10:1, 6:1) gave the corresponding PMB ether (143 mg) 
and diol 64 (122 mg including impurity). The PMB ether (143 mg) was used for the next step 
without further purification. 
To a solution of the TBS ether obtained above (143 mg) in THF (2.2 mL) was added TBAF 
(1.0 M in THF, 0.67 mL, 0.670 mmol) at room temperature. After the mixture was stirred at 
reflux for 2 h, the mixture was diluted with EtOAc and washed with H2O and brine. The 
aqueous phase was extracted with EtOAc and the combined organic phase was dried over 
Na2SO4. Concentration and column chromatography (hexane/EtOAc = 4:1) gave diol S23 
(82.4 mg, 33% in two steps): yellow oil; Rf = 0.42 (hexane/EtOAc = 2:1); IR (neat) 3386, 
2954, 2918, 2874, 1715, 1613 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.23–7.15 (m, 2 H), 6.84 
(d, J = 8.6 Hz, 2 H), 6.18 (d, J = 1.5 Hz, 1 H), 5.99 (ddd, J = 16.4, 10.4, 5.2 Hz, 1 H), 5.57 (s, 
1 H), 5.33–5.24 (m, 2 H), 5.16 (dt, J = 10.5, 1.5 Hz, 1 H), 5.11 (d, J = 9.0 Hz, 1 H), 4.56 (brs, 
1 H), 4.51–4.42 (m, 1 H), 4.32–4.21 (m, 2 H), 4.15 (q, J = 7.1 Hz, 2 H), 4.04–3.96 (m, 1 H), 
3.79 (s, 3 H), 3.67 (brs, 1 H), 2.68–2.56 (m, 1 H), 2.47–2.37 (m, 1 H), 2.31 (d, J = 16.6 Hz, 1 
H), 2.25–2.12 (m, 3 H), 2.12–1.97 (m, 3 H), 1.67 (s, 3 H), 1.60 (s, 3 H), 1.44–1.38 (m, 1 H), 
1.25 (t, J = 7.1 Hz, 3 H), 1.09 (d, J = 7.1 Hz, 3 H), 0.91 (d, J = 7.1 Hz, 3 H); 13C NMR (100 
MHz, CDCl3) δ 167.0, 158.9, 140.3, 139.1, 137.2, 131.9, 130.9, 129.1, 128.8, 128.7, 127.0, 
125.9, 114.5, 113.6, 73.3, 72.6, 69.5, 69.4, 68.4, 60.6, 55.3, 52.7, 47.2, 39.4, 38.5, 26.5, 26.4, 
21.9, 21.1, 16.8, 16.8, 16.1, 14.3; HRMS (ESI–TOF) calcd for C32H48O6Na [M + Na]+ 
551.3348, found 551.3353. 
Carboxylic Acid 65. To a solution of ester S23 (65.4 mg, 0.124 mmol) in THF (0.7 mL), 
MeOH (0.3 mL), and H2O (0.3 mL) was added LiOH·H2O (7.9 mg, 0.188 mmol) at room 
temperature. After the mixture was stirred at the same temperature for 2 days, to the mixture 
was added LiOH·H2O (7.9 mg, 0.188 mmol) at room temperature. After the mixture was 
stirred at the same temperature for 10 h, the mixture was neutralized with aqueous HCl at 
0 °C. The mixture was diluted with EtOAc and washed with H2O and brine. The aqueous 
phase was extracted with EtOAc four times and the combined organic phase was dried over 
Na2SO4. Concentration and column chromatography (hexane/EtOAc = 1:1) gave carboxylic 
acid 65 (54.9 mg, 89%): colorless oil; Rf = 0.56 (EtOAc); IR (neat) 3372, 2954, 2919, 2874, 
1696, 1629, 1613 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.21 (d, J = 8.0 Hz, 2 H), 6.85 (d, J = 
8.0 Hz, 2 H), 6.32–6.26 (m, 1 H), 5.98 (ddd, J = 16.0, 10.8, 5.6 Hz, 1 H), 5.66 (s, 1 H), 
5.34–5.24 (m, 2 H), 5.20–5.08 (m, 2 H), 4.63–4.60 (m, 1 H), 4.50 (d, J = 11.6 Hz, 1 H), 
4.34–4.22 (m, 2 H), 4.07–3.98 (m, 1 H), 3.79 (s, 3 H), 2.63 (dd, J = 13.9, 7.1 Hz, 1 H), 2.49 
(dd, J = 13.9, 5.6 Hz, 1 H), 2.30–1.97 (m, 7 H), 1.67 (s, 3 H), 1.62 (s, 1.5 H), 1.62 (s, 1.5 H), 
1.44–1.38 (m, 1 H), 1.09 (d, J = 7.1 Hz, 3 H), 0.92 (d, J = 7.1 Hz, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 170.4, 159.0, 140.1, 139.5, 136.8, 136.7, 131.9, 130.4, 129.2, 129.2, 129.1, 129.0, 
128.7, 128.6, 125.4, 125.4, 114.6, 113.7, 74.1, 74.0, 72.7, 69.6, 68.4, 55.3, 52.6, 52.5, 47.0, 
39.4, 39.3, 38.0, 37.9, 26.4, 26.2, 26.2, 21.9, 21.1, 16.8, 16.8, 16.1; HRMS (ESI–TOF) calcd 
for C30H44O6Na [M + Na]+ 523.3036, found 523.3036. 
Butenolide 67. To a solution of MNBA (45.1 mg, 0.131 mmol) and DMAP (32.8 mg, 0.268 
mmol) in CH2Cl2 (32 mL) was slowly added dihydroxycarboxylic acid 65 (36.6 mg, 73.1 
μmol) in CH2Cl2 (3.2 mL at 0.2 mL/h + 1.0 mL at 1.0 mL/h + 1.0 mL at 1.0 mL/h) at –5 °C 
with a syringe pump for 18 h. After the mixture was stirred at the same temperature for further 
5 h, to the mixture was added a solution of MNBA (15.0 mg, 43.6 μmol) and DMAP (11.0 mg, 
90.0 μmol) in CH2Cl2 (1.0 mL) at –5 °C. After the mixture was stirred at the same 
temperature for 1 h, the reaction was quenched with saturated aqueous NH4Cl. The mixture 
was diluted with EtOAc, washed with saturated aqueous NaHCO3, H2O, and brine, and then 
dried over Na2SO4. Concentration and short chromatography (hexane/EtOAc = 6:1) gave 
lactone 66 (16.8 mg), which was used for the next step without further purification. 
To a solution of alcohol 66 obtained above (16.8 mg) in CH2Cl2 (0.4 mL) were added 
pyridine (7.3 μL, 90.5 μmol) and AcCl (4.9 μL, 69.8 μmol) at 0 °C. After the mixture was 
stirred at the same temperature for 4 h, the reaction was quenched with saturated aqueous 
NH4Cl. The mixture was diluted with EtOAc, washed with H2O and brine, and then dried 
over Na2SO4. Concentration and short chromatography (hexane/EtOAc = 7:1) gave the 
corresponding acetate (15.9 mg), which was used for the next step without further 
purification. 
To a solution of the tetraene obtained above (15.9 mg) in toluene (6.0 mL) was added the 
second-generation Hoveyda–Grubbs catalyst (33) (4.6 mg, 7.34 μmol) at room temperature. 
After the mixture was stirred at 100 °C for 2 days, the mixture was filtered through short 
column chromatography (EtOAc). Concentration and column chromatography 
(hexane/EtOAc = 7:1, 4:1) gave butenolide 67 (7.1 mg, 20% in three steps): colorless oil; Rf = 
0.36 (hexane/EtOAc = 2:1); IR (neat) 2958, 2918, 2878, 2852, 1757, 1739, 1613 cm–1; 1H 
NMR (400 MHz, CDCl3) δ 7.36 (s, 1 H), 7.28 (d, J = 8.5 Hz, 2 H), 6.87 (d, J = 8.5 Hz, 2 H), 
5.28 (dd, J = 11.2, 6.4 Hz, 1 H), 5.11–5.01 (m, 3 H), 4.71–4.64 (m, 1 H), 4.45 (d, J = 10.8 Hz, 
1 H), 4.38 (d, J = 10.8 Hz, 1 H), 3.80 (s, 3 H), 2.95–2.85 (m, 1 H), 2.69–2.58 (m, 1 H), 2.48 
(dd, J = 12.8, 11.1 Hz, 1 H), 2.39–2.28 (m, 1 H), 2.28–2.06 (m, 5 H), 2.04 (s, 3 H), 1.54 (s, 3 
H), 1.46 (dd, J = 10.5, 2.4 Hz, 1 H), 1.41 (s, 3 H), 0.94 (d, J = 7.1 Hz, 3 H), 0.85 (d, J = 7.1 
Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 172.7, 169.5, 159.0, 151.2, 139.5, 130.7, 130.3, 
129.3, 129.2, 127.6, 113.8, 79.9, 72.5, 69.9, 68.8, 55.3, 46.7, 44.0, 38.9, 33.4, 28.3, 22.8, 21.7, 
21.4, 16.4, 15.9, 15.5; HRMS (ESI–TOF) calcd for C30H40O6Na [M + Na]+ 519.2723, found 
519.2728. 
Alcohol S24. To a solution of PMB ether 67 (7.1 mg, 14.3 μmol) in CH2Cl2 (0.2 mL) and 
phosphate pH standard solution (50 μL) was added DDQ (6.4 mg, 28.2 μmol) at 0 °C. After 
the mixture was stirred at the same temperature for 1 h, the reaction was quenched with 
saturated aqueous NaHCO3. The mixture was diluted with EtOAc and washed with saturated 
aqueous NaHCO3, H2O, and brine. The aqueous phase was extracted with EtOAc twice and 
the combined organic phase was dried over Na2SO4. Concentration and column 
chromatography (hexane/EtOAc = 1:1) gave alcohol S24 (4.9 mg, 91%): colorless oil; Rf = 
0.17 (hexane/EtOAc = 1:1); IR (neat) 3413, 2958, 2919, 2870, 2852, 1731, 1668, 1651 
cm–1; 1H NMR (400 MHz, CDCl3) δ 7.36 (s, 1 H), 5.29 (dd, J = 11.2, 6.4 Hz, 1 H), 5.13 (d, J 
= 9.5 Hz, 1 H), 5.09–4.95 (m, 3 H), 2.85–2.76 (m, 1 H), 2.64 (dd, J = 12.7, 5.9 Hz, 1 H), 2.47 
(dd, J = 12.7, 11.2 Hz, 1 H), 2.38–2.26 (m, 1 H), 2.24–2.17 (m, 1 H), 2.16–1.99 (m, 4 H), 2.04 
(s, 3 H), 1.54 (s, 3 H), 1.46 (dd, J = 10.7, 2.4 Hz, 1 H), 1.44 (s, 3 H), 0.94 (d, J = 7.1 Hz, 3 H), 
0.86 (d, J = 7.1 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 172.8, 169.5, 151.2, 138.2, 130.3, 
129.3, 129.1, 128.8, 79.9, 68.8, 66.1, 46.7, 44.0, 38.8, 35.4, 28.4, 22.7, 21.7, 21.4, 16.4, 15.9, 
15.4; HRMS (ESI–TOF) calcd for C22H32O5Na [M + Na]+ 399.2148, found 399.2151. 
Proposed Structure 10 of Isosarcophytonolide D. To a solution of alcohol S24 (1.2 mg, 
3.18 μmol) in CH2Cl2 (1.0 mL) were added MS4Å (2.0 mg), NMO (2.0 mg, 17.1 μmol), and 
a catalytic amount of TPAP at room temperature. After the mixture was stirred at the same 
temperature for 16 h, to the mixture were added NMO (2.0 mg, 17.1 μmol) and a catalytic 
amount of TPAP at room temperature. After the mixture was stirred at the same temperature 
for 1 h, the mixture was filtered through short column chromatography (EtOAc). 
Concentration and column chromatography (hexane/EtOAc = 2:1) gave the proposed 
structure 10 of isosarcophytonolide D (0.5 mg, 42%): colorless oil; Rf = 0.47 (hexane/EtOAc 
= 1:1); [α]D22 +45.0 (c 0.10, CHCl3); IR (neat) 2958, 2923, 2878, 2856, 1762, 1739, 1686, 
1619 cm–1; 1H and 13C NMR Table S8; HRMS (ESI–TOF) calcd for C22H30O5Na [M + Na]+ 
397.1991, found 397.1989. 
Ketone 68. To a solution of sarcophytonolide H (6) (1.0 mg, 2.66 μmol) in CH2Cl2 (0.3 mL) 
was added Dess–Martin periodinane (3.4 mg, 8.02 μmol) at room temperature. After the 
mixture was stirred at the same temperature for 16 h, to the mixture was added Dess–Martin 
periodinane (6.2 mg, 14.6 μmol) at room temperature. After the mixture was stirred at the 
same temperature for 6 h, the mixture was filtered through short column chromatography 
(EtOAc). Concentration and column chromatography (hexane/EtOAc = 2:1) gave ketone 68 
(0.4 mg, 40%): colorless oil; Rf = 0.55 (hexane/EtOAc = 1:1); [α]D24 –50.9 (c 0.07, CHCl3); 
literature10d [α]D20 –66 (c 0.67, CHCl3); IR (neat) 2954, 2924, 2874, 2852, 1762, 1734, 1687, 
1618 cm–1; 1H and 13C NMR Table S9; HRMS (ESI–TOF) calcd for C22H30O5Na [M + Na]+ 
397.1991, found 397.1988. 
Alcohols 70a and 70b. To a solution of aldehyde 52 (69.8 mg, 0.186 mmol) and allylic 
bromide 21a (79.2 mg, 0.248 mmol) in THF (1.9 mL) was added SmI2 (0.1 M in THF, 5.6 mL, 
0.560 mmol) at 0 °C. After the mixture was stirred at the same temperature for 30 min, the 
reaction was quenched with saturated aqueous NH4Cl. The mixture was diluted with EtOAc, 
washed with saturated aqueous Na2S2O3, H2O, and brine, and then dried over Na2SO4. 
Concentration and column chromatography (hexane/EtOAc = 20:1) gave alcohols 70a (33.2 
mg, 29%) and 70b (45.4 mg, 40%). Alcohol 70a: colorless oil; Rf = 0.48 (hexane/EtOAc = 
10:1); [α]D23 –1.0 (c 1.28, CHCl3); IR (neat) 3501, 2956, 2929, 2857, 1731 cm–1; 1H NMR 
(400 MHz, CDCl3) δ 5.21 (t, J = 6.8 Hz, 1 H), 4.11–4.07 (m, 3 H), 3.98–3.94 (m, 1 H), 3.66 
(d, J = 5.6 Hz, 2 H), 2.46 (brs, 1 H), 2.25–2.12 (m, 2 H), 2.07–1.93 (m, 3 H), 1.74–1.68 (m, 1 
H), 1.65 (s, 3 H), 1.61–1.54 (m, 1 H), 1.47–1.33 (m, 3 H), 1.26–1.21 (m, 1 H), 1.19 (s, 9 H), 
1.05 (d, J = 6.8 Hz, 3 H), 1.01 (d, J = 6.8 Hz, 3 H), 0.92 (d, J = 6.4 Hz, 3 H), 0.90 (s, 9 H), 
0.89 (s, 9 H), 0.08 (s, 3 H), 0.07 (s, 3 H), 0.07 (s, 3 H), 0.07 (s, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 178.5, 132.9, 127.7, 73.6, 67.4, 66.3, 62.8, 53.2, 46.7, 38.7, 37.0, 35.5, 29.8, 27.3, 
26.1, 26.0, 26.0, 25.5, 22.8, 22.5, 19.5, 18.5, 18.2, 16.1, –3.9, –4.7, –5.3; HRMS (ESI–TOF) 
calcd for C34H70O5Si2Na [M + Na]+ 637.4659, found 637.4658. Alcohol 70b: colorless oil; 
Rf = 0.34 (hexane/EtOAc = 20:1); [α]D27 +0.15 (c 2.28, CHCl3); IR (neat) 3547, 2957, 2928, 
2857, 1731 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.18 (t, J = 8.0 Hz, 1 H), 4.15–4.07 (m, 3 H), 
3.95–3.89 (m, 1 H), 3.72–3.67 (m, 2 H), 3.09 (d, J = 4.8 Hz, 1 H), 2.23–2.18 (m, 2 H), 
2.07–1.97 (m, 3 H), 1.70–1.66 (m, 1 H), 1.66 (s, 3 H), 1.58–1.54 (m, 1 H), 1.48–1.33 (m, 3 H), 
1.26–1.22 (m, 1 H), 1.19 (s, 9 H), 1.05 (d, J = 7.2 Hz, 3 H), 0.94 (d, J = 6.4 Hz, 3 H), 0.92 (d, 
J = 6.4 Hz, 3 H), 0.90 (s, 9 H), 0.89 (s, 9 H), 0.11 (s, 3 H), 0.11 (s, 3 H), 0.07 (s, 3 H), 0.06 (s, 
3 H); 13C NMR (100 MHz, CDCl3) δ 178.4, 132.7, 127.4, 74.4, 68.8, 66.1, 62.9, 51.2, 47.5, 
38.7, 37.0, 35.6, 29.8, 27.3, 26.5, 26.1, 26.0, 25.6, 22.0, 20.8, 19.5, 18.4, 18.1, 16.3, –3.9, –4.7, 
–5.2, –5.3; HRMS (ESI–TOF) calcd for C34H70O5Si2Na [M + Na]+ 637.4659, found 
637.4659. 
Alcohol 71. To a mixture of alcohol 70a (1.10 g, 1.79 mmol) and TBAI (212 mg, 0.573 
mmol) in CH2Cl2 (3.6 mL) were added i-Pr2NEt (1.84 mL, 10.7 mmol) and MOMCl (0.68 
mL, 8.95 mmol) at room temperature. After the mixture was stirred at 40 °C for 3 h, the 
reaction was quenched with saturated aqueous NH4Cl. The mixture was diluted with EtOAc, 
washed with saturated aqueous NH4Cl, saturated aqueous NaHCO3, H2O, and brine, and then 
dried over Na2SO4. Concentration and short column chromatography (hexane/EtOAc = 50:1, 
30:1) gave the corresponding MOM ether (1.14 g), which was used for the next step without 
further purification. 
To a solution of the bis-TBS ether obtained above (1.14 g) in MeOH (8.7 mL) and CH2Cl2 
(8.7 mL) was added CSA (121 mg, 0.519 mmol) at 0 °C. After the mixture was stirred at the 
same temperature for 1 h, the reaction was quenched with Et3N. The mixture was diluted with 
EtOAc, washed with H2O and brine, and then dried over Na2SO4. Concentration and column 
chromatography (hexane/EtOAc = 40:1, 15:1, 5:1) gave alcohol 71 (408 mg) and the bis-TBS 
ether (577 mg). 
To a solution of the bis-TBS ether recovered above (577 mg) in MeOH (4.4 mL) and 
CH2Cl2 (4.4 mL) was added CSA (61.1 mg, 0.263 mmol) at 0 °C. After the mixture was 
stirred at the same temperature for 1 h, the reaction was quenched with Et3N. The mixture 
was diluted with EtOAc, washed with H2O and brine, and then dried over Na2SO4. 
Concentration and column chromatography (hexane/EtOAc = 30:1, 15:1, 5:1) gave alcohol 71 
(224 mg) and the bis-TBS ether (274 mg). 
To a solution of the bis-TBS ether recovered above (274 mg) in MeOH (2.2 mL) and 
CH2Cl2 (2.2 mL) was added CSA (29.0 mg, 0.125 mmol) at 0 °C. After the mixture was 
stirred at the same temperature for 1 h, the reaction was quenched with Et3N. The mixture 
was diluted with EtOAc, washed with H2O and brine, and then dried over Na2SO4. 
Concentration and column chromatography (hexane/EtOAc = 30:1, 10:1, 5:1) gave alcohol 71 
(97.3 mg) and the bis-TBS ether (151 mg). 
To a solution of the bis-TBS ether recovered above (151 mg) in MeOH (1.0 mL) and 
CH2Cl2 (1.0 mL) was added CSA (14.5 mg, 57.9 μmol) at 0 °C. After the mixture was stirred 
at the same temperature for 2 h, the reaction was quenched with Et3N. The mixture was 
diluted with EtOAc, washed with H2O and brine, and then dried over Na2SO4. Concentration 
and column chromatography (hexane/EtOAc = 30:1, 10:1, 5:1) gave alcohol 71 (53.9 mg, 
totally 783 mg, 83% in two steps) and the bis-TBS ether (46.3 mg). Alcohol 71: colorless oil; 
Rf = 0.35 (hexane/EtOAc = 4:1); [α]D26 –13.5 (c 1.00, CHCl3); IR (neat) 3501, 2957, 2928, 
2852, 1730 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.18 (t, J = 6.8 Hz, 1 H), 4.62 (d, J = 6.4 Hz, 
1 H), 4.54 (d, J = 6.4 Hz, 1 H), 4.11–4.06 (m, 2 H), 3.98–3.95 (m, 2 H), 3.69 (dd, J = 11.6, 5.6 
Hz, 1 H), 3.61 (dd, J = 11.0, 4.4 Hz, 1 H), 3.33 (s, 3 H), 2.31–2.20 (m, 2 H), 2.09–1.96 (m, 2 
H), 1.69–1.63 (m, 2 H), 1.65 (s, 3 H), 1.58–1.53 (m, 1 H), 1.47–1.32 (m, 2 H), 1.26–1.17 (m, 
2 H), 1.19 (s, 9 H), 1.04 (d, J = 6.8 Hz, 3 H), 0.96 (d, J = 6.8 Hz, 3 H), 0.92 (d, J = 6.8 Hz, 3 
H), 0.90 (s, 9 H), 0.12 (s, 3 H), 0.08 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 178.5, 132.2, 
127.4, 95.4, 75.2, 72.0, 66.5, 62.8, 55.7, 50.4, 43.3, 38.7, 36.9, 35.5, 29.8, 27.3, 26.0, 25.6, 
25.6, 22.4, 21.6, 19.5, 18.3, 16.2, –3.9, –4.3; HRMS (ESI–TOF) calcd for C30H60O6SiNa [M 
+ Na]+ 567.4057, found 567.4054. 
Alkene 72. To a solution of alcohol 71 (1.01 g, 1.85 mmol) in CH2Cl2 (19 mL) were added 
PhI(OAc)2 (912 mg, 2.83 mmol) and TEMPO (89.2 mg, 0.570 mmol) at room temperature. 
After the mixture was stirred at the same temperature for 7 h, the reaction was quenched with 
saturated aqueous Na2S2O3. The mixture was diluted with EtOAc, washed with saturated 
aqueous NaHCO3, H2O, and brine, and then dried over Na2SO4. Concentration and short 
column chromatography (hexane/EtOAc = 40:1, 15:1) gave the corresponding aldehyde (1.01 
g), which was used for the next step without further purification. 
To a suspension of Ph3P+CH3Br− (1.68 g, 4.70 mmol) in THF (9.0 mL) was added NaHMDS 
(1.0 M in THF, 4.5 mL, 4.50 mmol) at 0 °C. After the mixture was stirred at the same 
temperature for 20 min, to the mixture was added the aldehyde obtained above (1.01 g) in 
THF (4.0 mL + 3.0 mL + 3.0 mL) at 0 °C. After the mixture was stirred at the same 
temperature for 1 h, the reaction was quenched with saturated aqueous NH4Cl. The mixture 
was diluted with EtOAc, washed with H2O and brine, and then dried over Na2SO4. 
Concentration and column chromatography (hexane/EtOAc = 70:1, 30:1) gave alkene 72 (816 
mg, 81% in two steps): colorless oil; Rf = 0.57 (hexane/ EtOAc = 10:1); [α]D25 –10.6 (c 0.98, 
CHCl3); IR (neat) 2957, 2927, 1731 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.94 (ddd, J = 17.2, 
10.4, 6.8 Hz, 1 H), 5.18–5.12 (m, 2 H), 5.04 (ddd, J = 10.4, 2.0, 1.2 Hz, 1 H), 4.57 (d, J = 8.0 
Hz, 1 H), 4.46 (d, J = 8.0 Hz, 1 H), 4.45–4.43 (m, 1 H), 4.12–4.06 (m, 2 H), 3.87 (td, J = 6.8, 
2.8 Hz, 1 H), 3.32 (s, 3 H), 2.26 (d, J = 4.0 Hz, 2 H), 2.05–1.96 (m, 3 H), 1.71–1.65 (m, 1 H), 
1.62 (s, 3 H), 1.48–1.32 (m, 3 H), 1.26–1.15 (m, 2 H), 1.20 (s, 9 H), 1.04 (d, J = 6.8 Hz, 3 H), 
1,03 (d, J = 6.8 Hz, 3 H), 0.92 (d, J = 6.4 Hz, 3 H), 0.89 (s, 9 H), 0.07 (s, 3 H), 0.03 (s, 3 
H); 13C NMR (100 MHz, CDCl3) δ 178.5, 141.9, 132.6, 127.1, 114.1, 96.1, 75.7, 73.0, 62.9, 
55.6, 53.8, 44.1, 38.8, 36.9, 35.6, 29.8, 27.3, 26.1, 25.8, 25.6, 22.9, 21.8, 19.5, 18.3, 16.2, –3.6, 
–4.5; HRMS (ESI–TOF) calcd for C31H60O5SiNa [M + Na]+ 563.4108, found 563.4105. 
Alcohol 73. To a solution of pivalate 72 (483 mg, 0.893 mmol) in CH2Cl2 (8.9 mL) was 
added DIBAL-H (1.02 M in THF, 2.63 mL, 2.68 mmol) at –78 °C. After the mixture was 
stirred at the same temperature for 1 h, the reaction was quenched with MeOH. The mixture 
was filtered through a Celite pad and washed with EtOAc. Concentration and short column 
chromatography (hexane/EtOAc = 5:1) gave the corresponding alcohol (395 mg), which was 
used for the next step without further purification. 
To a solution of the alcohol obtained above (395 mg) in CH2Cl2 (8.7 mL) were added 
PhI(OAc)2 (416 mg, 1.30 mmol) and TEMPO (42.9 mg, 0.260 mmol) at room temperature. 
After the mixture was stirred at the same temperature for 2 h, the reaction was quenched with 
saturated aqueous Na2S2O3. The mixture was diluted with EtOAc, washed with saturated 
aqueous NaHCO3, H2O, and brine, and then dried over Na2SO4. Concentration and short 
column chromatography (hexane/EtOAc = 10:1) gave the corresponding aldehyde (386 mg), 
which was used for the next step without further purification. 
To a solution of the aldehyde obtained above (386 mg) in THF (7.1 mL) and saturated 
aqueous NH4Cl (1.4 mL) were added ethyl (2-bromomethyl)acrylate (26) (0.27 mL, 2.55 
mmol) and zinc dust (294 mg, 4.49 mmol) at 0 °C. The mixture was stirred at the same 
temperature for 30 min. The mixture was filtered through a Celite pad and washed with 
EtOAc. The mixture was concentrated, washed with H2O and brine, and then dried over 
Na2SO4. Concentration and column chromatography (hexane/EtOAc = 7:1, 4:1) gave alcohol 
73 (468 mg, 92% in three steps) as a 1:1 diastereomeric mixture: colorless oil; Rf = 0.37 
(hexane/EtOAc = 4:1); IR (neat) 3465, 2955, 2928, 2857, 1716, 1630 cm–1; 1H NMR (400 
MHz, CDCl3) δ 6.26–6.25 (m, 1 H), 5.93 (ddd, J = 17.2, 10.4, 6.8 Hz, 1 H), 5.65 (s, 1 H), 
5.19–5.12 (m, 2 H), 5.03 (d, J = 10.4 Hz, 1 H), 4.57 (d, J = 6.8 Hz, 1 H), 4.49 (d, J = 6.8 Hz, 
1 H), 4.45–4.42 (m, 1 H), 4.26–4.18 (m, 2 H), 3.86–3.84 (m, 2 H), 3.32 (s, 3 H), 2.63–2.53 (m, 
1 H), 2.37–2.24 (m, 3 H), 2.12–1.96 (m, 4 H), 1.71–1.65 (m, 1 H) 1.62 (s, 3 H), 1.47–1.37 (m, 
3 H), 1.31 (t, J = 7.2 Hz, 3 H), 1.26–1.15 (m, 2 H), 1.04 (d, J = 6.4 Hz, 3 H), 1.02 (d, J = 6.4 
Hz, 3 H), 0.94 (d, J = 6.8 Hz, 1.5 H), 0.90 (d, J = 6.8 Hz, 1.5 H), 0.88 (s, 9 H), 0.06 (s, 3 H), 
0.03 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 167.5, 142.0, 137.8, 132.5, 132.4, 127.3, 127.3,  
114.1, 96.1, 75.7, 73.0, 68.7, 68.3, 61.0, 55.6, 53.8, 44.8, 44.8, 44.0, 41.3, 40.7, 37.8, 36.8, 
29.5, 29.2, 26.1, 25.8, 25.6, 25.5, 22.8, 21.8, 20.2, 19.2, 18.3, 16.2, 14.3, –3.6, –4.5; HRMS 
(ESI–TOF) calcd for C32H60O6SiNa [M + Na]+ 591.4057, found 591.4059. 
Alcohol 74. To a solution of alcohol 73 (468 mg, 0.823 mmol) in CH2Cl2 (1.6 mL) were 
added p-methoxybenzyl 2,2,2-trichloroacetimidate (0.36 mL, 2.06 mmol) and PPTS (104 mg, 
0.412 mmol) at room temperature. After the mixture was stirred at 40 °C for 16 h, the reaction 
was quenched with saturated aqueous NaHCO3. The mixture was diluted with EtOAc, 
washed with H2O and brine, and then dried over Na2SO4. Concentration and short column 
chromatography (hexane/EtOAc = 10:1, 4:1) gave the corresponding PMB ether (217 mg) 
and alcohol 73 (318 mg including impurity). 
To a solution of alcohol 73 recovered above (318 mg including impurity) in CH2Cl2 (0.9 
mL) were added p-methoxybenzyl 2,2,2-trichloroacetimidate (0.20 mL, 1.15 mmol) and 
PPTS (60.3 mg, 0.239 mmol) at room temperature. After the mixture was stirred at 40 °C for 
13 h, the reaction was quenched with saturated aqueous NaHCO3. The mixture was diluted 
with EtOAc, washed with H2O and brine, and then dried over Na2SO4. Concentration and 
short column chromatography (hexane/EtOAc = 10:1, 4:1) gave the corresponding PMB ether 
(136 mg) and alcohol 73 (224 mg including impurity). 
To a solution of alcohol 73 recovered above (224 mg including impurity) in CH2Cl2 (0.8 
mL) were added p-methoxybenzyl 2,2,2-trichloroacetimidate (0.17 mL, 0.985 mmol) and 
PPTS (49.7 mg, 0.197 mmol) at room temperature. After the mixture was stirred at 40 °C for 
14 h, the reaction was quenched with saturated aqueous NaHCO3. The mixture was diluted 
with EtOAc, washed with H2O and brine, and then dried over Na2SO4. Concentration and 
short column chromatography (hexane/EtOAc = 7:1, 4:1) gave the corresponding PMB ether 
(83.1 mg) and alcohol 73 (159 mg including impurity). The combined PMB ether (436 mg) 
was used for the next step without further purification. 
To a solution of the TBS ether obtained above (436 mg) in THF (6.3 mL) was added TBAF 
(1.0 M in THF, 1.9 mL, 1.90 mmol) at room temperature. After the mixture was stirred at 
60 °C for 12 h, the mixture was diluted with EtOAc, washed with H2O and brine, and then 
dried over Na2SO4. Concentration and column chromatography (hexane/EtOAc = 5:1) gave 
alcohol 74 (266 mg, 56% in two steps): colorless oil; Rf = 0.58 (hexane/EtOAc = 2:1); IR 
(neat) 3483, 2955, 2929, 2870, 1714, 1613 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.26–7.21 (m, 
2 H), 6.85 (dd, J = 8.0, 2.8 Hz, 2 H), 6.21 (s, 0.5 H), 6.21 (s, 0.5 H), 6.01 (ddd, J = 17.2, 10.8, 
6.0 Hz, 1 H), 5.62 (s, 0.5 H), 5.61 (s, 0.5 H), 5.30 (dd, J = 17.2, 1.6 Hz, 1 H), 5.20–5.12 (m, 2 
H), 4.60 (d, J = 6.8 Hz, 1 H), 4.53 (d, J = 6.8 Hz, 1 H), 4.50–4.38 (m, 3 H), 4.23–4.16 (m, 2 
H), 3.96–3.92 (m, 1 H), 3.79 (s, 1.5 H), 3.79 (s, 1.5 H), 3.67–3.59 (m, 1 H), 3.34 (s, 3 H), 2.69 
(dd, J = 13.6, 6.0 Hz, 0.5 H), 2.56–2.32 (m, 2.5 H), 2.20 (dd, J = 13.6, 4.4 Hz, 0.5 H), 
2.05–1.89 (m, 2.5 H), 1.67–1.52 (m, 5 H), 1.61 (s, 3 H), 1.48–1.34 (m, 1 H), 1.32–1.27 (m, 3 
H), 1.21–1.10 (m, 1 H), 1.07–1.02 (m, 6 H), 0.90 (d, J = 6.4 Hz, 1.5 H), 0.80 (d, J = 6.4 Hz, 
1.5 H); 13C NMR (100 MHz, CDCl3) δ 167.1, 159.0, 141.4, 141.3, 137.7, 131.9, 131.8, 130.9, 
129.3, 128.0, 128.0, 127.1, 114.5, 113.7, 96.0, 77.6, 75.6, 75.3, 73.0, 70.9, 70.8, 60.7, 55.7, 
55.3, 51.7, 42.8, 42.0, 41.9, 37.8, 37.6, 36.8, 29.4, 29.0, 26.0, 25.6, 25.5, 22.9, 21.6, 20.1, 29.4, 
16.1, 14.3; HRMS (ESI–TOF) calcd for C34H54O7Na [M + Na]+ 597.3767, found 597.3766. 
Lactone 75. To a solution of ester 74 (12.5 mg, 21.7 μmol) in THF (0.6 mL), MeOH (0.2 
mL), and H2O (0.2 mL) was added LiOH·H2O (1.4 mg, 32.6 μmol) at room temperature. 
After the mixture was stirred at the same temperature for 16 h, to the mixture was added 
LiOH·H2O (2.8 mg, 65.2 μmol) at room temperature. After the mixture was stirred at the 
same temperature for 7 h, the mixture was neutralized with aqueous HCl at 0 °C. The mixture 
was diluted with EtOAc and washed with H2O and brine. The aqueous phase was extracted 
with EtOAc three times and the combined organic phase was dried over Na2SO4. 
Concentration and short column chromatography (hexane/EtOAc = 2:1) gave the 
corresponding carboxylic acid (13.7 mg), which was used for the next step without further 
purification. 
To a solution of MNBA (21.5 mg, 60.2 μmol) and DMAP (14.3 mg, 0.120 mmol) in CH2Cl2 
(7.4 mL) was slowly added the hydroxycarboxylic acid obtained above (13.7 mg) in CH2Cl2 
(1.6 mL at 0.1 mL/h + 1.0 mL at 1.0 mL/h + 1.0 mL at 1.0 mL/h) at 40 °C with a syringe 
pump for 18 h. After the mixture was stirred at the same temperature for further 2 h, the 
reaction was quenched with saturated aqueous NH4Cl. The mixture was diluted with EtOAc, 
washed with saturated aqueous NaHCO3, H2O, and brine, and then dried over Na2SO4. 
Concentration and column chromatography (hexane/EtOAc = 12:1) gave lactone 75 (9.3 mg, 
81% in two steps): colorless oil; Rf = 0.50, 0.44 (hexane/EtOAc = 4:1); IR (neat) 2952, 2927, 
2872, 1714, 1613 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.31–7.18 (m, 2 H), 6.87–6.82 (m, 2 
H), 6.24 (d, J = 2.0 Hz, 0.3 H), 6.15 (d, J = 1.2 Hz, 0.7 H), 6.06 (ddd, J = 15.6, 10.8, 4.9 Hz, 
0.7 H), 5.71–5.53 (m, 2.3 H), 5.44 (t, J = 6.6 Hz, 0.3 H), 5.29–5.15 (m, 2 H), 4.93–4.91 (m, 
0.7 H), 4.67–4.54 (m, 2.7 H), 4.48–4.32 (m, 1.3 H), 3.83–3.77 (m, 2 H), 3.80 (s, 2.1 H), 3.79 
(s, 0.9 H), 3.56–3.42 (m, 1 H), 3.38 (s, 2.1 H), 3.36 (s, 0.9 H), 3.02 (dd, J = 13.4, 3.7 Hz, 0.7 
H), 2.76 (dd, J = 14.1, 3.2 Hz, 0.3 H), 2.39–1.91 (m, 5 H), 1.81–1.68 (m, 1 H), 1.65–1.56 (m, 
2 H), 1.62 (s, 0.9 H), 1.60 (s, 2.1 H), 1.54–1.26 (m, 4 H), 1.15 (d, J = 6.8 Hz, 2.1 H), 1.11 (d, 
J = 6.8 Hz, 2.1 H), 1.06 (d, J = 7.2 Hz, 0.9 H), 1.00 (d, J = 6.8 Hz, 0.9 H), 0.92 (d, J = 6.4 Hz, 
0.9 H), 0.85 (d, J = 6.4 Hz, 2.1 H); 13C NMR (100 MHz, CDCl3) δ 165.9, 165.3, 159.0, 137.9, 
137.7, 135.0, 134.5, 132.5, 131.4, 131.0, 130.7, 129.5, 129.2, 128.4, 127.8, 127.6, 126.6, 
117.6, 115.4, 113.7, 113.6, 96.9, 95.9, 76.1, 75.8, 75.8, 75.4, 74.0, 70.3, 55.9, 55.7, 55.3, 50.4, 
48.1, 45.2, 44.3, 42.5, 38.7, 37.8, 37.6, 36.6, 34.7, 28.4, 26.7, 25.9, 25.6, 24.7, 24.5, 24.0, 22.7, 
21.4, 20.5, 20.4, 20.0, 16.7, 16.6; HRMS (ESI–TOF) calcd for C32H48O6Na [M + Na]+ 
551.3348, found 551.3347. 
Alcohol 76. To a solution of PMB ether 75 (11.1 mg, 21.0 μmol) in CH2Cl2 (0.4 mL) and 
phosphate pH standard solution (0.1 mL) was added DDQ (9.2 mg, 40.5 μmol) at 0 °C. After 
the mixture was stirred at the same temperature for 2 h, the reaction was quenched with 
saturated aqueous NaHCO3. The mixture was diluted with EtOAc, washed with saturated 
aqueous NaHCO3, H2O, and brine, and then dried over Na2SO4. Concentration and column 
chromatography (hexane/EtOAc = 3:1) gave alcohol 76 (7.5 mg, 87%): colorless oil; Rf = 
0.42, 0.30 (hexane/EtOAc = 2:1); IR (neat) 3460, 2954, 2927, 1714, 1628 cm–1; 1H NMR 
(400 MHz, CDCl3) δ 6.29 (d, J = 1.5 Hz, 0.5 H), 6.16 (d, J = 1.4 Hz, 0.5 H), 6.04 (ddd, J = 
17.2, 10.8, 4.9 Hz, 0.5 H), 5.73 (ddd, J = 17.2, 10.8, 6.8 Hz, 0.5 H), 5.67–5.64 (m, 1 H), 5.61 
(s, 0.5 H), 5.53 (t, J = 6.8 Hz, 0.5 H), 5.31–5.15 (m, 2.5 H), 5.00–4.97 (m, 0.5 H), 4.64 (s, 1 
H), 4.63 (d, J = 6.6 Hz, 0.5 H), 4.56 (d, J = 6.6 Hz, 0.5 H), 3.86–3.75 (m, 2 H), 3.38 (s, 1.5 H), 
3.36 (s, 1.5 H), 2.86 (dd, J = 13.4, 3.2 Hz, 0.5 H), 2.72 (dd, J = 13.4, 5.4 Hz, 0.5 H), 
2.41–2.14 (m, 3 H), 2.09–1.96 (m, 2 H), 1.90–1.84 (m, 1 H), 1.64 (s, 1.5 H), 1.63 (s, 1.5 H), 
1.61–1.26 (m, 6 H), 1.13–1.05 (m, 6 H), 1.04–0.98 (m, 1 H), 0.95 (d, J = 6.4 Hz, 1.5 H), 0.92 
(d, J = 6.8 Hz, 1.5 H); 13C NMR (100 MHz, CDCl3) δ 165.8, 165.4, 137.9, 137.7, 135.0, 
134.5, 132.4, 131.5, 128.3, 128.0, 126.7, 117.8, 115.3, 97.0, 95.9, 76.3, 76.0, 75.4, 74.3, 69.2, 
68.8, 55.9, 55.7, 50.2, 48.4, 45.1, 45.1, 44.3, 42.2, 40.9, 40.5, 36.7, 34.9, 29.1, 27.0, 25.9, 25.6, 
24.7, 24.4, 24.0, 23.0, 21.3, 20.6, 20.4, 20.3, 16.6; HRMS (ESI–TOF) calcd for C24H40O5Na 
[M + Na]+ 431.2773, found 431.2778. 
Ketone 78. To a solution of triene 76 (31.7 mg, 77.6 μmol) in toluene (5.1 mL) was added 
the second-generation Hoveyda–Grubbs catalyst (33) (11.7 mg, 18.7 μmol) at room 
temperature. After the mixture was stirred at 100 °C for 22 h, the mixture was filtered through 
short column chromatography (EtOAc). Concentration and column chromatography 
(hexane/EtOAc = 7:1, 4:1, 1:1) gave butenolide 77 (11.0 mg) and triene 76 (9.9 mg, 31% 
recovery). Butenolide 77 (11.0 mg) was used for the next step without further purification. 
To a solution of alcohol 77 obtained above (11.0 mg) in CH2Cl2 (0.5 mL) were added 
PhI(OAc)2 (14.0 mg, 43.4 μmol) and TEMPO (1.3 mg, 8.67 μmol) at room temperature. The 
mixture was stirred at the same temperature for 2 h. Column chromatography (hexane/EtOAc 
= 5:1) gave ketone 78 (6.2 mg, 21% in two steps, 31% based on recovered 76 in two steps): 
colorless oil; Rf = 0.61 (hexane/EtOAc = 1:1); [α]D27 +97.0 (c 0.29, CHCl3); IR (neat) 2955, 
2920, 2849, 1759, 1705 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.50 (s, 1 H), 5.18 (d, J = 11.2 
Hz, 1 H), 4.94 (d, J = 7.2 Hz, 1 H), 4.71 (d, J = 7.2 Hz, 1 H), 4.54 (d, J = 7.2 Hz, 1 H), 3.73 
(dd, J = 11.2, 3.2 Hz, 1 H), 3.54 (d, J = 14.8 Hz, 1 H), 3.40 (s, 3 H), 3.22 (d, J = 14.8 Hz, 1 H), 
2.51 (dd, J = 12.0, 5.6 Hz, 1 H), 2.31–2.20 (m, 2 H), 2.17–2.05 (m, 4 H), 1.65 (s, 3 H), 
1.62–1.44 (m, 4 H), 1.23 (t, J = 6.8 Hz, 3 H), 1.13 (d, J = 7.2 Hz, 3 H), 0.87 (d, J = 6.8 Hz, 3 
H); 13C NMR (100 MHz, CDCl3) δ 205.1, 172.1, 151.8, 131.9, 127.8, 127.7, 94.9, 81.9, 76.9, 
55.9, 50.4, 50.1, 41.4, 40.5, 35.4, 29.7, 29.7, 25.8, 25.3, 24.2, 19.9, 18.8, 18.3; HRMS 
(ESI–TOF) calcd for C22H34O5Na [M + Na]+ 401.2304, found 401.2299. 
Acetate 69. To a solution of MOM ether 78 (6.2 mg, 16.4 μmol) in i-PrOH (0.5 mL) was 
added concentrated aqueous HCl (10 μL) at room temperature. After the mixture was stirred 
at 50 °C for 5 h, the reaction was quenched with saturated aqueous NaHCO3. The mixture 
was diluted with EtOAc, washed with H2O and brine, and then dried over Na2SO4. 
Concentration and short column chromatography (hexane/EtOAc = 1:1) gave the 
corresponding alcohol (5.0 mg), which was used for the next step without further purification. 
To a solution of the alcohol obtained above (5.0 mg) in CH2Cl2 (0.5 mL) were added 
pyridine (6.3 μL, 77.5 μmol) and AcCl (4.6 μL, 65.6 μmol) at 0 °C. After the mixture was 
stirred at the same temperature for 20 min, the reaction was quenched with saturated aqueous 
NH4Cl. The mixture was diluted with EtOAc, washed with H2O and brine, and then dried 
over Na2SO4. Concentration and column chromatography (hexane/EtOAc = 4:1) gave acetate 
69 (3.7 mg, 60% in two steps): colorless oil; Rf = 0.58 (hexane/EtOAc = 1:1); [α]D26 +31.7 (c 
0.08, CHCl3); literature10c [α]D20 +32 (c 1.08, CHCl3); IR (neat) 3435, 2922, 2851, 1761, 
1733, 1646 cm–1; 1H and 13C NMR Table S14, HRMS (ESI–TOF) calcd for C22H32O5Na [M 
+ Na]+ 399.2148, found 399.2148. 
Cell Growth-Inhibitory Activity. HL60 cells were cultured at 37 °C with 5% CO2 in RPMI 
(Nissui, Tokyo, Japan) supplemented with 10% heat-inactivated fetal bovine serum (FBS; 
Sigma-Aldrich Co., St. Louis, MO), 100 units/mL penicillin, 100 μg/mL streptomycin, 0.25 
μg/mL amphotericin, 300 μg/mL L-glutamine, and 2.25 mg/mL NaHCO3. HL60 cells were 
seeded at 1 × 104 cells/well in 96-well plates (Iwaki, Tokyo, Japan). Various concentrations of 
the synthetic compounds were then added, and cells were incubated for 72 h. Cell 
proliferation was measured by the MTT assay. 
Antifouling Activity and Toxicity. Adult barnacles of Balanus (Amphibalanus) amphitrite 
were collected at Mega fishing port (Himeji, Hyogo, Japan) and maintained in aquaria at 20 ± 
1 °C by feeding with brine shrimp (Artemia salina) nauplii for one week. Cypris larvae of 
barnacle Balanus (Amphibalanus) amphitrite were obtained by larval culture in the laboratory 
according to the method reported by Nogata and co-workers.62 Obtained cypris larvae were 
aged for 2–3 days prior to use at 5 °C in the dark. The effects of the synthetic compounds on 
the barnacle cyprids settlement were tested using 24-well polystyrene plates (Corning, NY, 
USA) according to our previous report.63 Each compound was dissolved in MeOH. If the 
compound did not dissolve in MeOH, it was dissolved in a small amount of DMSO. Aliquots 
of the solution were applied to wells of 24-well polystyrene plates (0.1, 0.3, 1.0, 3.0, 10, and 
50 μg) and air-dried. DMSO alone showed no effects on larval settlement at the concentration 
used in this assay (0.2%). Approximately 10 cypris larvae were added to each well filled with 
filtered natural seawater (28 psu) at final volume of 1.0 mL. After the incubation at 25 °C in 
the dark for 96 h, the number of larvae, which settled (including metamorphosed larvae), died, 
or did not settle, was counted under a microscope. Each level of the experiments was carried 
out with three wells and the assay was repeated three times. The assay was performed with 
CuSO4 (0.01, 0.03, 0.1, 0.3, 1.0, 3.0, and 10 μg) as a positive control. The assay without 
compound was performed as a control. The antifouling activity and toxicity were expressed as 
EC50 and LC50 values, respectively. The EC50 and LC50 values were calculated by probit 
analysis according to Nogata’s report.64 When probit analysis could not be applied to calculate 
the values, these were estimated by straight-line graphical interpolation. 
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Stereochemical determination of the synthetic products, NMR data comparison of the natural 
products and the synthetic products, computed geometries and energies of 1a and 1b, and 
NMR spectra of all compounds (PDF) 
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